{"Title": ["Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics", "CRISPR Therapeutics and Vertex Pharmaceuticals Deliever New CTX001 Data", "IBB, VRTX, BIIB, ILMN: Large Outflows Detected at ETF", "Tuesday Sector Leaders: Technology & Communications, Healthcare", "BUZZ-U.S. STOCKS ON THE MOVE-Fate Therapeutics, Tiffany, MoneyGram", "Worried Another Stock Market Crash Is Coming? 3 Things You Should Do Right Now", "3 Top Biotech Stocks to Buy in June", "2 Healthcare Stocks That Have a Killer Advantage", "Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics", "CRISPR Therapeutics and Vertex Pharmaceuticals Deliever New CTX001 Data", "IBB, VRTX, BIIB, ILMN: Large Outflows Detected at ETF", "Tuesday Sector Leaders: Technology & Communications, Healthcare", "BUZZ-U.S. STOCKS ON THE MOVE-Fate Therapeutics, Tiffany, MoneyGram", "Worried Another Stock Market Crash Is Coming? 3 Things You Should Do Right Now", "3 Top Biotech Stocks to Buy in June", "2 Healthcare Stocks That Have a Killer Advantage", "Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics", "Here's Why You Might Not Want to Buy Stocks Right Now", "Noteworthy ETF Inflows: MTUM, BMY, ABBV, VRTX", "2 Top Biotech Picks for May", "3 Great Stocks to Buy If You Get a Second Stimulus Check", "Vertex Pharmaceuticals Reaches Analyst Target Price", "2 Top Gene Editing Stocks to Watch in June", "Monday Sector Leaders: Healthcare, Technology & Communications", "If You'd Invested $10,000 in Moderna's IPO, Here's How Much Money You'd Have Now", "3 Top Biotech Stocks to Buy in May", "Moderna\u2019s Potential COVID-19 Vaccine Isn\u2019t the Only Reason It\u2019s Worth a Buy", "3 Reasons to Buy Vertex Pharmaceuticals Stock Right Now", "Here's My Top Stock to Buy in May", "Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals", "Vertex: KALYDECO Gets European CHMP Positive Opinion For CF In Children", "Interesting VRTX Put And Call Options For June 12th", "BUZZ-U.S. STOCKS ON THE MOVE-Cellect Biotechnology, Under Armour, AMC Entertainment", "BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Valaris, QEP Resources", "Better Buy: Crispr Therapeutics vs. bluebird bio", "Vertex Pharmaceuticals Inc (VRTX) Q1 2020 Earnings Call Transcript", "Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates", "Vertex Pharmaceuticals Q1 20 Earnings Conference Call At 5:00 PM ET", "How These 15 Stock Suggestions Fared Against the Market", "Nasdaq 100 Movers: DXCM, NXPI", "IBB, GILD, VRTX, BIIB: ETF Inflow Alert", "BUZZ-U.S. STOCKS ON THE MOVE-Kohl's, tanker operators, oil and gas companies, U.S. casinos", "First Week of June 19th Options Trading For Vertex Pharmaceuticals (VRTX)", "These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?", "Noteworthy ETF Inflows: IBB, VRTX, BIIB, REGN", "What's The Best Biotech Stock to Buy for Treating Sickle Cell Disease?", "Drug trial specialists see coronavirus-fueled spike in demand for virtual services", "VRTX Crosses Above Average Analyst Target", "BUZZ-U.S. STOCKS ON THE MOVE-Regeneron, Zoom Video, U.S. oil companies, Apple, U.S. insurers", "2 Great Stocks You Can Buy and Hold Forever", "Should You Buy Biotech Stocks Right Now?", "3 Top Biotech Stocks to Buy in April", "Have An Extra $1,000? Buy These 2 Biotech Stocks", "Where Will Vertex Pharmaceuticals Be in 1 Year?", "Wednesday Sector Laggards: Healthcare, Consumer Products", "Should I Trade My Growth Stocks for Value Stocks?", "Drug trial specialists see coronavirus-fueled spike in demand for virtual services", "Better Buy: Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals", "Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?", "IBB, VRTX, BIIB, ILMN: ETF Outflow Alert", "Nasdaq 100 Movers: AAL, VRTX", "4 Reasons Drug Stocks Are a Buy Right Now", "My Top Healthcare Stocks to Buy in the Market Crash", "Vertex Pharmaceuticals to Pause Some Clinical Trials", "3 Top Biotech Stocks to Buy Now", "Vertex Pharma Confirms 2020 Business Outlook, Supply Chain Continuity", "4 Reasons Biotech Stocks Are a Buy Right Now", "3 Stocks to Buy to Make Your Coronavirus Lockdown a Profitable One", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Coronavirus Crisis: 3 Biotech Stocks to Buy Right Now", "Nasdaq 100 Movers: MAR, CTXS", "S&P 500 Movers: WCG, CTXS", "First Week of May 15th Options Trading For Vertex Pharmaceuticals (VRTX)", "First Week of May 1st Options Trading For Vertex Pharmaceuticals (VRTX)", "5 Biotech Stocks to Buy for a Strong Growth Prognosis", "IBB, GILD, VRTX, BIIB: Large Outflows Detected at ETF", "With the Market Down, I'm Buying These 3 Stocks", "How to Be Greedy When Others Are Fearful", "Vertex Pharma Says No Coronavirus Impact On Supply Chain Or 2020 Outlook", "2 Biotech Stocks to Buy as Coronavirus Fears Tank the Market", "Why Biogen, GW Pharmaceuticals, and Vertex Pharmaceuticals Stocks Jumped Today", "Is iShares Nasdaq Biotechnology Index Fund a Buy?", "3 Biotech Stocks That Are Coronavirus Safe Havens", "Analysts Predict 13% Upside For TQQQ", "3 Top Healthcare Stocks to Buy in March", "All the Stocks I'm Selling If the Coronavirus Keeps Spreading", "Can CRISPR Therapeutics Double Your Money in 2020?", "Noteworthy ETF Inflows: IBB, GILD, VRTX, BIIB", "Hematology-Focused Biotech Imara to IPO Soon", "Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease", "Better Buy: CRISPR Therapeutics vs. Intellia", "Better Buy: Vertex Pharmaceuticals vs. Incyte", "Stock Alert: VRTX Trading Close To 52-Week High", "IBB, GILD, VRTX, BIIB: ETF Outflow Alert", "3 Best Biotech Stocks to Buy for the Next Decade", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "What Happens With AbbVie If Its Allergan Buyout Is Blocked?", "2 Ultra-Risky Stocks That Could Make You Filthy Rich", "Where Will Vertex Pharmaceuticals Be in 10 Years?", "Is Vertex Pharmaceuticals Stock Still a Strong Buy?", "Vertex Pharmaceuticals Inc (VRTX) Q4 2019 Earnings Call Transcript", "Vertex Pharma (VRTX) Q4 Results Trounce Estimates, Sees Stronger 2020", "Vertex Pharmaceuticals Reports Q4 Financial Earnings, Beats Estimates", "Vertex Pharmaceuticals Inc. Q4 adjusted earnings Beat Estimates", "3 Biotech Companies Analyzed", "Noteworthy ETF Outflows: IBB, GILD, VRTX, BIIB", "3 Biotech Start-Ups That Could Soar in 2020", "Vertex's $950 Million Bet That Could Pay Off Big-Time for Investors", "Better Buy: Vertex Pharmaceuticals vs. Galapagos", "March 6th Options Now Available For Vertex Pharmaceuticals (VRTX)", "2 Ultra-Expensive Biotech Stocks Still Worth Buying", "Interesting VRTX Put And Call Options For March 20th", "Vertex Pharmaceuticals Q4 19 Earnings Conference Call At 4:30 PM ET", "3 Top Biotech Picks for 2020", "2 Biotech Stocks to Watch In 2020", "Are Biotech Stocks Due for a Correction in 2020?", "These 3 Momentum Stocks Have Room for Further Upside, Says Jefferies", "Vertex Pharma To Present At The J.P. Morgan Conference; Webcast At 2:30 PM ET", "IBB, GILD, VRTX, BIIB: Large Inflows Detected at ETF", "Why Has Vertex Pharmaceuticals' Stock Gained 30% In The Last Quarter?", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Why Your 2020 Resolution Should Be to Buy More Healthcare Stocks", "Notable Wednesday Option Activity: GIII, VRTX, ACM", "Wednesday Sector Leaders: Healthcare, Technology & Communications", "Monday Sector Leaders: Energy, Healthcare", "3 High-Growth Stocks That Can Soar", "3 Top Stocks to Buy in January", "Is Vertex Pharmaceuticals Stock a Buy?", "Here's Why CRISPR Therapeutics Stock Jumped 113.2% in 2019", "IBB, GILD, VRTX, BIIB: ETF Outflow Alert", "5 Stocks to Buy in January", "The 3 Best Healthcare Stocks to Buy for 2020", "Notable ETF Outflow Detected - RPG, KEYS, ADSK, VRTX", "Why 2020 Should Be the Biggest Year Yet for CRISPR Gene-Editing Stocks", "Why Longer-Term Investors Should Buy Amarin Stock on Weakness", "5 Biotech Stocks to Buy for a Strong Growth Prognosis", "Better Buy: Crispr Therapeutics vs. Editas", "Here's Why Proteostasis Therapeutics Stock Plummeted Today", "IBB, GILD, VRTX, ILMN: ETF Outflow Alert", "3 Top Healthcare Stocks to Buy in December", "Despite Massive Gains This Year, This Biotech Stock Is a Risky Bet", "Here's Why Vertex Pharmaceuticals Rose 13.4% in November", "Here's Why CRISPR Therapeutics Jumped 42.2% in November", "3 Top Biotech Stocks to Buy in December", "Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals", "IBB, GILD, VRTX, ILMN: Large Outflows Detected at ETF", "CRISPR vs. Gene Therapy Round 1: What Investors Need to Know", "2 Small-Cap Biotechs That Soared Last Week", "3 Top Healthcare Stocks to Buy Now", "More CRISPR Stock Catalysts Ahead", "Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?", "S&P 500 Analyst Moves: VRTX", "5 New Drug Approvals the FDA Gave Top Priority", "Check Out These 5 Fast-Growing Stocks to Buy", "Health Care Sector Update for 11/19/2019: MDCO,NVS,MYOV,CRSP,VRTX,KRTX", "Here's Why CRISPR Stocks Are Soaring Today", "Health Care Sector Update for 11/19/2019: MYOV,CRSP,VRTX,KRTX", "Drug Approvals, Upbeat Earnings Help Vertex Pharmaceuticals' Stock Jump 20% In A Month", "The Best Biotech Stock to Buy Right Now", "Here's Why Solid Biosciences Collapsed Today", "Here's Why CRISPR Therapeutics Stock Is Falling Today", "2 Beaten-Down Biotech Stocks That Could Make You Rich", "3 Top Stocks to Buy in November", "Why the Opioid Crisis Makes Vertex Pharmaceuticals a Buy", "Noteworthy ETF Outflows: IBB, CELG, GILD, VRTX", "Vertex Pharmaceuticals Inc (VRTX) Q3 2019 Earnings Call Transcript", "2 Top Healthcare Stocks Every Investor Should Own", "Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "3 Reasons CRISPR Therapeutics Stock Can Reach Record Highs Again", "Vertex Pharmaceuticals Gains FDA Approval for Cystic Fibrosis Drug", "Better Buy: Vertex Pharmaceuticals vs. Incyte", "5 Top Healthcare ETFs", "5 Biotech Stocks to Buy for a Strong Growth Prognosis", "2 Things Just Happened That Make Vertex Pharmaceuticals Stock a Screaming Buy", "First Trust NYSE Arca Biotechnology Index Fund Experiences Big Outflow", "Notable Wednesday Option Activity: WHR, VRTX, CBS", "Implied RPG Analyst Target Price: $132", "Vertex In Deal With NHS England For Access To All Licensed CF Medicines", "5 Healthcare Stocks to Buy", "Odonate On The Move With CONTESSA, FDA Snubs CLSD, It's A Yes For AZN, VRTX", "2 High-Growth Stocks to Buy Right Now", "IBB, CELG, VRTX, ILMN: Large Outflows Detected at ETF", "10 High-Quality, High-Growth Stocks to Buy", "3 Reasons BioMarin Pharmaceutical Stock Is a Buy Right Now", "3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year", "Check Out These 5 Fast-Growing Stocks to Buy", "Interesting VRTX Put And Call Options For November 22nd", "Forget Vertex Pharmaceuticals; CRISPR Therapeutics Is a Better Biotech Growth Stock", "A Biotech Set to Dominate the Next 20 Years", "3 Top Biotech Stocks to Buy Right Now", "Noteworthy ETF Outflows: IBB, CELG, VRTX, ILMN", "5 Large-Cap Stocks With Growth in the Tank", "Better Buy: Vertex Pharmaceuticals vs. Galapagos", "2 Pharma Stocks You Should Buy Now", "Vertex Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for VRTX", "First Week of January 2022 Options Trading For Vertex Pharmaceuticals (VRTX)", "3 Top Stocks You Can Buy and Hold for the Next Decade", "Is iShares Nasdaq Biotechnology Index Fund a Buy?", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "3 Top Healthcare Stocks to Buy Right Now", "Wednesday Sector Laggards: Utilities, Healthcare", "Vertex Pharmaceuticals' $950 Million Bet on Curing Type 1 Diabetes Could Have an Astronomical Payoff", "3 Healthcare Stocks That Have a Killer Advantage", "3 Top Biotech Stocks to Buy Right Now", "Noteworthy ETF Outflows: IBB, GILD, CELG, VRTX", "3 Big Stock Charts for Tuesday: TechnipFMC PLC, Vertex Pharmaceuticals and Constellation Brands", "Check Out These 5 Fast-Growing Stocks to Buy", "Don\u2019t Blink or You\u2019ll Miss Vertex\u2019s Next Move, And It\u2019s Bound to Be a Good One", "IBB, CELG, VRTX, ILMN: ETF Outflow Alert", "Interesting VRTX Put And Call Options For April 2020", "Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals", "The 10 Largest-Cap Growth Stocks", "Vertex Has \"Significant Financial Firepower\"", "Will This Asteroid Heading Toward Vertex Pharmaceuticals Make Impact?", "Thursday Sector Leaders: Utilities, Healthcare", "Analysts Anticipate 12% Upside For QQEW", "Vertex Pharmaceuticals Inc (VRTX) Q2 2019 Earnings Call Transcript", "Is Intellia Therapeutics a Buy?", "Interesting VRTX Put And Call Options For September 20th", "September 6th Options Now Available For Vertex Pharmaceuticals (VRTX)", "Pfizer Closes in on a Major Spinoff", "3 'Perfect 10' Biotech Companies to Buy", "Where Will CRISPR Therapeutics Be in 5 Years?", "VRTX Makes Bullish Cross Above Critical Moving Average", "5 Biotech Stocks to Buy for a Strong Growth Prognosis", "Look Under The Hood: QQXT Has 10% Upside", "Notable ETF Inflow Detected - IBB, GILD, CELG, VRTX", "2 Supercharged Growth Stocks I'd Buy Right Now", "August 30th Options Now Available For Vertex Pharmaceuticals (VRTX)", "3 Top Biotech Stocks to Buy for the 2nd Half of 2019", "3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals", "Is Vertex Pharmaceuticals a Buy?", "VRTX Crosses Above Key Moving Average Level", "August 23rd Options Now Available For Vertex Pharmaceuticals (VRTX)", "9 Health-Care Stocks for Your Portfolio", "How to Invest in Biotech Stocks", "3 Growth Stocks to Buy and Hold for the Next 50 Years", "August 9th Options Now Available For Vertex Pharmaceuticals (VRTX)", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Here's Why CRISPR Gene Editing Stocks Rose as Much as 32.4% in June", "3 Stocks That Could Double Your Money", "Health Care Sector Update for 06/21/2019: VRTX,CTLT,CTRV,GCG,WEED.TO", "Check Out These 5 Fast-Growing Stocks to Buy Today", "VRTX Makes Bullish Cross Above Critical Moving Average", "Notable ETF Outflow Detected - IBB, GILD, BIIB, VRTX", "3 Cheap Drug Stocks You Can Buy Right Now", "7 Top-Rated Biotech Stocks to Invest In Today", "The 10 Biggest Biotech Stocks", "5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit", "3 Healthcare Stocks I'd Buy Right Now", "Gene Therapy vs. Gene Editing: Which Is Better for Tackling Muscular Dystrophy?", "Health Care Sector Update for 06/07/2019: XFOR,CRSP,VRTX,LJPC,MRTX,AMGN", "Friday Sector Leaders: Healthcare, Services", "Health Care Sector Update for 06/07/2019: CRSP,VRTX,LJPC,MRTX,AMGN", "Here's Why Crispr Therapeutics Rose as Much as 18.7% Today", "3 Big Stock Charts for Friday: Symantec, Vertex Pharmaceuticals and Nektar Therapeutics", "3 Top Gene Therapy Stocks That Could Soar", "3 Big Biotech Stocks That Warren Buffett Might Like", "Noteworthy Thursday Option Activity: INTU, HA, VRTX", "Better Buy: Vertex Pharmaceuticals vs. Galapagos", "5 Growthy Biotech Stocks to Buy Despite the Scrutiny", "Here's My Top Stock to Buy in May", "IBB, BIIB, VRTX, ILMN: Large Outflows Detected at ETF", "July 26th Options Now Available For Vertex Pharmaceuticals (VRTX)", "Better Buy: Vertex Pharmaceuticals vs. Galapagos", "5 Things You Need to Know From Vertex Pharmaceuticals' Q1 Earnings Update", "Vertex Pharmaceuticals Inc (VRTX) Q1 2019 Earnings Call Transcript", "Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates", "Vertex Pharma: FDA Approves Expanded Indication For KALYDECO - Quick Facts", "Health Care Stocks: Buy Them While They're Down", "3 Top Biotech Stocks to Buy Right Now", "Vertex Pharmaceuticals Looks to Jump From 18,000 Patients to 68,000", "2 Best Biotech Buyout Plays", "5 Top Pharmaceutical Stocks to Buy in 2019", "5 Top Biotech Stocks to Buy in 2019", "5 Top Healthcare Stocks to Buy in 2019", "Sum Up The Pieces: QQXT Could Be Worth $58", "Vertex Pharmaceuticals Becomes Oversold (VRTX)", "Notable Wednesday Option Activity: TNDM, VRTX, LLY", "Everything You Need to Know About Investing in Healthcare", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Vertex, CRISPR's Gene Editing Drug Gets FDA's Fast Track Tag", "Notable Wednesday Option Activity: TNDM, VRTX, LLY", "Health Care Sector Update for 04/16/2019: CRSP, VRTX, UNH, JNJ, PFE, ABT, MRK, AMGN", "Why Vertex Pharmaceuticals Could Conceivably Succeed Too Well", "5 Stocks in the Age of Miracles", "The 10 Fastest-Growing Stocks to Invest In Right Now", "VRTX Makes Notable Cross Below Critical Moving Average", "Check Out These 5 Fast-Growing Stocks to Buy Today", "Nasdaq 100 Movers: INTC, ALGN", "Nasdaq 100 Movers: INTC, ALGN", "Vertex Appoints Charles Wagner As New CFO - Quick Facts", "IBB, GILD, CELG, VRTX: Large Outflows Detected at ETF", "3 Top Biotech Stocks to Buy Right Now", "Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics", "Check Out These 7 Fast-Growing Stocks to Buy Today", "May 3rd Options Now Available For Vertex Pharmaceuticals (VRTX)", "Better Buy: Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals", "First Week of VRTX May 17th Options Trading", "First Week of VRTX October 18th Options Trading", "Biotech Stock Roundup: REGN Gets FDA Nod for Dupixent & Other Pipeline News", "CELG vs. VRTX: Which Stock Is the Better Value Option?", "Peek Under The Hood: SPHQ Has 10% Upside", "Proteostasis Plunges on Weak Data From Cystic Fibrosis Study", "Why Is Vertex (VRTX) Down 0.7% Since Last Earnings Report?", "Vertex's VX-445 Triple Combo Cystic Fibrosis Trials Succeed", "Top Research Reports for Amazon, Berkshire Hathaway & Thermo Fisher", "4 Low-Priced Stocks Under $10 for 2019", "Vertex cystic fibrosis triple combo therapy succeeds in important trials", "Vertex's cystic fibrosis therapy meets goal of late-stage studies", "3 Hot Stocks to Buy in March", "Why Vertex's Dilemma Makes It the Best Biotech Stock to Buy Now", "5 Pharmaceutical Stocks With Big Moats and Bridges", "3 Arguments For and Against Buying GW Pharmaceuticals", "Biotech Stock Roundup: ONCE, CMTA Soar on Merger News, Other Pipeline Updates", "CRISPR Therapeutics Up as Dosing Starts in Thalassemia Study", "Health Care Sector Update for 02/25/2019: FOLD,ONCE,CRSP,AKCA,IONS,NVS", "Health Care Sector Update for 02/25/2019: ONCE,CRSP,AKCA,IONS,NVS", "Could Vertex Pharmaceuticals Be a Millionaire-Maker Stock?", "5 Top Stocks to Buy in March", "The Zacks Analyst Blog Highlights: Intercept, Gilead, Vertex, Alkermes and Clovis", "Top Stock Reports for Nike, 3M & Vertex", "Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?", "3 Most Profitable Drugmakers in the S&P 500 -- Are They Buys?", "Here's Why CRISPR Therapeutics Rose 13.5% in January", "Groupon (GRPN) to Report Q4 Earnings: What's in the Cards?", "This Is the Best Biotech Stock on the Market", "The Zacks Analyst Blog Highlights: Nike, 3M, Vertex, PepsiCo and Verisk", "Factors Likely to Influence Cisco's (CSCO) Earnings in Q2", "Factors Expected to Influence Akamai's (AKAM) Q4 Earnings", "The Zacks Analyst Blog Highlights: Gilead, Vertex, Celgene, Alkermes and AVEO", "Vertex Pharmaceuticals: New Drug, Same Great Growth Story", "Vertex (VRTX) Q4 Earnings Beat on Solid CF Products Sales", "Vertex Pharmaceuticals (VRTX) Q4 2018 Earnings Conference Call Transcript", "Biotech Stock Roundup: Celgene Tops in Q4, Gilead Disappoints, ALKS & AVEO Sink", "Check Out These 7 Fast-Growing Stocks to Buy Today", "Vertex Pharmaceuticals Inc. Q4 adjusted earnings Beat Estimates", "Vertex Pharmaceuticals Q4 18 Earnings Conference Call At 4:30 PM ET", "After-Hours Earnings Report for February 5, 2019 : DIS, CB, SU, VRTX, ALL, EA, APC, DLR, MCHP, CERN, PAA, MKL", "S&P 500 Movers: WY, CLX", "Nasdaq 100 Movers: VRTX, LBTYA", "Regeneron (REGN) to Report Q4 Earnings: Is a Beat in Store?", "Qorvo (QRVO) to Report Q3 Earnings: What's in the Cards?", "Vertex Pharmaceuticals (VRTX) Q4 Earnings and Revenues Top Estimates", "March 22nd Options Now Available For Vertex Pharmaceuticals (VRTX)", "Will Gilead (GILD) Q4 Earnings Disappoint on Weak HCV Sales?", "Is a Beat in Store for Vertex (VRTX) This Earnings Season?", "Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?", "Vertex's Kalydeco Wins Health Canada Nod to Treat CF in Kids", "Is a Beat in the Cards for Celgene (CELG) in Q4 Earnings?", "3 Top Biotech Stocks to Buy Right Now", "6 Biotech Stocks to Watch Now", "Merck KGaA Gives Vertex Rights to Two Gene-Editing Compounds", "Vertex Terminates COO Ian Smith on Code of Conduct Violation", "Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth", "CELG or VRTX: Which Is the Better Value Stock Right Now?", "Biotech Stock Roundup: Amgen, Vertex Get EC Nod for Label Expansion of Drugs", "Better Buy: CRISPR Therapeutics vs. Editas Medicine", "Vertex Pharmaceuticals Fires COO Ian Smith", "Is Vertex Pharmaceuticals a Buy?", "Vertex Pharma terminates interim CFO's employment for code violations", "Vertex's Orkambi Wins EU Nod to Treat Cystic Fibrosis in Kids", "Should You Sell CRISPR Therapeutics Following an Analyst Downgrade?", "Why Vertex (VRTX) is Poised to Beat Earnings Estimates Again", "Vertex: EC Approves ORKAMBI To Treat Children With CF Aged 2 To 5 Years Old", "After Hours Most Active for Jan 16, 2019 : INVH, AMD, CVS, TAK, XOM, MU, GE, FOXA, CTL, QQQ, SBUX, VRTX", "3 Biotech Stocks to Watch in 2019", "Vertex Pharma boots out COO for \"personal behavior\" violations", "VRTX March 1st Options Begin Trading", "Moderna (MRNA) Announces Pipeline Progress, Shares Rise", "5 Things to Expect for Vertex Pharmaceuticals in 2019", "Vertex, CRISPR's Sickle Disease Drug Gets FDA's Fast Track Tag", "Better Buy: CRISPR Therapeutics vs. Vertex Pharmaceuticals", "Vertex Joins Forces With Arbor to Build Gene-Editing Therapies", "Bullish Two Hundred Day Moving Average Cross - VRTX", "Noteworthy Friday Option Activity: VRTX, EXAS, WIN", "The Zacks Analyst Blog Highlights: Amgen, Aduro, Vertex, Evofem and Incyte", "Analysts Expect QQXT To Hit $58", "Market Close Report: NASDAQ Composite index closes at 6,528.41 down -108.42 points", "Biotech Stock Roundup: Pipeline Updates From VRTX & AMGN, ADRO Teams Up With LLY", "Vertex's (VRTX) 3rd Study on Pain Drug Meets Primary Endpoint", "3 Biotechs With Potential Blockbusters Near the Finish Line", "Why Dova Pharmaceuticals Is Nosediving Today", "Year in Review: Best CEOs, IPOs, and More", "Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?", "Notable Thursday Option Activity: PDFS, VRTX, WDC", "3 Highest-Growth Stocks in Today's Market", "Better Buy: Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals", "Why Crispr Therapeutics Stock Is Up By 65% So Far in 2018", "Why Crispr Therapeutics Stock Is Up 65% So Far in 2018", "4 'Strong Buy' Stocks Oppenheimer Likes Right Now", "5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019", "Vertex Looks to Capture the Rest of Its Multibillion-Dollar Market", "VRTX Crosses Above Key Moving Average Level", "Nasdaq 100 Movers: SHPG, VRTX", "S&P 500 Movers: UTX, VRTX", "Market Close Report: NASDAQ Composite index closes at 7,082.70 up .85 points", "Health Care Sector Update for 11/27/2018: DVA,VRTX,ACAD,GTHX", "Health Care Sector Update for 11/27/2018: VRTX,HALO,GTHX,ACAD", "Biotech Stock Roundup: Pipeline Updates From CELG & VRTX, ZFGN Plunges on Hold News", "First Week of VRTX July 2019 Options Trading", "Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal", "10 Stocks That Are Screaming Buys Right Now", "Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?", "Vertex (VRTX) Gets Positive CHMP Opinion for Orkambi in Kids", "Celldex (CLDX) Q3 Earnings Beat Estimates, Revenues Miss", "Spectrum (SPPI) Earnings and Sales Beat Estimates in Q3", "Noteworthy Tuesday Option Activity: AVGO, VRTX, TIF", "Jazz Pharma (JAZZ) Beats on Q3 Earnings, Lowers Sales View", "Ironwood (IRWD) Q3 Earnings & Revenues Miss, Shares Down", "VIVUS (VVUS) Q3 Loss Narrower Than Expected, Revenues Up Y/Y", "Geron's (GERN) Q3 Earnings Beat, Revenues Miss, Shares Down", "S&P 500 Analyst Moves: VRTX", "The Zacks Analyst Blog Highlights: Gilead Sciences, Amgen, Vertex Pharmaceuticals, Celgene and Regeneron Pharmaceuticals", "Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?", "Perrigo (PRGO) Beats on Q3 Earnings, Cuts View, Shares Down", "Better Buy: Vertex Pharmaceuticals Incorporated vs. Incyte Corporation", "AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated", "Vertex (VRTX) Q3 Earnings and Revenues Surpass Estimates", "Vertex Pharmaceuticals Inc (VRTX) Q3 2018 Earnings Conference Call Transcript", "Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Surpass Estimates", "After-Hours Earnings Report for October 24, 2018 : MSFT, V, TSLA, VRTX, LVS, AFL, F, NOW, ORLY, ALGN, AMD, XLNX", "Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT", "Vertex Pharmaceuticals Waits to Hit the Triple", "What's in Store for Anika Therapeutics (ANIK) in Q3 Earnings?", "Why Proteostasis Therapeutics Tumbled 23.2% on Friday", "Vertex Pharmaceuticals (VRTX) Q3 Earnings Preview: What's Shaping Up?", "CELG vs. VRTX: Which Stock Should Value Investors Buy Now?", "J&J (JNJ) to Set the Ball Rolling for Pharma Q3 Earnings", "Why CRISPR Therapeutics Stock Is Heading Higher Today", "Why the Earnings Surprise Streak Could Continue for Vertex (VRTX)", "Is a Beat in Store for Vertex (VRTX) This Earnings Season?", "What's in Store for Anika Therapeutics (ANIK) in Q3 Earnings?", "7 Fast-Growing Stocks to Buy Today", "3 Biotech Stocks With Virtual Monopolies", "3 Biotech Stocks With Rising Estimates in the Past Month", "Better Buy: Vertex Pharmaceuticals Incorporated vs. Galapagos NV", "Guide to CRISPR Stocks & Latest Apple, Fed, GDP News | Free Lunch", "10 Stocks That Are Screaming Buys Right Now", "Better Buy: Crispr Therapeutics AG vs. Editas", "Notable Friday Option Activity: DIS, ALGN, VRTX", "3 Top Healthcare Stocks to Buy in September", "Lilly (LLY) Hits 52-Week High, Can the Run Continue?", "Vertex Completes Enrollment in Triple Combination Studies", "PBE, ILMN, BIIB, VRTX: ETF Inflow Alert", "The Zacks Analyst Blog Highlights: Amgen, Puma Biotechnology, MannKind, United Therapeutics and Vertex Pharmaceuticals", "Biotech Stock Roundup: AMGN, PBYI Get EC Nod for Their Drugs, MNKD Soars", "Is CRISPR Therapeutics AG a Buy?", "Vertex Inks Reimbursement Agreement for Orkambi in Australia", "3 Biotech Stocks That Could Soar Next Week", "3 Stocks That Could Put Netflix's Returns to Shame", "Vertex Inks Deal With Genomics to Make Serious Disease Drugs", "Vertex (VRTX) Hits Fresh High: Is There Still Room to Run?", "Why Is Vertex (VRTX) Up 0.1% Since Last Earnings Report?", "3 Relatively Safe Ways to Invest in Gene Editing", "Forget CRISPR Therapeutics: Vertex Pharmaceuticals Incorporated Is a Better Biotech Stock", "Interesting VRTX Put And Call Options For October 5th", "4 Biotech Stocks Investors Can Bet on Post Solid Q2 Earnings", "Mallinckrodt's Stannsoporfin Gets Complete Response Letter", "Biotech Stock Roundup: Label Expansion of Regeneron's Eylea, Vertex's Kalydeco", "Looking for a Growth Stock? Why It is Time to Focus on Vertex Pharmaceuticals (VRTX)", "Zacks.com highlights: Illumina, Vertex Pharmaceuticals, Surmodics and McDermott International", "Novo Nordisk Buys Ziylo to Develop Glucose Responsive Insulin", "Notable Friday Option Activity: WDAY, VRTX, DE", "4 Winning Stocks With Solid Efficiency Level", "Should Vertex Pharmaceuticals (VRTX) Be On Your Radar Now?", "Vertex's Cystic Fibrosis Drug Gets FDA Nod for Children", "Bayer Plunges as Monsanto Fined $289M in Roundup Lawsuit", "7 Fast-Growing Stocks to Buy Today", "Spectrum (SPPI) Earnings and Sales Miss Estimates in Q2", "Endo (ENDP) Beats on Q2 Earnings & Sales, Raises Guidance", "Lilly (LLY) Hits 52-Week High, Can the Run Continue?", "Perrigo (PRGO) Beats on Q2 Earnings, Cuts View, Shares Down", "Sarepta (SRPT) Q2 Loss Narrows, Exondys 51 Drives Sales", "Infinity (INFI) Posts Narrower-Than-Expected Loss in Q2", "Horizon Pharma (HZNP) Q2 Earnings & Sales Beat, Shares Rise", "Mallinckrodt (MNK) Beats on Q2 Earnings and Sales, Ups View", "Catalyst (CPRX) Posts Narrower-Than-Expected Loss in Q2", "Jazz Pharma's (JAZZ) Stock Down Despite Q2 Earnings Beat", "Is Crispr Therapeutics Stock Grossly Overvalued?", "3 Top Biotech Stocks to Buy in August", "Arena Pharmaceuticals (ARNA) Q2 Loss Wider Than Expected", "Ironwood (IRWD) Q2 Earnings & Revenues Miss, Shares Down", "Medicines Company (MDCO) Q2 Loss Narrows, Revenues Tank Y/Y", "Ophthotech (OPHT) Q2 Loss Narrows, Zimura Progress On Track", "Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q2, Gilead's CEO to Exit", "Geron (GERN) Q2 Loss In Line, Revenues Up Y/Y, Shares Down", "Biotech Stock Roundup: Regeneron Shines, BLUE Surges, ONCE Plunges", "3 Reasons Why Vertex Pharmaceuticals Stock Isn't Nearly as Expensive as It Looks", "Vertex (VRTX) Q2 Earnings and Revenues Surpass Estimates", "Vertex Pharmaceuticals (VRTX) Q2 2018 Earnings Conference Call Transcript", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 33.3% Follow-Through Indicator, 2.2% Sensitive", "After-Hours Earnings Report for July 25, 2018 : FB, V, PYPL, GILD, QCOM, SU, MDLZ, LVS, VRTX, F, NOW, ALGN", "4 of the Best U.S. Stocks to Buy Today for Long-Term Growth", "Is a Beat in Store for Vertex (VRTX) This Earnings Season?", "Here's Why Vertex Pharmaceuticals Earnings Are Growing Faster Than Revenue", "Why bluebird bio's Shares Have Tumbled 11.9% in 2018 So Far", "10 Underappreciated Biotech Stocks to Buy", "Company News For Jul 2, 2018", "Vertex's Shares Rally as a Rival's CF Candidate Disappoints", "4 Drug and Biotech Stocks Awaiting FDA Decisions in July", "Why Vertex Pharmaceuticals Incorporated Stock Surged 14% Today", "Bad News Delivers a Decisive Blow to Galapagos N.V.", "10 Stocks That Are Screaming Buys Right Now", "S&P 500 Movers: STZ, VRTX", "Market Close Report: NASDAQ Composite index closes at 7,510.30 up 6.62 points", "Friday's ETF Movers: FBT, FM", "This Biotech Has the Most Valuable Pipeline Asset in the World -- Is the Stock a Buy?", "Interesting VRTX Put And Call Options For August 17th", "2 High-Flying Biotech Stocks With Even More Room to Grow", "5 Experimental New Drugs That Could Be Worth $47 Billion", "Nasdaq 100 Movers: LBTYA, VRTX", "10 Stocks That Are Screaming Buys Right Now", "Nasdaq 100 Movers: AMAT, MELI", "Now's the Time to Buy These 3 Stocks", "Biotech Stock Roundup: Regeneron, Celgene, Amgen Impress at ASCO", "Vertex Pharmaceuticals Enters Oversold Territory", "Buy These 2 Biotech Stocks on the Dip After an FDA Delay", "Zacks Investment Ideas feature highlights: CRISPR, Intellia Therapeutics, Editas and Vertex", "Bullish Two Hundred Day Moving Average Cross - VRTX", "Is Crispr Therapeutics Stock a Bad News Buy?", "Should You Buy the Dip in CRISPR Therapeutics?", "Health Care Sector Update for 05/31/2018: SESN,ASND,CRSP,VRTX", "What Makes This CRISPR Stock Better Than the Rest?", "Vertex Pharmaceuticals (VRTX) Down 1.2% Since Earnings Report: Can It Rebound?", "3 Stocks That Could Put Alibaba's Returns to Shame", "July 6th Options Now Available For Vertex Pharmaceuticals (VRTX)", "Vertex/CRISPR's Sickle Disease Candidate Put on Hold by FDA", "IBB, BIIB, CELG, VRTX: ETF Outflow Alert", "The Zacks Analyst Blog Highlights: General Dynamics, Enbridge, CSX, Humana and Vertex", "Top Research Reports for General Dynamics, Enbridge & CSX Corporation", "CRISPR: 3 Strong Buy Biotechs Trying To Edit Our Genes", "VRTX Crosses Above Key Moving Average Level", "IBB, CELG, BIIB, VRTX: ETF Inflow Alert", "10 Stocks That Are Screaming Buys Right Now", "Is Genome Editing the Next Biotech Breakthrough?", "7 Fast-Growing Stocks to Buy Today", "Here's My Top Stock to Buy in May", "IBB, CELG, BIIB, VRTX: ETF Outflow Alert", "Biotech Stock Roundup: ALXN, VRTX Post Solid Results, GILD Disappoints in Q1", "Vertex Pharmaceuticals Takes a Detour Around the FDA's Roadblock", "5 Things You'll Want to Know From Vertex Pharmaceuticals' Q1 Conference Call", "Vertex (VRTX) Q1 Earnings Beat on Strong CF Products Sales", "3 Top Biotech Stocks to Buy in May", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 30.0% Follow-Through Indicator, 2.1% Sensitive", "After-Hours Earnings Report for April 26, 2018 : MSFT, AMZN, INTC, SBUX, BIDU, SYK, VRTX, WDC, DFS, FTV, DLR, HIG", "Is a Beat in Store for Vertex (VRTX) This Earnings Season?", "Why Earnings Season Could Be Great for Vertex Pharmaceuticals (VRTX)", "3 Growth Stocks That Could Put Facebook's Returns to Shame", "The Zacks Analyst Blog Highlights: Agios Pharmaceuticals, BioMarin Pharmaceutical, Vertex Pharmaceuticals and Incyte", "Pharma M&A Active This Week: 4 Potential Buyout Targets", "Notable Thursday Option Activity: LVS, SQ, VRTX", "IBB, GILD, BIIB, VRTX: ETF Outflow Alert", "Is PowerShares Dynamic Biotechnology & Genome Portfolio (PBE) a Hot ETF Right Now?", "Novartis and Other Drug Stocks With FDA Catalysts in April", "We Did The Math MGK Can Go To $129", "10 Healthcare Stocks to Stave Off the Market Flu", "10 Stocks That Are Screaming Buys Right Now", "Notable ETF Outflow Detected - IBB, BIIB, VRTX, ILMN", "3 Top Healthcare Stocks to Buy in April", "Top Research Reports for Oracle, Vale & General Mills", "10 Triple-A Stocks for the Second Quarter", "3 Highest-Growth Stocks in the Market Today", "Does Crispr Therapeutics AG Deserve This Massive Rally?", "7 Things Vertex Pharmaceuticals' CEO Just Said That Will Probably Make You Want to Buy the Stock", "Why CRISPR Therapeutics Slipped 10% on Thursday", "Notable ETF Outflow Detected - BBH, CELG, BIIB, VRTX", "First Week of VRTX May 18th Options Trading", "Implied ESGU Analyst Target Price: $66", "10 Stocks That Are Screaming Buys Right Now", "Tuesday Sector Laggards: Utilities, Healthcare", "Why Investors Are Paying a Premium For These 3 Biotech Stocks", "7 Fast-Growing Stocks to Buy Today", "IBB, REGN, VRTX, ALXN: Large Outflows Detected at ETF", "Biotech Stock Round Up: Celgene Suffers Setback, Gilead Teams Up with Sangamo", "3 Biotech Stocks With Rising Earnings Estimates Post Q4", "The Zacks Analyst Blog Highlights: Amgen, TOTAL, Marriott, PG&E and Vertex", "Top Analyst Report for Amgen, TOTAL S.A. & Marriott", "3 High-Growth Stocks That Could Soar", "3 Stocks That Could Put Amazon's Future Returns to Shame", "Vertex Pharmaceuticals Scores an Important Win", "Stocks To Watch: Alkermes Sees Relative Strength Rating Rise To 85", "Alkermes Gets IBD Stock Rating Upgrade", "Market Close Report: NASDAQ Composite index closes at 7,337.39 up 127.30 points", "The Zacks Analyst Blog Highlights: Amgen, TOTAL, Marriott, PG&E and Vertex", "Portola Pharmaceuticals Getting Closer To Key Technical Benchmark", "Alder Biopharmaceuticals Shows Rising Relative Strength; Still Shy Of Key Benchmark", "3 High-Growth Stocks That Are Just Getting Started", "Vertex's Third Cystic Fibrosis Treatment Gets FDA Approval", "Is Now a Good Time to Buy Vertex Pharmaceuticals?", "3 Great Acquisition Targets for Gilead Sciences -- and 1 Iffy Candidate", "Here's What Pushed Intellia Therapeutics Inc. Up 33.7% in January", "March 29th Options Now Available For Vertex Pharmaceuticals (VRTX)", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "The Zacks Analyst Blog Highlights: Wells Fargo, Caterpillar, Schlumberger, Vertex and Republic Services", "Why Crispr Therapeutics AG Stock Bolted Higher in January", "REGN vs. ALXN: Which Stock is Poised for Better Q4 Earnings?", "Top Stock Reports for Wells Fargo, Caterpillar & Schlumberger", "Is AbbVie or Vertex Pharmaceuticals the Better Buy Now?", "Monday Sector Laggards: Energy, Healthcare", "3 Top Orphan-Drug Stocks to Buy Now", "Omeros Trying To Close In On Key Technical Measure", "Vertex (VRTX) Q4 Earnings Beat on Strong CF Products Sales", "Biotech Stock Roundup: AbbVie 4Q Results Impress, Ablynx to be Acquired by Sanofi", "What Vertex Pharmaceuticals Just Said About Its Future", "Vertex Pharmaceuticals Picks Between \"Sirloin Steak and Filet Mignon\"", "The Zacks Analyst Blog Highlights: Sanofi, Seattle Genetics, AbbVie, Celgene and Vertex", "Vertex (VRTX) & Other Drug Stocks with FDA Catalysts this February", "Vertex Beats Views, Closes In On Cystic Fibrosis Treatments", "After-Hours Earnings Report for January 31, 2018 : MSFT, FB, T, PYPL, QCOM, MDLZ, EBAY, VRTX, AFL, NOW, AVB, LNC", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 33.3% Follow-Through Indicator, 2.2% Sensitive", "Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX", "Vertex (VRTX) to Report Q4 Earnings: What's in the Cards?", "Gilead Sciences, Take-Two Interactive Hit Buys After Vertex Breakout", "La Jolla Pharmaceutical Meets 80-Plus Relative Strength Rating Benchmark", "Vertex (VRTX) & Other Drug Stocks with FDA Catalysts this February", "RPG, VRTX, LRCX, CNC: Large Inflows Detected at ETF", "Quality Fund Support Is Crucial To A Stock's Success", "Vertex (VRTX) Stock Up 70% in a Year's Time: Here's Why", "Innoviva Clears Technical Benchmark, Hitting 80-Plus RS Rating", "Stocks Showing Market Leadership: Concert Pharmaceuticals Earns 93 RS Rating", "First Week of March 16th Options Trading For Vertex Pharmaceuticals (VRTX)", "Stock Futures Fall As Treasury Yields Climb; Why These 7 Earnings Stand Out", "What's in the Cards for Novartis (NVS) This Earnings Season?", "Celgene (CELG) Q4 Preview: Will It Beat on Earnings Again?", "Amgen Gets FDA Nod to Add ENDEAVOR Data on Kyprolis Label", "3 Top-Ranked Drug Stocks That Are Broker Favorites", "3 Top-Ranked Drug Stocks that are Broker Favorites", "Stocks With Rising Relative Strength: Biogen", "3 Biotech Stocks Start Healthy in \u201918: Will the Rally Last?", "Here's What's Driving Crispr Therapeutics AG Higher Today", "BlackRock, Pier One Imports, Alkermes, Vertex Pharmaceuticals and Agenus highlighted as Zacks Bull and Bear of the Day", "Biotech Stock Roundup: Juno Surges on Acquisition Rumor, Concert Down on Patent News", "3 Biotech Stocks Start Healthy in '18: Will the Rally Last?", "Stocks Showing Market Leadership: Voyager Therapeutics Earns 91 RS Rating", "Concert Pharmaceuticals Plunges on Patent Petition Setback", "The Zacks Analyst Blog Highlights: Celgene, Amgen, Exelixis, Alexion and Vertex", "Atara Biotherapeutics Joins Elite Club Of Stocks With RS Ratings Over 90", "RPG, VRTX, CNC, PHM: Large Outflows Detected at ETF", "Vertex's Cystic Fibrosis Drug Ok'd for Pediatric Use in EU", "Biogen Trying To Close In On Key Technical Measure", "Omeros Scores Relative Strength Rating Upgrade; Hits Key Threshold", "Stocks Showing Improving Market Leadership: Agios Pharmaceuticals Earns 81 RS Rating", "Stocks To Watch: Halozyme Therapeutics Sees RS Rating Rise To 92", "Alder Biopharmaceuticals Meets 80-Plus Relative Strength Rating Benchmark", "Heron Therapeutics Joins Elite Club Of Stocks With RS Ratings Over 90", "Can Biotech Keep Last Year's Momentum Alive in 2018?", "Notable ETF Outflow Detected - IBB, REGN, VRTX, ILMN", "Health Care Sector Update for 01/10/2018: JNJ, PFE, ABT, MRK, AMGN, APHB, LPCN, GKOS, AVDL, VRTX, ALKS, SNDX, RHHBY", "Biotech Stock Roundup: Celgene to Acquire Impact, J.P. Morgan Healthcare Conference in Focus", "Supernus Pharmaceuticals Earns Relative Strength Rating Upgrade; Hits Key Threshold", "Stocks Showing Market Leadership: Array Biopharma Earns 91 RS Rating", "Portola Pharmaceuticals Reaches 80-Plus Relative Strength Rating Benchmark", "Dow Returns to New Year's Rally", "Stocks With Rising Relative Price Strength: Regenxbio", "10 Things to Expect From Vertex Pharmaceuticals in 2018", "Avexis Joins Rank Of Stocks With RS Ratings Over 90", "PTC Therapeutics Clears Key Benchmark, Hitting 80-Plus RS Rating", "Galapagos Reports Topline Data From Osteoarthritis Study", "Amgen's (AMGN) Xgeva Gets FDA Approval for Multiple Myeloma", "Stocks Showing Market Leadership: CRISPR Therapeutics Earns 92 RS Rating", "Stocks Generating Improved Relative Strength: Supernus Pharmaceuticals", "2018 J.P. Morgan Healthcare Conference Roundup", "Why CRISPR Therapeutics AG Stock Is Rising Today", "Here's What Pushed Crispr Therapeutics AG Up 23.6% in December", "The 3 Best-Performing Healthcare Stocks in the S&P 500 in 2017", "Nasdaq 100 Movers: INTC, EXPE", "Will These 2 Large-Cap Biotechs Be on Investor Radar in '18?", "Stocks Generating Improved Relative Strength: Biogen", "PTC Therapeutics Shows Market Leadership With Jump To 84 RS Rating", "3 Big Biotech Stocks to Buy in January", "These 4 S&P 500 Stocks Doubled in 2017", "Why These 2 Biotechs Could Outperform Amid 'Hyper-Competition'", "Flexion Therapeutics Getting Closer To Key Technical Measure", "Supernus Pharmaceuticals Shows Rising Price Performance With Jump To 81 RS Rating", "Another Reason 2018 Might Not Be A Banner Year For Biotech Mergers", "Biotech Stock Roundup: BIIB, CELG Hit by Pipeline News, Acquisition Deals for Ignyta, Sucampo", "Innoviva Sees RS Rating Rise To 74", "La Jolla Pharmaceutical Hits 80-Plus Relative Strength Rating Benchmark", "PTC Therapeutics Clears Key Benchmark, Hitting 80-Plus RS Rating", "Stocks Showing Improving Market Leadership: Voyager Therapeutics Earns 84 RS Rating", "Array Biopharma Shows Rising Price Performance With Jump To 85 RS Rating", "Stocks Showing Market Leadership: Exelixis Earns 93 RS Rating", "Q&A: Vertex Chief Talks About Company's 'Transformational Year'", "10 Top S&P 500 Stocks in 2017", "Innoviva Earns Relative Strength Rating Upgrade", "IBD Rating Upgrades: Pacira Pharmaceuticals Shows Improved Relative Price Strength", "Editas Medicine Joins Elite Club Of Stocks With RS Ratings Over 90", "Array Biopharma Trying To Close In On Key Technical Benchmark", "Corcept Therapeutics Shows Rising Price Performance With Jump To 95 RS Rating", "3 Great Stocks for Your IRA", "Stocks Showing Rising Market Leadership: Voyager Therapeutics Earns 83 RS Rating", "Acceleron Pharma Hits 80-Plus Relative Strength Rating Benchmark", "Regenxbio Shows Rising Price Performance With Jump To 93 RS Rating", "Acceleron Pharma Joins Rank Of Stocks With RS Ratings Over 90", "Stocks Showing Improving Market Leadership: Exelixis Earns 83 RS Rating", "Stocks To Watch: Portola Pharmaceuticals Sees Relative Strength Rating Jump To 94", "Aerie Pharmaceuticals Shows Market Leadership With Jump To 81 RS Rating", "Heron Therapeutics Earns Relative Strength Rating Upgrade; Hits Key Benchmark", "5 Hot Stocks Driving the Nasdaq ETF Rally", "Stocks Showing Improved Relative Strength: Acceleron Pharma", "Proteostasis Stock Surges on Positive Data From CF Studies", "Biotech Stock Roundup: Label Expansion for Exelixis's Cabometyx, FDA Nod for Spark's Gene Therapy", "Nasdaq 100 Movers: ORLY, BMRN", "4 Drug/Biotech Stocks That Could Be Buyout Targets in 2018", "Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $17.7 million of Shares", "The 5 Best Stocks in the S&P 500 in 2017", "3 Growth Stocks I'd Buy Right Now", "Vertex Kalydeco Study Successful in Children Aged 1-2 Years", "3 Top Stocks To Boost Your Portfolio In 2018", "Biotech Stock Roundup: ASH Data in Focus, Gilead to Buy Cell Design Labs", "Agree To Buy Vertex Pharmaceuticals At $110, Earn 10.4% Using Options", "Building a Circle of Competency", "5 Top Biotech Stocks to Buy Now", "The Zacks Analyst Blog Highlights: Starbucks, NIKE, Manulife, Intuit and Vertex", "New Pharma ETF PILL : What Investors Need to Know", "Top Analyst Reports for Starbucks, NIKE & Manulife", "3 Stocks That Could Put Amazon's Returns to Shame", "The Implied Analyst 12-Month Target For XLV", "Sage Therapeutics Shows Rising Price Performance With Jump To 91 RS Rating", "3 Stocks That Have Doubled and Still Have Room to Grow", "S&P 500 Movers: VRTX, DLPH", "Galapagos' CF Candidate Shows Potential in Phase II Study", "Galapagos Pops To Vertex's Detriment \u2014 But Can It Compete?", "Biotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3", "Biotech Stock Roundup: Dynavax Vaccine Gets FDA Nod, Loxo Inks Deal with Bayer", "Zynerba Pharmaceuticals Joins Rank Of Stocks With RS Ratings Over 90", "Biotech Stock Roundup: Regeneron Delivers Strong Q3 Results, Cellectis Clinical Hold Lifted", "How The Pieces Add Up: FXH Headed For $77", "These 3 Stocks Look Expensive but Are Actually Cheap", "Vertex Pops As Analyst Questions Whether Rival Has 'Viable Drug'", "Biotech Stock Roundup: Celgene, Amgen, Gilead Hit by Q3 Results, Vertex Beats on All Fronts", "Biogen Sees Relative Strength Rating Climb To 75", "Sarepta Therapeutics Clears Key Benchmark, Hitting 90-Plus RS Rating", "Vertex Gets CHMP Recommendation for Orkambi Label Expansion", "Intra-Cellular Therapies Earns Relative Strength Rating Upgrade", "Vertex Pharmaceuticals Incorporated: One Eye on Earnings, One on the Pipeline", "Vertex (VRTX) Beats on Q3 Earnings & Sales, Raises 2017 View", "Bristol-Myers: More Bad Medicine for the Market", "5 Biotech Stocks That Are Getting Battered Too Hard for Comfort", "Adamas Pharmaceuticals Clears Technical Benchmark, Hitting 80-Plus RS Rating", "RSI Alert: Vertex Pharmaceuticals (VRTX) Now Oversold", "Stocks Flashing Renewed Technical Strength: Adamas Pharmaceuticals", "Three Biotech Firms Top Third-Quarter Views \u2014 But Only One Pops", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 40.0% Follow-Through Indicator, 2.7% Sensitive", "After-Hours Earnings Report for October 25, 2017 : AMGN, SU, LVS, NXPI, VRTX, PSA, AFL, DLR, NOW, WCN, ABX, ORLY", "Drug/Biotech Stocks Q3 Earnings on Oct 25: AMGN, GSK, VRTX", "Why Earnings Season Could Be Great for Vertex Pharmaceuticals (VRTX)", "3 Top Biotech Stocks to Buy Now", "Aimmune Therapeutics Scores Relative Strength Rating Upgrade", "Biotech Stock Roundup: Biogen Tops Q3 Earnings, Gilead's CAR T Drug Gets FDA Nod", "IBD's No. 1 Group Under Pressure; These 6 Key Earnings Loom; S&P 500 Futures", "Is Celgene (CELG) Poised for a Beat This Earnings Season?", "Is a Beat in the Cards for Vertex (VRTX) in Q3 Earnings?", "4 of the Most Efficient Stocks to Buy Now", "Zacks Industry Outlook Highlights: Novo, Vertex Pharmaceuticals, Celgene and Ligand Pharmaceuticals", "What's in the Cards for Novartis (NVS) This Earnings Season?", "A Foolish Take: The Best-Performing S&P 500 Stock This Year", "Nasdaq 100 Movers: JBHT, WYNN", "The 1 Stock You've Been Overlooking for Your Roth IRA", "Vertex Pharmaceuticals, USG and J. Jill highlighted as Zacks Bull and Bear of the Day", "Rhenman & Partners Asset Management AB Buys Arena Pharmaceuticals Inc, Vertex ...", "Bull of the Day: Vertex Pharmaceuticals (VRTX)", "Is a Beat in Store for Abbott (ABT) This Earnings Season?", "Biotech Stock Roundup: Amgen's Imlygic Data Promising, Regeneron Scores Win in PCSK9 Lawsuit", "Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks", "5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings", "Why the Earnings Streak Will Continue for Vertex Pharmaceuticals (VRTX)", "Forget Teva (TEVA), Buy These 5 Drug Stocks Instead", "Biotech Stock Roundup: Endocyte Shoots up on Deal, Amgen-AbbVie Settle Humira Litigation", "FEX, TROW, HPE, VRTX: Large Outflows Detected at ETF", "3 Top-Ranked Big Biotech Stocks to Buy Now", "Stocks Open Mixed; Musk Talks Mars; Zogenix Soars On Drug News", "Amgen Label Expansion Application for Prolia Accepted by FDA", "5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings", "Biotech Stock Roundup: Amgen Reiterates 2017 Outlook, Intercept Hit by Ocaliva Safety Issues", "3 Highest-Growth Stocks in the Market Today", "3 Monster Biotech Stocks in the Making", "Biotech Stock Roundup: FDA Nod for First Cancer Biosimilar, HALO up on Deals, Raised Outlook", "The Zacks Analyst Blog Highlights: iShares Core S&P 500 ETF, Vertex Pharmaceuticals, Align Technology, NRG Energy and Activision Blizzard", "5 Top-Performing Stocks Driving S&P 500 ETF Higher", "Vertex Pharmaceuticals: The Gilead Sciences of Cystic Fibrosis?", "Noteworthy ETF Outflows: FEX, VRTX, PYPL, TROW", "Nasdaq 100 Movers: ALXN, PAYX", "2 Views on Vertex Pharmaceuticals Stock: Short Term vs. Long Term", "Notable Thursday Option Activity: OXY, VRTX, AIG", "Nasdaq 100 Biotechnology: Beyond Pure Tech; Still Pure Innovation", "Biotech Stock Roundup: Cellectis Down on Clinical Hold, Insmed Soars on Positive Data", "4 Biotech Stocks That More Than Doubled This Year", "Biotech Stock Roundup: Alexion to Cut Jobs, Streamline Operations, Kura Up on Cancer Data", "4 Biotech Stocks That More Than Doubled This Year", "Don\u2019t Sell Facebook Inc (FB) Stock Just Because It\u2019s Losing the Teen Crowd", "Biotech Stock Roundup: CAR-T in Focus on Gilead-Kite Deal, Incyte Up on Baricitinib Update", "XBI, EXEL, ALXN, VRTX: ETF Inflow Alert", "Why Micron Technology, Inc. (MU) Stock Suddenly Looks So Sunny", "Vertex Pharmaceuticals (VRTX) Down 5.2% Since Earnings Report: Can It Rebound?", "3 Reasons to Be Cautious on Vertex Pharmaceuticals Incorporated (VRTX) Stock", "3 Growth Stocks for the 21st Century", "4 of the Highest-Growth Stocks in Biotech Today", "Commit To Buy Vertex Pharmaceuticals At $100, Earn 4.5% Using Options", "Biotech Stock Roundup: EU Label Expansion for Alexion, BIIB Facing Drug Price Probe", "Noteworthy ETF Inflows: XBI, EXEL, ALXN, VRTX", "Nasdaq 100 Movers: MYL, VRTX", "Trade of the Day: Freeport-McMoRan Inc (FCX) Stock Is Rally-Ready", "Market Close Report: NASDAQ Composite index closes at 6,297.48 up 84.35 points", "Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.", "Vertex Pharmaceuticals Incorporated (VRTX) Stock Is Too Expensive", "The 3 Best Stocks in Healthcare", "Biotech Stock Roundup: Regeneron Drops RSV Antibody, Gilead HIV Drug Gets Priority Review", "3 Stocks That Could Put Alibaba's Returns to Shame", "Why Gilead Sciences Might Not Make an Oncology Acquisition", "3 Big Stock Charts for Monday: Nvidia Corporation (NVDA), Micron Technology, Inc. (MU) and Western Digital Corp (WDC)", "Is TJX Companies Inc (TJX) Stock Ready to Shine Again?", "Tuesday Sector Leaders: Technology & Communications, Healthcare", "3 'Strong Buy' Biotech Stocks You Should Watch", "Hot Fidelity Fund Owns Stocks Like Tencent That Jump In Stock Market", "Market Close Report: NASDAQ Composite index closes at 6,256.56 up 39.69 points", "Friday Sector Leaders: Technology & Communications, Healthcare", "Biotech Stock Roundup: Q2 Earnings from Regeneron, Kite & More, FibroGen Up on IPF Data", "Why Vertex Pharmaceuticals Incorporated (VRTX) Will Keep Rolling Higher", "Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals: Which Company Reported Better Earnings", "Why Vertex Pharmaceuticals Incorporated (VRTX) Stock Isn\u2019t Worth the Risk", "Why Vertex Pharmaceuticals Skyrocketed 17.8% in July", "Biotech Stock Roundup: Q2 Earnings from Gilead, CELG & More, Dynavax Up on Panel Vote", "Noteworthy ETF Outflows: FEX, VRTX, LRCX, BG", "Vertex Pharmaceuticals Incorporated Chugs Along", "Pharma Stocks to Watch for Earnings on Jul 28: ABBV, MRK", "Zacks.com featured highlights: Farmers & Merchants Bancorp, Advanced Energy Industries, NVR, Vertex Pharmaceuticals and Sanderson Farms", "Vertex (VRTX) Q2 Earnings Top on Solid Cystic Fibrosis Sales", "Should You Buy Vertex Pharmaceuticals Incorporated (VRTX) Stock? 3 Pros, 3 Cons", "5 Top Efficient Stocks to Buy for a Winning Portfolio", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 40.0% Follow-Through Indicator, 2.6% Sensitive", "After-Hours Earnings Report for July 26, 2017 : FB, GILD, PYPL, SU, LVS, VRTX, PSA, LRCX, EW, DFS, ABX, NOW", "Drug Stocks Q2 Earnings Releases on Jul 26: GILD, VRTX, GSK", "What's in the Cards for Geron (GERN) this Earnings Season?", "Can Intercept (ICPT) Beat Estimates this Earnings Season?", "Will Radius Health (RDUS) Disappoint this Earnings Season?", "Thursday Sector Laggards: Healthcare, Technology & Communications", "DST Systems (DST) Q2 Earnings: Is a Surprise in Store?", "Xilinx (XLNX) to Post Q1 Earnings: What's in the Cards?", "Why Vertex Pharmaceuticals (VRTX) Might Surprise This Earnings Season", "Top Stock Picks for the Week of July 24th", "What's in the Cards for Exelixis (EXEL) in Q2 Earnings?", "Is Celgene (CELG) Poised For a Beat This Earnings Season?", "Top Ranked Momentum Stocks to Buy for July 24th", "Gigamon (GIMO) to Report Q2 Earnings: What's in the Cards?", "DST Systems (DST) Q2 Earnings: Is a Surprise in Store?", "What's in the Offing for F5 Networks (FFIV) in Q3 Earnings?", "What's in the Offing for Bristol-Myers (BMY) in Q2 Earnings?", "Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $34.9 million of Shares", "Vertex Pharma, A10 Networks, Microsoft, Visa and eBay highlighted as Zacks Bull and Bear of the Day", "Can Merck (MRK) Pull Off a Surprise this Earnings Season?", "Seres Therapeutics (MCRB) Catches Eye: Stock Gains 9.2%", "Zacks.com featured highlights: Vertex Pharmaceuticals, AGCO, Owens Corning, Five9 and Axcelis Technologies", "5 Stock Picks with Earnings Beat Potential", "Is a Beat in the Cards for Vertex (VRTX) in Q2 Earnings?", "Sarepta (SRPT) Q2 Loss Narrows, Ups Exondys 51 Sales View", "Trade Philip Morris International Inc. (PM) Stock While It\u2019s Up in Smoke", "Buy Vertex Pharmaceuticals Incorporated (VRTX) Stock Like Its 20% Gain Never Happened", "Company News for July 20, 2017", "Is Gilead (GILD) Poised for a Beat This Earnings Season?", "Bull of the Day: Vertex Pharma (VRTX)", "The Zacks Analyst Blog Highlights: Apple, JPMorgan, Celgene, PayPal and Vertex Pharmaceuticals", "Nasdaq 100 Movers: CSX, VRTX", "S&P 500 Movers: NTRS, VRTX", "Vertex (VRTX) Triple Combination CF Studies Data Positive", "Pre-Market Most Active for Jul 19, 2017 : MT, VRTX, RAD, BFR, SNI, MS, BABA, SNY, TVIX, MU, QQQ, FB", "Biotech Stock Roundup: Vertex Boosted by CF Data, FDA Nod for Gilead, Puma Drugs", "Micron Technology, Inc. (MU) Stock Is About to Break Out", "Here's Why Vertex Pharmaceuticals (VRTX) Soared Today", "What Happened in the Stock Market Today", "Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,385.04.", "Vertex Pharmaceuticals Stock Is Soaring: Here's Why It's Still Not Too Late to Buy", "Health Care Sector Update for 07/19/2017: VRTX,AEZS,CYCC", "Why Vertex Pharmaceuticals Incorporated Stock Is Soaring Today", "Forget GW Pharmaceuticals: These 2 Stocks Are Better Buys", "Top Stock Reports for Apple, JPMorgan & Celgene", "3 Stocks to Watch on Wednesday: Vertex Pharmaceuticals Incorporated (VRTX), CSX Corporation (CSX) and International Business Machines Corp. (IBM)", "Why You're Smart to Buy Vertex Pharmaceuticals Stock", "The Zacks Analyst Blog Highlights: Crescent Point Energy, Vertex Pharmaceuticals, SodaStream International, Commercial Vehicle Group and Melco Crown Entertainment", "Can Novartis (NVS) Spring a Surprise This Earnings Season?", "Amgen's Myeloma Drug Improves Overall Survival in Phase III", "5 Companies That Consistently Beat Earnings Estimates", "Thursday Sector Laggards: Healthcare, Technology & Communications", "Biotech Stock Roundup: Arena Shoots Up on Study Data, CELG Inks Immuno-Oncology Deal", "Wall Street\u2019s 5 Hottest Biotech Stocks Right Now", "Zacks.com featured highlights: Sanderson Farms, American Woodmark, Vertex Pharmaceuticals, Baxter International and A. O. Smith", "5 Top Multibagger Biotech Stocks to Buy in the 2nd Half", "BIB, BIIB, REGN, VRTX: ETF Outflow Alert", "5 Efficient Stocks to Buy for a Winning Portfolio", "The Nasdaq 100's 3 Best Stocks in 2017's First Half", "3 Reasons Why Gilead Sciences Shouldn't Buy Vertex Pharmaceuticals", "Vertex Pharmaceuticals Reaches Analyst Target Price", "The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences", "Is Vertex Pharmaceuticals Running Out of Steam or Taking a Breather?", "Will Oil Prices Spoil Tesla Inc\u2019s (TSLA) Model 3 Party?", "Here's Why Investors Are Glued to Vertex Pharma (VRTX) Stock", "3 Growth Stocks That Could Soar More Than Tesla", "Fresh Capital to Be Injected into Biotech Stocks: 5 Must-Buys", "Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt", "Zacks.com featured highlights: Etsy, Live Nation Entertainment, Salesforce.com, Vertex Pharmaceuticals and NeoGenomics", "The 3 Best S&P Stocks in 2017's First Half", "The SPDR S&P Biotech (ETF) (XBI) Is on Breakout Watch", "What Are Good Stocks to Invest In Now?", "Wednesday Sector Leaders: Healthcare, Utilities", "3 Growth Stocks for June", "Weekly CFO Sells Highlight", "3 Highest-Growth Stocks in the Market Today", "Top Health Stocks to Buy Now", "5 Toxic Stocks to Discard or Play Short for Profit", "Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $19 million of Shares", "3 Biotech Stocks to Buy If You've Never Bought a Biotech Stock", "3 Stocks With Vertex Pharmaceuticals-Like Return Potential", "SDS, PBE: Big ETF Inflows", "VRTX Crosses Above Average Analyst Target", "Noteworthy ETF Outflows: XBI, VRTX, EXAS, REGN", "Market Close Report: NASDAQ Composite index closes at 6,198.52 down -4.67 points", "Zacks.com featured highlights: Salesforce.com, Vertex Pharmaceuticals, Live Nation Entertainment, Covanta Holding and Etsy", "Why Is Vertex (VRTX) Up 2.1% Since the Last Earnings Report?", "Agree To Buy Vertex Pharmaceuticals At $80, Earn 4.9% Annualized Using Options", "Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data", "XBI, VRTX, REGN, EXAS: Large Inflows Detected at ETF", "Concert Pharma Falls After Clinical Hold on Hair Loss Drug", "Vertex Ups Kalydeco Sales View as FDA Okays Label Expansion", "Zacks.com featured highlights: Covanta Holding, PTC, Etsy, Vertex Pharmaceuticals and Live Nation Entertainment", "3 Stocks the Smartest Investors Are Buying Right Now", "Love High-Growth? Here Are 3 Stocks to Consider", "5 Toxic Stocks to Steer Clear Of or Play Short Right Now", "Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer Deal", "Why Is Vertex Pharma (VRTX) Stock Soaring This Year?", "3 Best Stocks in Personalized Medicine", "Notable ETF Outflow Detected - XBI, EXAS, VRTX, IONS", "I Still Can't Believe Gilead Sciences, Inc. Spent $14.8 Billion on Shareholder Rewards", "A Doomed Trump Presidency Would Be a Terrifying Development for Pharmaceutical Stocks", "Noteworthy ETF Inflows: XBI, VRTX, IONS, SRPT", "The 3 Best Comeback Stocks to Buy in 2017", "Vertex Pharmaceuticals Incorporated: Solid Sales, Prepping for Next Generation", "3 Top Biotech Stocks to Buy Now", "Vertex (VRTX) Q1 Earnings Top, CF Products Sales Strong", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 40.0% Follow-Through Indicator, 2.8% Sensitive", "After-Hours Earnings Report for April 27, 2017 : MSFT, AMZN, GOOGL, INTC, SBUX, BIDU, AFL, VRTX, WDC, RSG, CERN, SWKS", "Here's Why Vertex Pharmaceuticals Incorporated Gained 8% in April", "What's in Store for Nivalis (NVLS) this Earnings Season?", "Biotech Stock Roundup: Biogen Gains on Strong Q1, NASH Data on Gilead Drug", "What's in Store for Vertex (VRTX) this Earnings Season?", "3 Healthcare Bargain Stocks You Can Buy Right Now", "3 Stocks That Growth Investors Should Love", "XBI, VRTX, BIVV, EXEL: Large Inflows Detected at ETF", "Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals", "Notable ETF Inflow Detected - XBI, VRTX, BIVV, NBIX", "Retirement Accounts Benefit From Columbia Fund's Tech Bets", "Top Research Reports for Today: MSFT, BLK, NOC", "TherapeuticsMD Falls on Likely Delay in TX-004HR Approval", "Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback", "3 Best Performing Stocks in March", "What's Next for Corbus Pharmaceuticals After Its Controversial Cystic Fibrosis Results?", "The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar Therapeutics, Argos Therapeutics and Cidara Therapeutics", "5 Toxic Stocks to Shun or Play Short Right Now", "Friday Sector Leaders: Healthcare, Financial", "Vertex Pharmaceuticals (VRTX) Shares March Higher, Can It Continue?", "3 of the Best & Worst Performing Drug Stocks of Q1", "3 Top Stocks to Buy in Q2", "Noteworthy Thursday Option Activity: VRTX, ENR, PSMT", "Stocks to Watch in Market Weakness", "Amgen Files for Xgeva Label Expansion, To Include Myeloma", "3 Great Stocks on Sale to Buy Today", "Is Vertex Pharmaceuticals the Best Biotech Stock?", "Sanofi's (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk", "Why Vertex Pharmaceuticals Rocketed 21.1% Higher in March", "5 Stocks that Outperformed the S&P 500 in Q1", "5 Stocks that Chaperoned Nasdaq to Double-Digit Gains in Q1", "AstraZeneca's (AZN) Lung Cancer Drug Gets Full FDA Approval", "The Zacks Analyst Blog Highlights: Disney, Texas Instruments, Lockheed Martin, Bank of New York Mellon and Vertex Pharmaceuticals", "Biotech Stock Roundup: Acorda Down on Court Ruling, Patent Challenge for CELG Drug", "Is Vertex Pharmaceuticals the Best Biotech Stock?", "Sanofi's (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk", "Top Research Reports for Today: DIS, TXN, LMT", "Company News for March 30, 2017", "VRTX Crosses Above Average Analyst Target", "Mid-Day Market Update: Crude Oil Up 1.5%; Alliqua Biomedical Shares Slide", "Here's Why Vertex Pharmaceuticals Is Flying High Today", "3 Big Healthcare Stocks That Wall Street Predicts Will Grow the Fastest", "Nasdaq 100 Movers: BIIB, VRTX", "S&P 500 Movers: FFIV, VRTX", "Pre-Market Most Active for Mar 29, 2017 : EXAR, ATH, TNXP, SNAP, MT, ASX, NOK, VRTX, QQQ, VOD, XIV, AAPL", "Buy Wells Fargo & Co (WFC) Stock on Any Dips", "Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study", "3 Stocks to Watch on Wednesday: RH (RH), Vertex Pharmaceuticals Incorporated (VRTX) and Ollie\u2019s Bargain Outlet Holdings Inc (OLLI)", "Market Close Report: NASDAQ Composite index closes at 5,897.55 up 22.41 points", "Vertex Combo Data on Kalydeco+VX-661 Positive in Phase III", "Health Care Sector Update for 03/29/2017: VRTX,TNXP,RTTR", "Nasdaq 100 Movers: VRTX, TSLA", "NASDAQ Composite Index closes up 11.64 points for the week, rising for the 3rd straight day", "Noteworthy Friday Option Activity: VRTX, GILD, HD", "Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals", "5 Toxic Stocks to Dump or Play Short to Make Gains", "3 Biotech Stocks to Buy in March", "Mid-Afternoon Market Update: RH Gains After Strong Q4 Results; Quorum Health Shares Plummet", "Health Care Sector Update for 03/29/2017: VRTX,TNXP,RTTR", "Mid-Day Market Update: Dow Falls 80 Points; Concert Pharma Shares Spike Higher", "Why Concert Pharmaceuticals Stock Is Soaring Today", "Mid-Morning Market Update: Markets Open Lower; Deutsche Bank Plans to Raise Capital", "The Probable Reason Behind Vertex Pharmaceuticals 5% Jump in February", "Health Care Sector Update for 03/06/2017: CNCE,VTRX,TGTX,IONS", "Mid-Afternoon Market Update: GoPro Slides Following Goldman Sachs Downgrade; TG Therapeutics Shares Spike Higher", "Biotech Stock Roundup: Trump Tweet Hits Biotech Stocks, Concert Gains on Vertex Deal", "Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Vertex Pharmaceuticals, Etsy and Incyte", "5 Toxic Stocks to Abandon or Play Short Right Now", "VRTX Makes Bullish Cross Above Critical Moving Average", "First Week of VRTX October 20th Options Trading", "How High Can Corbus Pharmaceuticals Stock Go?", "Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,865.95.", "Zacks.com featured highlights: Ets, Incyte, Abercrombie & Fitch, Vertex Pharmaceuticals and Bottomline Technologies", "Biotech Stock Roundup: Kite Soars on CAR-T Data, EXEL in Immuno-Oncology Deals", "Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Vertex Pharmaceuticals, Etsy and Incyte", "5 Toxic Stocks to Dump or Play Short for Gains", "Why Vertex Pharmaceuticals Stock Surged Higher in January", "Top Analyst Reports for Alphabet, Citigroup, Chevron & Others", "Vertex Pharma's (VRTX) Q4 Earnings & Sales Beat; Stock Up", "Vertex Pharmaceuticals Incorporated Turns a Profit", "Health Care Sector Update for 01/26/2017: VRTX,AVGR,ENTL", "Is Gilead Sciences Getting Ready for a Massive Acquisition?", "What Lies in Store for Pfizer (PFE) this Earnings Season?", "The Zacks Analyst Blog Highlights: RedHill Biopharma, Cempra, Vertex Pharmaceuticals, Acorda Therapeutics and Kite Pharma", "Biotech Stock Roundup: Synergy Drug Gets FDA Nod, AbbVie, GILD HCV Drugs under EU Review", "After-Hours Earnings Report for January 25, 2017 : T, QCOM, LVS, MCK, EBAY, CCI, WDC, VRTX, LRCX, XLNX, CTXS, NOW", "Why Vertex (VRTX) Might Surprise This Earnings Season", "Will These 5 Drug Stocks Be Big Winners in the Q4 Earnings Season?", "Can AbbVie (ABBV) Spring a Surprise This Earnings Season?", "Will Eli Lilly's (LLY) Earnings Surpass Estimates in Q4?", "4 Drug Stocks Poised to Surprise this Earnings Season", "3 Beaten-Down Biotech Stocks You Can Buy Right Now", "Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?", "Concert Offers Update on Cystic Fibrosis Drug, Stock Down", "Why Vertex Pharmaceuticals (VRTX) Could Be Positioned for a Surge", "Why Vertex Pharmaceuticals Stock Sank 42% in 2016", "Merck KGaA, Vertex Announce Tie-Up for Oncology Programs", "Concert's (CNCE) CTP-656 Gets Orphan Drug Status in U.S.", "5 Ways Vertex Pharmaceuticals Plans to Grow in 2017 and Beyond", "Vertex Pharma Issues Disappointing 2017 Orkambi Outlook", "Biotech Stock Roundup: Inotek Plunges on Pipeline Setback, Kite Files IND for Study Initiation", "Is Vertex Pharma (VRTX) Poised for a Turnaround in 2017?", "Regeneron vs. Vertex: Which Stock is a Better Pick?", "Biotech Stock Roundup: FDA Nod for Biogen/Ionis Drug, Seattle Genetics Hit by Clinical Hold", "Stock Market News for December 27, 2016", "Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short", "Nasdaq 100 Movers: CTAS, NTES", "Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Herc Holdings, Conns and Vertex Pharmaceuticals", "Market Close Report: NASDAQ Composite index closes at 5,462.69 up 15.27 points", "Are These 3 Stocks the Biggest Comeback Opportunities of 2017?", "5 Toxic Stocks to Remove from Your Portfolio or Play Short", "First Week of VRTX February 2017 Options Trading", "We Did The Math PBE Can Go To $52", "3 Precision Medicine Stocks to Buy in January", "The Worst American Stocks of 2016", "Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus", "Why Celgene Corporation (CELG), Nu Skin Enterprises, Inc. (NUS) and Pioneer Energy Services Corp (PES) Are 3 of Today\u2019s Worst Stocks", "Market Close Report: NASDAQ Composite index closes at 5,323.68 down -56.24 points", "Nasdaq 100 Movers: BMRN, NFLX", "Nivalis (NVLS) Cystic Fibrosis Study Misses Primary Endpoint", "Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola", "These Growth Stocks Could Double in 2017", "5 Toxic Stocks to Get Rid Of or Play Short Right Now", "Biotech Stock Roundup: Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved", "IBB, REGN, ALXN, VRTX: ETF Inflow Alert", "Peek Under The Hood: SPYX Has 10% Upside", "Nasdaq 100 Movers: ALXN, NVDA", "Why Vertex Pharmaceuticals Stock Slipped 13% in October", "Why These Biotechs Are Soaring Today", "Zacks.com featured highlights: Allegheny Technologies, salesforce.com, United States Steel, Vertex Pharmaceuticals and Continental Resources", "Zacks Industry Outlook Highlights: Amgen, Vertex, Valeant Pharmaceuticals International, Mylan N.V. and Gilead Sciences", "The Zacks Analyst Blog Highlights: Cabot Oil & Gas, Zayo Group Holdings, Etsy, Live Nation Entertainment and Vertex Pharmaceuticals", "Health Care Sector Update for 11/07/2016: HZNP, VRTX", "3 Value Stocks Near 52-Week Lows Worth Buying", "Nivalis (NVLS) Q3 Earnings Preview: Can the Stock Surprise?", "Peek Into Drug Stocks' Earnings on Oct 28: ABBV & IMGN", "Vertex Pharmaceuticals Incorporated Pushes Forward With Drug Combinations (and Reports Earnings, Too)", "VRTX Crosses Above Key Moving Average Level", "Vertex's (VRTX) Q3 Loss Wider than Expected, Sales Miss", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 55.6% Follow-Through Indicator, 3.5% Sensitive", "After-Hours Earnings Report for October 25, 2016 : AAPL, CB, CNI, ESRX, COF, EW, DFS, EQR, VRTX, BXP, BCR, AMP", "Nasdaq 100 Movers: VRTX, TMUS", "S&P 500 Movers: COL, QRVO", "Market Close Report: NASDAQ Composite index closes at 5,309.83 up 52.43 points", "Vertex (VRTX) Q3 Earnings: What's in Store for the Stock?", "Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex Q3 Results Miss Estimates", "Vertex's (VRTX) Q3 Loss Wider than Expected, Sales Miss", "What Makes Vertex Pharmaceuticals (VRTX) a Strong Sell?", "Biotech Stock Roundup: Alnylam Slumps on Revusiran Update, TESARO Impresses at ESMO", "Biotech Stock Roundup: Summit Soars on Sarepta Deal, Regeneron Presents Data", "Vertex Orkambi's Label Expanded in U.S., Outlook Revised", "3 Critical FDA Decisions You Can't Afford to Miss", "Nasdaq 100 Movers: BMRN, BBBY", "Biotech Stock Roundup: ARIAD Down on Drug Pricing Tweet, Regeneron Study on Clinical Hold", "The Math Shows QUS Can Go To $69", "Nasdaq 100 Movers: EXPE, WDC", "The Zacks Analyst Blog Highlights: Spectrum Pharmaceuticals, Amgen, AbbVie and Vertex Pharmaceuticals", "3 Drug Stocks That Could Benefit from Key FDA Events in Sep 2016", "3 Growth Stocks That Could Double", "Drug Stocks Remain in Focus as Pricing Debate Continues", "Zacks.com featured highlights: Covanta Holding, ZELTIQ Aesthetics, Capital Senior Living, Live Nation Entertainment and Vertex Pharmaceuticals", "Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD Drug", "Nasdaq 100 Movers: GILD, TMUS", "Stock Market News for August 25, 2016", "S&P 500 Analyst Moves: VRTX", "S&P 500 Movers: MRO, REGN", "P-s-s-st! Here's What Fidelity Has Been Buying And Selling", "The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen", "Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data", "5 Toxic Stocks to Steer Clear Of Before It's Too Late", "These 2 Catalysts Lifted Vertex Pharmaceuticals Incorporated 13% in July", "Nivalis (NVLS) Reports Wider-than-Expected Loss in Q2", "Vertex Pharmaceuticals Incorporated Prepares for (More) Growth", "Vertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short", "Nivalis (NVLS): Can the Stock Surprise This Earnings Season?", "Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 66.7% Follow-Through Indicator, 3.7% Sensitive", "Vertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down", "Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?", "I Just Bought These 4 Fast-Growing Biotech Stocks", "Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly", "7 Biotech Stocks to Watch for Runaway Gains", "Implied QQXT Analyst Target Price: $46", "Friday Sector Laggards: Utilities, Healthcare", "After-Hours Earnings Report for July 27, 2016 : FB, AMGN, MCK, PSA, SU, NXPI, ORLY, PXD, ABX, VRTX, MAR, O", "5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More", "Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?", "I Just Bought These 4 Fast-Growing Biotech Stocks", "3 Biotech Stocks to Buy in the Wake of the Brexit Vote", "How This Former Market Darling Became an Undervalued Stock", "5 Toxic Stocks to Discard from Your Portfolio Right Now", "Why Galapagos NV Shares Soared 30.5% in May", "Can Vertex Pharmaceuticals Incorporated Bounce Back From Its 28.9% Drop?", "Biotech Stock Roundup: Sarepta Shoots Up on FDA Delay, Ionis Falls on Pipeline News", "Last Week's Best Healthcare ETF", "Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Drug Fares Well", "A Heavy Hitter Just Stepped Up to the Cystic Fibrosis Plate", "Biotech Stock Roundup: Pfizer to Buy Anacor for $5.2B, Pipeline Setbacks for Aduro, Trevena", "Nasdaq 100 Movers: ALXN, STX", "Nivalis Starts Dosing in Second Phase II Cystic Fibrosis Study", "Vertex (VRTX) Orkambi sNDA Accepted with Priority Review", "Forget Bluebird Bio, Inc.: These 3 Stocks Are Better Buys", "Vanguard Boosts Stake in Incyte in \u2013st Quarter", "Will Vertex (VRTX) Stock Decline on 1Q Earnings Miss?", "Orkambi a 2016 Blockbuster? Vertex Pharmaceuticals Incorporated Thinks So", "Biotech Stock Roundup: Biogen Tops on Q1 Earnings, Sarepta, Catalyst Plunge on Regulatory News", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 75.0% Follow-Through Indicator, 3.4% Sensitive", "After-Hours Earnings Report for April 27, 2016 : FB, TXN, ORLY, AVB, VRTX, MAR, AMP, SNDK, BCR, GG, EFX, XLNX", "Look Under The Hood: CSM Has 12% Upside", "Big Drug Stocks to Report This Week: LLY, GSK, VRTX, BMY, ABBV", "Vertex (VRTX) to Report Q1 Earnings: Is a Surprise in Store?", "Top 5 Stocks Boasting Earnings Acceleration", "S&P 500 Movers: CHK, HAS", "Nasdaq 100 Movers: VRTX, NVDA", "Friday's ETF with Unusual Volume: IYH", "Biotech Stock Roundup: FDA Advisory Panels Say Yes to Intercept, No to Clovis", "The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, FLIR Systems, Medtronic, Cirrus Logic and HollySys Automation Technologies", "Nasdaq 100 Movers: EBAY, BBBY", "How The Pieces Add Up: SPXE Targets $47", "Nasdaq 100 Movers: WDC, VRTX", "Nasdaq 100 Movers: VRTX, NVDA", "3 Biggest Challenges Facing Raptor Pharmaceuticals Corp. Stock", "Do You Own Any Of These Top Sector Funds?", "Biotech Stock Roundup: GW Pharma Soars on Epidiolex Data, Gilead's Zydelig in Trouble?", "Why Vertex Pharmaceuticals Incorporated Stock Dipped 11% in March", "Instant Analysis: Vertex Pharmaceuticals Inc Wins Another Approval", "Biotech Stock Roundup: AbbVie's Imbruvica Label Expanded, Celldex Slumps on Study Update", "Nivalis (NVLS) Provides Update on Cystic Fibrosis Candidate", "What Does Trump's Healthcare Plan Mean for Investors?", "These 3 Biotechs Are Growing Fast -- Which Is the Best Buy Today?", "Biotech Stock Roundup: Gilead HIV Drug Approved, Baxalta in Immuno-Oncology Deal", "Concert's Early-Stage Cystic Fibrosis Drug Shows Promise", "The Zacks Analyst Blog Highlights: AbbVie, Vertex, Celldex and Celgene", "3 Biotechs that Could Snap Back and Soar Even Higher", "3 Reasons Vertex Stock Could Fall", "Biotech Stock Roundup: Alexion, Regeneron Miss Estimates; Setback for CTI BioPharma", "Vertex Pharmaceuticals Inc. Dropped 26% in January -- Here's Why", "Vertex (VRTX) Down on CRL for Kalydeco Label Expansion", "Health Care Sector Update for 02/05/2016: JNJ, PFE, ABT, MRK, AMGN, IMMU, VRTX", "Health Care Sector Update for 02/05/2016: VRTX, DHRM", "Biotech Stock Roundup: Incyte Down on Jakafi Update, Is Intercept a Buyout Target?", "Ignore Regeneron Pharmaceuticals, Inc: Here Are 3 Better Buys Right Now", "What's in Store for Nivalis (NVLS) this Earnings Season?", "Mid-Morning Market Update: Markets Open Higher; Ford Tops Q4 Views", "Vertex (VRTX) Posts Narrower 4Q Loss, Maintains Outlook", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 75.0% Follow-Through Indicator, 3.7% Sensitive", "After-Hours Earnings Report for January 27, 2016 : FB, QCOM, TXN, MCK, LVS, EBAY, CCI, VRTX, DFS, AMP, SNDK, NOW", "Will 2016 Be Vertex's Best Year Yet?", "Vertex Pharmaceuticals Inc.'s Q4 Revenues Surge on New Drug", "Regeneron Pharmaceuticals Inc. Stock: Bargain or Rip-Off?", "Biotech Stock Roundup: Sarepta Plunges on Briefing Documents, Acorda to Buy Biotie", "Nivalis' N91115 Gets Orphan Drug Status for Cystic Fibrosis", "Vertex Pharmaceuticals (VRTX) Jumps: Stock Moves Up 5.8%", "Biotech Stock Roundup: Baxalta - Shire to Combine, JPM Healthcare Conference in Focus", "3 Biotechs With Major Catalysts Incoming", "Biotech ETFs Snap Back After Undercutting Sept. Lows", "Will Higher Expenses Hurt Vertex's (VRTX) 4Q Earnings?", "Vertex (VRTX) Gives 2016 View, Orkambi View to Come Later", "Agree To Purchase Vertex Pharmaceuticals At $80, Earn 8.4% Using Options", "Tuesday's ETF with Unusual Volume: IWY", "Bullish Two Hundred Day Moving Average Cross - VRTX", "Nasdaq 100 Movers: NXPI, NCLH", "3 Stocks With Huge Growth Opportunities", "3 New Drugs Ready to Explode in 2016", "Nasdaq 100 Movers: LBTYA, ADI", "The Best 3 Biotech Stocks for 2016", "PBE, BMRN, INCY, VRTX: Large Outflows Detected at ETF", "Interesting VRTX Put And Call Options For January 2016", "The Zacks Analyst Blog Highlights: BioMarin, Amgen, Vertex, Gilead, Biogen and Repros", "Biotech Stock Roundup: KaloBios Soars as Shkreli Steps In, FDA Panel Not Convinced about BioMarin Drug", "Vertex's (VRTX) Orkambi Approved in EU for Cystic Fibrosis", "3 Biotech Stocks to Buy in December", "Biotech Stock Roundup: KaloBios Removes CEO Shkreli, Actelion PAH Drug Approved", "Instant Analysis: Vertex Pharmaceuticals Scores 2 Regulatory Wins", "Vertex Pharmaceuticals Incorporated Moved 16% Higher in October -- Here's Why", "Biotech Stock Roundup: Clovis Plunges, Label Expansion for Gilead's Harvoni", "5 Drugs That Are the Face of Prescription Drug Reform", "Vertex Pharmaceuticals' $2.6 Billion Bet on CRISPR", "5 Exciting Biotech Stocks to Buy on November Upswing", "Vertex Pharmaceuticals Incorporated: Profit on the Horizon", "Instant Analysis: Vertex Pharmaceuticals Grabs an Important Regulatory Win", "Vertex Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for VRTX", "Vertex (VRTX) Posts Narrower Q3 Loss, Ups Kalydeco View", "Biotech Stock Roundup: Biogen Tops Estimates, FDA Approves Alexion's Strensiq", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 77.8% Follow-Through Indicator, 4.2% Sensitive", "After-Hours Earnings Report for October 28, 2015 : AMGN, PSA, SU, VRTX, WMB, ORLY, NXPI, MAR, WPZ, EQIX, LNC, TSO", "Will Orkambi Help Vertex (VRTX) Post a Lower Loss in Q3?", "Health Care Sector Update for 10/26/2015: RDHL, TBPH, VRTX", "Nivalis (NVLS): A Surprise in Store this Earnings Season?", "Stock Market News for October 14, 2015", "Want Lower Drug Prices? These 3 Proposals Won't Help You!", "Vertex (VRTX) Provides Updates on Cystic Fibrosis Pipeline", "Vertex's Kalydeco Gets Priority Review for Expanded Use", "3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical", "Nasdaq 100 Movers: ILMN, VIAB", "A Double-Dose of Bad News Rocks Vertex Pharmaceuticals in September", "Vertex Turns Up the Heat on Cystic Fibrosis Challengers", "Biotech Stock Roundup: Pricing Concerns Hit Biotech Stocks, EU Nod for Regeneron's Praluent", "Nasdaq 100 Movers: DISCA, YHOO", "Stock Market News for September 28, 2015", "A Double Dose of Good News for Vertex Pharmaceuticals Incorporated Investors", "Interesting VRTX Put And Call Options For November 20th", "Vertex Pharmaceuticals is Now Oversold (VRTX)", "Shareholders Breathe Easier As Concert Pharmaceuticals Rockets Higher by 23%", "The Zacks Analyst Blog Highlights: Regeneron, Vertex, Gilead, Biogen and Celgene", "Nasdaq 100 Movers: VIP, ADBE", "VRTX Makes Notable Cross Below Critical Moving Average", "Could These 2 Biopharmas Be the Real Apples of Gilead Sciences' Eye?", "Health Care Sector Update for 09/14/2015: SGEN, TBPH, VRTX", "Vertex Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for VRTX", "VRTX October 2nd Options Begin Trading", "First Trust NYSE Arca Biotechnology Index Fund Experiences Big Inflow", "5 Biotech Stocks Hit Hard by Hillary Clinton's Tweet", "Nasdaq 100 Movers: JD, VRTX", "The Zacks Analyst Blog Highlights: Amgen, Vertex, Regeneron, Baxalta and VIVUS - Press Releases", "Biotech Stock Roundup: Baxalta Rejects Shire Bid, Amgen's Beat & Raise Quarter - Analyst Blog", "Vertex Posts Wider Y/Y Loss but Raises Kalydeco Outlook - Analyst Blog", "Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst Blog", "The Secret to Vertex Pharmaceuticals' Success", "Vertex Pharmaceuticals Rolls Along", "Nasdaq 100 Movers: YHOO, BIIB", "After-Hours Earnings Report for July 29, 2015 : FB, MET, MCK, WMB, SU, PSA, VRTX, WPZ, ORLY, NXPI, BAX, MAR", "Will Vertex (VRTX) Surprise with a Lower Loss in Q2? - Analyst Blog", "Nasdaq 100 Movers: AAL, CELG", "S&P 500 Movers: YUM, CELG", "The Zacks Analyst Blog Highlights: Vertex, Biogen, Applied Genetic, Gilead and Alexion - Press Releases", "Biotech Stock Roundup: Vertex CF Drug Approved, Biogen Strikes Deal for Gene Therapy - Analyst Blog", "Vertex Pharmaceuticals' CF Drug Orkambi Gets FDA Nod - Analyst Blog", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 66.7% Follow-Through Indicator, 3.8% Sensitive", "Biotech Stock Roundup: BioMarin Jumps on Dwarfism Data, Vical Plunges on Vaccine Data - Analyst Blog", "The Zacks Analyst Blog Highlights: Regeneron, Vertex, Celgene, Seattle Genetics and SAGE Therapeutics - Press Releases", "Biotech Stock Roundup: FDA Panel Recommends Regeneron's Praluent, SAGE Gains on Data - Analyst Blog", "IWP, INTU, VRTX, MHFI: ETF Outflow Alert", "Nasdaq 100 Movers: VRTX, WYNN", "The Highest Paid CEOs in Biotech", "3 Types of Risks Facing Biotech Stocks", "Vertex Investors Sigh at FDA Approval", "Nasdaq 100 Movers: VRTX, VIP", "Vertex Pharmaceuticals' Orkambi Wins FDA Panel Backing - Analyst Blog", "Health Care Sector Update for 05/13/2015: VRTX,FCSC,RMD", "Biotech Stock Roundup: Alexion to Buy Synageva, FDA Panel Backs Vertex's Orkambi - Analyst Blog", "Nasdaq 100 Movers: MAT, VIP", "Nasdaq 100 Movers: VRTX, NFLX", "IWP, KR, NFLX, VRTX: ETF Outflow Alert", "S&P 500 Movers: GMCR, NFLX", "Vertex Posts Wider 1Q Loss, Affirms Kalydeco Outlook - Analyst Blog", "3 Stable Large-Cap Biotech Stocks to Buy Now - Analyst Blog", "Vertex Pharmaceuticals Incorporated: Waiting to Exhale", "What's Behind Vertex Pharmaceuticals Incorporated's Disappointing Q1", "Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 75.0% Follow-Through Indicator, 4.1% Sensitive", "After-Hours Earnings Report for April 29, 2015 : BIDU, SU, WMB, VRTX, WPZ, MAR, NXPI, LNC, EQIX, MAC, AR, O", "Will BioMarin (BMRN) Top Earnings Again on Vimzim Sales? - Analyst Blog", "The Zacks Analyst Blog Highlights: Amgen, Celladon, Kite Pharma, Pharmacyclics and Vertex Pharmaceuticals - Press Releases", "Will Vertex (VRTX) Surprise with a Lower Loss in Q1? - Analyst Blog", "Will United Therapeutics (UTHR) Miss This Earnings Season? - Analyst Blog", "Biotech Investors Shouldn't Miss These Stocks This Earnings - Earnings ESP", "3 Potential Blockbuster Drugs That Could Be Approved Before Year's End", "Nasdaq 100 Movers: VRTX, WDC", "Biotech Stock Roundup: Favorable Briefing Documents for MDCO's Kengreal, Alexion Soliris Label Update - Analyst Blog", "Health Care Sector Update for 04/10/2015: ARNA, VRTX, ANIP", "Will Celgene (CELG) Beat Q1 Earnings on Strong Sales? - Analyst Blog", "Stock Market News for April 01, 2015 - Market News", "The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex, Gilead and Amgen - Press Releases", "Biotech Stock Roundup: Biogen Soars on Alzheimer's Data, Gilead HCV Drugs Label Update - Analyst Blog", "Vertex Falls on Disappointing Kalydeco+VX-661 Combo Data - Analyst Blog", "Pre-Market Most Active for Mar 23, 2015 : STO, GSK, GILD, AAPL, VRTX, IMGN, RDS/B, QQQ, FB, RDS/A, SDRL, NVS", "Health Care Sector Update for 03/23/2015: KMDA, EVDY, VRTX", "Health Care Sector Update for 03/23/2015: VRTX,CAPN,MEIP", "S&P 500 Movers: GM, FDX", "Nasdaq 100 Movers: VRTX, VIP", "Vertex's Kalydeco Gets FDA Nod for Additional Indication - Analyst Blog", "Nasdaq 100 Movers: WYNN, AVGO", "Biotech Stock Roundup: AbbVie to Buy Pharmacyclics, FDA Approves First Biosimilar - Analyst Blog", "3 Biotech Stocks to Buy in March", "Nasdaq 100 Movers: AAL, MYL", "Biotech Stock Roundup: Orexigen Soars on Contrave Data, Amgen Scores in Study - Analyst Blog", "S&P 500 Movers: VRTX, GNW", "Surprise! We Still Need Drugmakers to Develop Revolutionary Hepatitis C Drugs", "3 Upcoming FDA Decisions We're Most Excited About", "Could This Be The Biggest Advance in Hepatitis C since Gilead Sciences' Sovaldi?", "In Case You Missed It, There's a New Fastest Growing Drug in the World", "Biotech Stock Roundup: Biogen Impresses with 4Q Results, Gilead & AbbVie HCV Drugs in Focus - Analyst Blog", "Vertex Pharmaceuticals Slumps: VRTX Falls 5.9% in Session - Tale of the Tape", "Vertex Posts Wider 4Q Loss, Affirms Kalydeco Outlook - Analyst Blog", "Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog", "After-Hours Earnings Report for January 28, 2015 : FB, QCOM, LVS, VRTX, GGP, AMP, AVB, LRCX, SLG, TSCO, NOW, CTXS", "Will Vertex (VRTX) Surprise with a Lower Loss in Q4? - Analyst Blog", "Vertex Pharmaceuticals Going to Get Fat on Cystic Fibrosis Pie", "How Much Could AbbVie Inc. Make Selling Its Hepatitis C Drug This Year?", "Vertex Pharmaceuticals' Kalydeco Remains in Focus in 2015 - Analyst Blog", "Nasdaq 100 Movers: TSLA, VRTX", "S&P 500 Movers: DNR, VRTX", "No Surprises From Vertex Pharmaceuticals Incorporated. Yet.", "The Market for This Drug Just Got 19% Bigger, but You Haven't Seen Anything Yet", "3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog", "Vertex Pharmaceuticals' Kalydeco Label Expanded in the U.S. - Analyst Blog", "Is Gilead Sciences, Inc. a Value Stock Following Its Tumble?", "Noteworthy ETF Outflows: VO, VRTX, AVGO, MCO", "Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog", "Why Gilead Sciences and AbbVie Care About This Tiny Company", "Friday Sector Leaders: Healthcare, Utilities", "S&P 500 Movers: NBR, CELG", "Nasdaq 100 Movers: VIP, CELG", "Time to Buy This Dip in Gilead Sciences, Inc. Stock?", "Biotech Stock Roundup: Avanir to be Acquired by Japanese Firm, Biogen Scores in Alzheimer's Study - Analyst Blog", "Notable ETF Inflow Detected - IWP, KR, VRTX, CCI", "Vertex Pharmaceuticals' 52-Week High Driven by Kalydeco - Analyst Blog", "Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval - Analyst Blog", "Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data - Analyst Blog", "Nasdaq 100 Movers: GMCR, DLTR", "Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog", "Stock Market News for November 11, 2014 - Market News", "Vertex Pharmaceuticals Seeks Approval for CF Combination - Analyst Blog", "Is This Trend Making Gilead Sciences, Inc. Worry?", "Biotech Stock Roundup: Regeneron's Eylea Stumbles, Geron Up on Lifting of Clinical Hold - Analyst Blog", "S&P 500 Analyst Moves: VRTX", "Nasdaq 100 Movers: VRTX, ADSK", "Nasdaq 100 Movers: GMCR, DLTR", "Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog", "Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog", "Vertex Pharmaceuticals Incorporated Plays the Earnings Waiting Game", "After-Hours Earnings Report for October 28, 2014 : FB, GILD, ESRX, MCK, APC, AFL, VRTX, EQR, AMP, WDC, MAR, EIX", "Should You Buy Vertex Pharmaceuticals (VRTX) Ahead of Earnings? - Tale of the Tape", "Will Aegerion (AEGR) Disappoint This Earnings Season? - Analyst Blog", "5 Staggering Statistics About the Fastest Growing Drug in the World", "The 5 Most Expensive Drugs in the World", "Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog", "Will Ligand Pharmaceuticals Beat Q3 Earnings Estimates? - Analyst Blog", "Will Amgen (AMGN) Disappoint in the Q3 Earnings Season? - Analyst Blog", "Will Vertex Pharmaceuticals (VRTX) Post a Lower Q3 Loss? - Analyst Blog", "Will Gilead (GILD) Miss Earnings on High Operating Costs? - Analyst Blog", "Is Johnson & Johnson's Worst Nightmare Becoming Reality?", "Will Express Scripts (ESRX) Beat Q3 Earnings Estimates? - Analyst Blog", "Will Agenus (AGEN) Incur Wider-than-Expected Q3 Loss? - Analyst Blog", "5 Best Biotech Stocks to Buy Now", "Pacific Biosciences to Incur Narrower-than-Expected Q3 Loss - Analyst Blog", "Will BioMarin (BMRN) Disappoint This Earnings Season? - Analyst Blog", "Will Alexion (ALXN) Earnings Suffer Due to Higher Costs? - Analyst Blog", "Celgene (CELG) Q3 Earnings to Be Overrun by Expenses? - Analyst Blog", "Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog", "Will Biogen Idec (BIIB) Pull a Surprise this Earnings Season? - Analyst Blog", "180 Million People Have This Disease, Yet Few Are Aware of It", "Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer - Analyst Blog", "Gilead Sciences, inc. Stock's Green Light Sparks Offensive", "Nasdaq 100 Movers: TSLA, VRTX", "Vertex Pharmaceuticals (VRTX) Updates on Kalydeco Studies - Analyst Blog", "Why You Shouldn't Bet Against Vertex Pharmaceuticals (VRTX) Stock - Tale of the Tape", "Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog", "Vertex Pharmaceticals insiders sell 537,645 shares this month", "The Most Important Number You Need to Know Before Buying Gilead Sciences Inc. Stock", "S&P 500 Movers: VRTX, MYL", "Nasdaq 100 Movers: VIP, MYL", "Nasdaq 100 Movers: ADP, VOD", "Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - Analyst Blog", "Vertex Pharmaceuticals (VRTX) Jumps: Stock Rises 6.6% - Tale of the Tape", "Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update - Analyst Blog", "Vertex Pharmaceticals insiders sell 537,645 shares this month", "The Most Important Number You Need to Know Before Buying Gilead Sciences Inc. Stock", "S&P 500 Movers: KORS, VRTX", "Nasdaq 100 Movers: GILD, VRTX", "Nasdaq 100 Movers: VIP, VRTX", "Guggenheim S&P 500 Equal Weight ETF Experiences Big Inflow", "Nasdaq 100 Movers: MU, AMZN", "Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog", "Stock Market Today: Equities Rally Despite Poor Retail Earnings - Stocks in the News", "Wednesday's ETF with Unusual Volume: PBP", "S&P 500 Movers: VRTX, KMI", "Nasdaq 100 Movers: ILMN, TSLA", "Biotech Stock Roundup: Amgen Plans Job Cuts, Regeneron's Eylea Continues to Impress - Analyst Blog", "FXD, RYH: Big ETF Inflows", "Has Gilead Sciences, Inc.'s Star Drug Already Peaked?", "Nasdaq 100 Movers: CTRX, VRTX", "Nasdaq 100 Movers: GRMN, REGN", "Vertex Pharmaceuticals Posts Wider Q2 Loss, Maintains View - Analyst Blog", "After-Hours Earnings Report for July 29, 2014 : AXP, AMGN, APC, ESRX, AFL, EQR, AMP, VRTX, MAR, BXP, FISV, NEM", "Should You Buy Vertex Pharmaceuticals (VRTX) Ahead of Earnings? - Tale of the Tape", "Will Vertex Pharmaceuticals (VRTX) Loss be Below Estimates? - Analyst Blog", "Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Analyst Blog", "Vertex Pharmaceuticals' Kalydeco Label Expanded in EU - Analyst Blog", "Vertex Pharmaceuticals Inc. (VRTX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report", "Merck, Gilead Lead Race To Eradicate Hepatitis C", "Biotech Stock Roundup: Vertex Jumps on Phase III Data, MannKind Scores FDA Approval - Analyst Blog", "Vertex Pharmaceuticals Up on Kalydeco sNDA Submission - Analyst Blog", "Vertex Pharmaceuticals' Kalydeco Wins Positive EU Opinion - Analyst Blog", "Sector Update: Health Care", "Sector Update: Health-Care Shares Fairly Flat Pre-Market", "Nasdaq 100 Movers: VRTX, MYL", "Sector Update: Healthcare Stocks Drifting Lower; Vertex Pharma Falling Despite Recommendation For Additional Indications for Cystic Fibrosis Drug", "Sector Update: Healthcare", "Vertex Pharma Skyrockets on Cystic Fibrosis Drug Trial Results - Analyst Blog", "Strength Seen in Vertex Pharmaceuticals Incorporated (VRTX) as Stock Shoots 40.41% - Tale of the Tape", "Micron Gains On Upbeat Earnings; Elizabeth Arden Shares Slide", "S&P 500 Movers: ICE, VRTX", "Nasdaq 100 Movers: BRCM, VRTX", "Are Biotech Stocks Overdue for a Summer Pullback?", "The Seasonally Quiet Period - Ahead of Wall Street", "US Stock Futures Mixed as Home Prices Miss Expectations; Nasdaq Slightly Higher", "Sector Update: Healthcare", "Sector Update: Shares Steady Pre-Market; Vertex Surges 53% on Results of Study on Cystic Fibrosis Lung Treatment", "US Futures Slip With European Stocks And Ahead of Home Price, Sales and Consumer Data", "Pre-Market Most Active for Jun 24, 2014 : BSBR, VRTX, MU, RDS/A, VOD, SYT, WAG, BBRY, XIV, FB, MT, GFI", "Tuesday's ETF Movers: FBT, FCG", "Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Misses Estimates", "Sector Update: Healthcare Stocks Rising This Afternoon; Vertex Pharmaceuticals Surging on Late-Stage Study Results for Prospective Cystic Fibrosis Drug", "Sector Update: Healthcare", "Nasdaq 100 Movers: NVDA, TSLA", "Dow 30 Stock Roundup: Intel Ups Q2 Guidance, Boeing Set to Win China Eastern's $7.4B Order - Analyst Blog", "Vertex Pharmaceuticals-Johnson & Johnson Collaborate on Flu Drug - Analyst Blog", "Vertex Pharmaceuticals Crumbles on Analyst Worries - Analyst Blog", "Nasdaq 100 Movers: YHOO, TSLA", "Utility Sector Rises; Elizabeth Arden Shares Slide Over 3.6%", "Sector Update: Healthcare Stocks Rising This Afternoon; Vertex Pharmaceuticals Surging on Late-Stage Study Results for Prospective Cystic Fibrosis Drug", "Positive Data on Vertex Pharma's Kalydeco - Analyst Blog", "Stock Market News for June 02, 2014 - Market News", "Nasdaq 100 Movers: AVGO, TSLA", "Vertex Pharmaceuticals (VRTX) Shares Cross Above 200 DMA", "Sector Update: Healthcare Shares Mixed; Vertex Up 6% on Positive Coverage", "Sector Update: Healthcare", "S&P 500 Movers: YHOO, COV", "Nasdaq 100 Movers: EXPE, WYNN", "Host Hotels & Resorts Now #263 Largest Company, Surpassing Vertex Pharmaceuticals", "After-Hours Earnings Report for May 1, 2014 : KRFT, PSA, WYNN, LNKD, VRTX, NU, DVA, FLR, SBAC, MHK, AKAM, FLT", "Is Actavis (ACT) Poised to Beat Earnings Estimates? - Analyst Blog", "Will Forest Labs (FRX) Keep Its Earnings Streak Alive? - Analyst Blog", "Progenics Finishes Patient Enrollment - Analyst Blog", "Johnson & Johnson Boosts Dividend 6.1% - Analyst Blog", "Vertex Down on Wider-than-Expected Loss - Analyst Blog", "The Medicines Co.'s Q1 Earnings Surpass Expectations - Analyst Blog", "Teradyne Beats on Q1 Earnings, Revs - Analyst Blog", "Medivation Signs Deal with OncoFusion Therapeutics - Analyst Blog", "Can Microsoft (MSFT) Keep the Earnings Streak Alive? - Analyst Blog", "Will KLA-Tencor (KLAC) Outperform Earnings? - Analyst Blog", "Biogen's Q1 Earnings Soar Y/Y on Tecfidera Sales - Analyst Blog", "Vertex Pharmaceuticals (VRTX) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape", "IBB, CELG, VRTX, BMRN: Large Inflows Detected at ETF", "BioMed Realty Trust Leases Space To Life Science Firms", "Nasdaq 100 Movers: BIIB, INTU", "S&P 500 Movers: BTU, VFC", "Nasdaq 100 Movers: VIP, REGN", "Vertex' Kalydeco Approved for an Additional Indication - Analyst Blog", "Loss Widens at Vertex, Guidance Disappoints - Analyst Blog", "After-Hours Earnings Report for January 29, 2014 : QCOM, FB, LVS, VRTX, SYMC, AVB, MUR, CTXS, TSCO, SLG, CLB, LRCX", "S&P 500 Analyst Moves: VRTX", "BioMed Realty Trust Leases Space To Life Science Firms", "Nasdaq 100 Movers: BIIB, INTU", "S&P 500 Movers: BTU, VFC", "Narrower-than-Expected Loss at Achillion, Shares Up - Analyst Blog", "VRTX Shares Down on Q3 Results - Analyst Blog", "After-Hours Earnings Report for October 29, 2013 : GILD, BIDU, AFL, LNKD, AMP, VRTX, BXP, EIX, FISV, RRC, WU, KIM", "Healthcare Stocks Unable to Gain Much Traction Today; Vertex Pharma Slips After Arthritis Drug Has High Rate of Adverse Events", "Setback for Vertex Pharma - Analyst Blog", "Setback for Achillion - Analyst Blog", "AbbVie in another Deal with Galapagos - Analyst Blog", "After Hours Most Active for Sep 20, 2013 : AMD, VRTX, AME, SAI, MSFT, FB, BAC, KRFT, FCX, GM, SIRI, QCOM", "U.S. Patent Allowance for BioLineRx' BL-8020 - Analyst Blog", "Bonds, Stocks Rally in Response to Larry Summers Withdrawal", "Market Close Report: NASDAQ Composite index closes at 3,722.18 up 6.21 points", "Sector Update: Healthcare Shares Mixed Pre-Market; Bristol-Myers Study on Yervoy Misses Endpoint", "Sector Update: Healthcare", "After Hours Most Active for Aug 16, 2013 : BAC, SNV, QQQ, QCOM, PGR, SE, RSG, FE, VRTX, DELL, GILD, CA", "Wider Loss at Achillion in Q2 - Analyst Blog", "Vertex Pharma Posts In-Line 2Q Loss - Analyst Blog", "After-Hours Earnings Report for July 29, 2013 : ESRX, APC, GGP, VRTX, HIG, EMN, XL, FMC, AGNC, PCL, JEC, MAS", "Partial Clinical Hold on VRTX' Candidate, Shares Down - Analyst Blog", "Benzinga Market Primer: Friday, July 26: Futures Flat On Mixed Global Stocks Overnight", "Zynga, Expedia, and Vertex Pharmaceuticals Get Downgraded", "Sector Update: Healthcare", "Chelsea's NDA for Northera Accepted - Analyst Blog", "Setback for Achillion - Analyst Blog", "Another Setback for Idenix - Analyst Blog", "Market Close Report: NASDAQ Composite index closes at 3,469.22 up 45.17 points", "Mid-Afternoon Market Update: Markets Cool Off Slightly, Vertex Rises", "Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog", "Benzinga Market Primer: Wednesday, May 1", "Pacira Reports New Data - Analyst Blog", "Chelsea's NDA for Northera Accepted - Analyst Blog", "Merck - BMY in HCV Deal - Analyst Blog", "FDA Approves Novartis' Simbrinza - Analyst Blog", "Merck In-Licenses from Xenon - Analyst Blog", "Market Close Report: NASDAQ Composite index closes at 3,233.55 up 27.49 points", "Mid-Morning Market Update: Markets Mixed, General Electric Q1 Profit Surges 16%", "Pre-Market Most Active for Apr 19, 2013 : DELL, GE, VOD, QQQ, TOT, MSFT, BAC, VRTX, SAP, NOK, BIOS, DEO", "Benzinga Market Primer: Tuesday, April 30", "PSTI Plans to Start Phase I Study - Analyst Blog", "BMY, Santaris Pharma Team Up - Analyst Blog", "Vertex CF Candidate Impresses - Analyst Blog", "Mid-Day Market Update: Celanese Jumps On Upbeat Results, Rambus Declines", "After Hours Most Active for Apr 18, 2013 : QQQ, JCP, MSFT, VRTX, HTA, BAC, AMD, IBM, VMED, MDLZ, NOK, ORCL", "Achillion's HCV Candidates Progress - Analyst Blog", "Actelion Beats Earnings, Sales Rise - Analyst Blog", "Market Close Report: NASDAQ Composite index closes at 3,206.06 up 39.70 points", "Vertex-Bristol-Myers Collaborate for HCV - Analyst Blog", "Label Expansion for Roche's Pegasys - Analyst Blog", "Regeneron Pharmaceuticals Inc (REGN): Today's Most Compelling Buy", "Market Close Report: NASDAQ Composite index closes at 3,244.37 up 12.28 points", "Vertex Flu Drug Shows Promise - Analyst Blog", "Kalydeco Funding Cleared in Ireland - Analyst Blog", "Market Close Report: NASDAQ Composite index closes at 3,142.31 down -11.35 points", "Roche Teams Up with Ascletis - Analyst Blog", "After-Hours Earnings Report for January 29, 2013 : AMZN, ACE, BRCM, BXP, VRTX, RHI, QGEN, AJG, JLL, FSL, SLGN, AZPN", "Safest Way to Play Biotech - Cook`s Kitchen", "Vertex attracts unusual time strategy", "Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC", "Canada Approves Vertex's Kalydeco - Analyst Blog", "Market Close Report: NASDAQ Composite index closes at 2,836.94 down -9.87 points", "Disappointing Quarter from Vertex - Analyst Blog", "4Q Revenues Decline at Vertex - Analyst Blog", "Market Close Report: NASDAQ Composite index closes at 2,982.13 down -37.93 points", "How one investor is hedging Vertex", "Trade gives Vertex more room to rally", "After Hours Most Active for Oct 8, 2012 : QQQ, ACTV, BAC, INTC, QCOM, EW, VRTX, WFC, BSBR, PFE, TLAB, EXXI", "Mixed Results from Vertex Studies - Analyst Blog", "Vertex Misses, Cuts Incivek Outlook - Analyst Blog", "EU Approval for Vertex's Kalydeco - Analyst Blog", "Benzinga Mid-Morning Market Update", "Pre-Market Most Active for Jun 28, 2012 : BAC, BCS, JPM, ARNA, VRTX, NOK, OREX, C, ETP, EBAY, FB, QQQ", "Follow-Up Data on Vertex's Kalydeco - Analyst Blog", "Vertex Corrects Earlier Interim Data - Analyst Blog", "CHMP Positive on Vertex's Kalydeco - Analyst Blog", "Pre-Market Most Active for May 29, 2012 : VRTX, BAC, NOK, LCRY, FB, GNOM, STD, BHP, GRFS, AMRN, BUD, C", "Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN", "Vertex Pharma's CF Drug Outperforms - Analyst Blog", "Vertex Presents Phase II Data - Analyst Blog", "Pre-Market Most Active for May 7, 2012 : AIG, HMC, VRTX, T, NYB, BAC, DPZ, SIRI, ERIC, QQQ, ZNGA, AAPL", "Western Markets Shake Off Euro Election Jitters: Daily Markets Wrap.", "Merck Beats by a Penny; Affirms View - Analyst Blog", "Vertex Reports Positive Data on Incivek - Analyst Blog", "Vertex' HCV-HIV Treatment Impresses - Analyst Blog", "Positive Data on VRTX Combo Therapy - Analyst Blog", "3 Killer Criteria for Super Swing Trades - Weekend Wisdom", "Dow Endures a 198-Point Collapse as Greece Takes the Reins", "Are Portfolio Managers Irrational? - Cook`s Kitchen", "Incivek Catalyst at Play for Vertex - Analyst Blog", "Company News for February 1, 2012 - Corporate Summary", "The Zacks Analyst Blog Highlights: Gilead Sciences, Bristol-Myers Squibb, Inhibitex, Vertex Pharmaceuticals and Merck - Press Releases", "Gilead Clinches Pharmasset Buy - Analyst Blog", "Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo - Press Releases", "Spotlight on Hepatitis-C Market - Analyst Blog", "Label Update for Merck's Victrelis - Analyst Blog", "Stocks Lower at Session's Half as Europe Debt Regains Focus; Commodities Lower", "Mid-Day Update: Stocks Adding to Early Losses; Europe, Manufacturing Data Weigh", "Pfizer Poised to Introduce Blockbuster Arthritis Pill", "Healthcare Takeovers Targets: Express Scripts Buys Medco", "The Cancer Conference Trade: Picking Up Biotech Bargains", "Stocks Follow Global Markets Lower on European Debt Worries", "Mid-Day Update: Stocks Ensconced in Red as European Debt Overhangs World Markets", "Biotech Update: Pharmasset\u2019s Hepatitis C Drug Shows 100% Cure Rate in Ph2 Trial", "Mid-Day Update: Stocks Mixed as GDP Data Weighs; Jobless Claims Rise", "FDA to review Hepatitis C medications this week", "Stocks Positive at Mid-Day, Despite Disappointing Consumer, Housing Price Data", "Mid-Day Update: Stocks Higher as Investors Shrug Off Disappointing Consumer Confidence Data", "11 Famous Health Care Stocks to Sell", "Stocks Mixed at Session's Half on Slowing Q1 Economy; Crude Futures Advance"], "Elapsed Time": ["3 HOURS AGO", "1 DAY AGO", "1 DAY AGO", "4 DAYS AGO", "4 DAYS AGO", "JUN 7, 2020", "JUN 6, 2020", "JUN 6, 2020", "3 HOURS AGO", "1 DAY AGO", "1 DAY AGO", "4 DAYS AGO", "4 DAYS AGO", "JUN 7, 2020", "JUN 6, 2020", "JUN 6, 2020", "3 HOURS AGO", "MAY 24, 2020", "MAY 21, 2020", "MAY 20, 2020", "MAY 19, 2020", "MAY 18, 2020", "MAY 16, 2020", "MAY 11, 2020", "MAY 24, 2020", "MAY 10, 2020", "MAY 10, 2020", "MAY 8, 2020", "MAY 3, 2020", "MAY 2, 2020", "MAY 1, 2020", "APR 30, 2020", "MAY 11, 2020", "APR 30, 2020", "APR 30, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 28, 2020", "APR 28, 2020", "APR 30, 2020", "APR 27, 2020", "APR 23, 2020", "APR 23, 2020", "APR 22, 2020", "APR 22, 2020", "APR 20, 2020", "APR 17, 2020", "APR 27, 2020", "APR 16, 2020", "APR 15, 2020", "APR 12, 2020", "APR 10, 2020", "APR 10, 2020", "APR 8, 2020", "APR 3, 2020", "APR 17, 2020", "APR 1, 2020", "APR 1, 2020", "MAR 31, 2020", "MAR 30, 2020", "MAR 30, 2020", "MAR 29, 2020", "MAR 27, 2020", "APR 2, 2020", "MAR 27, 2020", "MAR 25, 2020", "MAR 24, 2020", "MAR 23, 2020", "MAR 22, 2020", "MAR 18, 2020", "MAR 18, 2020", "MAR 27, 2020", "MAR 16, 2020", "MAR 11, 2020", "MAR 10, 2020", "MAR 10, 2020", "MAR 10, 2020", "MAR 9, 2020", "MAR 7, 2020", "MAR 17, 2020", "MAR 5, 2020", "MAR 5, 2020", "MAR 3, 2020", "MAR 3, 2020", "MAR 1, 2020", "FEB 28, 2020", "FEB 26, 2020", "MAR 5, 2020", "FEB 23, 2020", "FEB 21, 2020", "FEB 19, 2020", "FEB 19, 2020", "FEB 18, 2020", "FEB 16, 2020", "FEB 10, 2020", "FEB 26, 2020", "FEB 6, 2020", "FEB 2, 2020", "JAN 31, 2020", "JAN 30, 2020", "JAN 30, 2020", "JAN 30, 2020", "JAN 30, 2020", "FEB 7, 2020", "JAN 29, 2020", "JAN 27, 2020", "JAN 26, 2020", "JAN 25, 2020", "JAN 23, 2020", "JAN 23, 2020", "JAN 22, 2020", "JAN 30, 2020", "JAN 20, 2020", "JAN 17, 2020", "JAN 15, 2020", "JAN 14, 2020", "JAN 13, 2020", "JAN 13, 2020", "JAN 9, 2020", "JAN 21, 2020", "JAN 9, 2020", "JAN 8, 2020", "JAN 8, 2020", "JAN 6, 2020", "JAN 6, 2020", "JAN 5, 2020", "JAN 4, 2020", "JAN 9, 2020", "JAN 3, 2020", "DEC 30, 2019", "DEC 29, 2019", "DEC 23, 2019", "DEC 22, 2019", "DEC 19, 2019", "DEC 18, 2019", "JAN 4, 2020", "DEC 17, 2019", "DEC 13, 2019", "DEC 8, 2019", "DEC 6, 2019", "DEC 4, 2019", "DEC 3, 2019", "DEC 1, 2019", "DEC 18, 2019", "NOV 27, 2019", "NOV 26, 2019", "NOV 25, 2019", "NOV 24, 2019", "NOV 23, 2019", "NOV 22, 2019", "NOV 22, 2019", "NOV 29, 2019", "NOV 20, 2019", "NOV 19, 2019", "NOV 19, 2019", "NOV 19, 2019", "NOV 19, 2019", "NOV 17, 2019", "NOV 12, 2019", "NOV 21, 2019", "NOV 11, 2019", "NOV 10, 2019", "NOV 6, 2019", "NOV 4, 2019", "OCT 31, 2019", "OCT 31, 2019", "OCT 30, 2019", "NOV 12, 2019", "OCT 30, 2019", "OCT 28, 2019", "OCT 27, 2019", "OCT 26, 2019", "OCT 25, 2019", "OCT 25, 2019", "OCT 24, 2019", "OCT 30, 2019", "OCT 24, 2019", "OCT 24, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 17, 2019", "OCT 15, 2019", "OCT 11, 2019", "OCT 24, 2019", "OCT 8, 2019", "OCT 4, 2019", "OCT 3, 2019", "OCT 2, 2019", "OCT 1, 2019", "OCT 1, 2019", "SEP 27, 2019", "OCT 8, 2019", "SEP 22, 2019", "SEP 21, 2019", "SEP 20, 2019", "SEP 18, 2019", "SEP 16, 2019", "SEP 15, 2019", "SEP 11, 2019", "SEP 23, 2019", "SEP 4, 2019", "SEP 4, 2019", "SEP 1, 2019", "AUG 28, 2019", "AUG 28, 2019", "AUG 27, 2019", "AUG 22, 2019", "SEP 4, 2019", "AUG 20, 2019", "AUG 20, 2019", "AUG 11, 2019", "AUG 9, 2019", "AUG 6, 2019", "AUG 4, 2019", "AUG 1, 2019", "AUG 22, 2019", "AUG 1, 2019", "JUL 31, 2019", "JUL 31, 2019", "JUL 29, 2019", "JUL 29, 2019", "JUL 25, 2019", "JUL 25, 2019", "AUG 1, 2019", "JUL 23, 2019", "JUL 22, 2019", "JUL 19, 2019", "JUL 18, 2019", "JUL 15, 2019", "JUL 14, 2019", "JUL 12, 2019", "JUL 23, 2019", "JUL 9, 2019", "JUL 8, 2019", "JUL 3, 2019", "JUL 1, 2019", "JUN 29, 2019", "JUN 27, 2019", "JUN 25, 2019", "JUL 10, 2019", "JUN 22, 2019", "JUN 21, 2019", "JUN 20, 2019", "JUN 18, 2019", "JUN 17, 2019", "JUN 16, 2019", "JUN 14, 2019", "JUN 25, 2019", "JUN 12, 2019", "JUN 9, 2019", "JUN 9, 2019", "JUN 7, 2019", "JUN 7, 2019", "JUN 7, 2019", "JUN 7, 2019", "JUN 14, 2019", "MAY 30, 2019", "MAY 26, 2019", "MAY 23, 2019", "MAY 19, 2019", "MAY 13, 2019", "MAY 12, 2019", "MAY 7, 2019", "JUN 6, 2019", "MAY 2, 2019", "MAY 2, 2019", "MAY 1, 2019", "APR 30, 2019", "APR 30, 2019", "APR 30, 2019", "APR 28, 2019", "MAY 2, 2019", "APR 23, 2019", "APR 19, 2019", "APR 19, 2019", "APR 19, 2019", "APR 18, 2019", "APR 17, 2019", "APR 17, 2019", "APR 24, 2019", "APR 17, 2019", "APR 17, 2019", "APR 17, 2019", "APR 16, 2019", "APR 9, 2019", "APR 9, 2019", "APR 9, 2019", "APR 17, 2019", "APR 5, 2019", "APR 5, 2019", "APR 5, 2019", "APR 2, 2019", "APR 1, 2019", "MAR 31, 2019", "MAR 28, 2019", "APR 5, 2019", "MAR 25, 2019", "MAR 24, 2019", "MAR 22, 2019", "MAR 21, 2019", "MAR 13, 2019", "MAR 13, 2019", "MAR 11, 2019", "MAR 26, 2019", "MAR 7, 2019", "MAR 7, 2019", "MAR 7, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 5, 2019", "MAR 10, 2019", "FEB 28, 2019", "FEB 27, 2019", "FEB 27, 2019", "FEB 26, 2019", "FEB 25, 2019", "FEB 25, 2019", "FEB 24, 2019", "MAR 1, 2019", "FEB 21, 2019", "FEB 21, 2019", "FEB 20, 2019", "FEB 17, 2019", "FEB 11, 2019", "FEB 11, 2019", "FEB 10, 2019", "FEB 22, 2019", "FEB 8, 2019", "FEB 8, 2019", "FEB 7, 2019", "FEB 7, 2019", "FEB 6, 2019", "FEB 6, 2019", "FEB 6, 2019", "FEB 8, 2019", "FEB 5, 2019", "FEB 5, 2019", "FEB 5, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 5, 2019", "JAN 31, 2019", "JAN 31, 2019", "JAN 30, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "FEB 1, 2019", "JAN 25, 2019", "JAN 24, 2019", "JAN 23, 2019", "JAN 23, 2019", "JAN 23, 2019", "JAN 23, 2019", "JAN 23, 2019", "JAN 26, 2019", "JAN 23, 2019", "JAN 22, 2019", "JAN 22, 2019", "JAN 21, 2019", "JAN 21, 2019", "JAN 16, 2019", "JAN 12, 2019", "JAN 23, 2019", "JAN 10, 2019", "JAN 9, 2019", "JAN 8, 2019", "JAN 7, 2019", "JAN 6, 2019", "JAN 4, 2019", "JAN 3, 2019", "JAN 11, 2019", "DEC 20, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 19, 2018", "DEC 19, 2018", "DEC 18, 2018", "DEC 17, 2018", "DEC 27, 2018", "DEC 13, 2018", "DEC 13, 2018", "DEC 7, 2018", "DEC 1, 2018", "NOV 30, 2018", "NOV 30, 2018", "NOV 29, 2018", "DEC 14, 2018", "NOV 28, 2018", "NOV 27, 2018", "NOV 27, 2018", "NOV 27, 2018", "NOV 27, 2018", "NOV 27, 2018", "NOV 27, 2018", "NOV 28, 2018", "NOV 21, 2018", "NOV 21, 2018", "NOV 21, 2018", "NOV 21, 2018", "NOV 19, 2018", "NOV 9, 2018", "NOV 9, 2018", "NOV 27, 2018", "NOV 8, 2018", "NOV 8, 2018", "NOV 2, 2018", "NOV 2, 2018", "NOV 1, 2018", "NOV 1, 2018", "OCT 30, 2018", "NOV 8, 2018", "OCT 28, 2018", "OCT 27, 2018", "OCT 25, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 23, 2018", "OCT 29, 2018", "OCT 22, 2018", "OCT 19, 2018", "OCT 17, 2018", "OCT 17, 2018", "OCT 11, 2018", "OCT 11, 2018", "OCT 10, 2018", "OCT 22, 2018", "OCT 8, 2018", "OCT 5, 2018", "OCT 3, 2018", "SEP 28, 2018", "SEP 28, 2018", "SEP 27, 2018", "SEP 19, 2018", "OCT 9, 2018", "SEP 14, 2018", "SEP 12, 2018", "SEP 10, 2018", "SEP 7, 2018", "SEP 6, 2018", "SEP 6, 2018", "SEP 5, 2018", "SEP 16, 2018", "SEP 4, 2018", "SEP 2, 2018", "SEP 1, 2018", "AUG 31, 2018", "AUG 30, 2018", "AUG 24, 2018", "AUG 24, 2018", "SEP 5, 2018", "AUG 23, 2018", "AUG 23, 2018", "AUG 23, 2018", "AUG 22, 2018", "AUG 21, 2018", "AUG 20, 2018", "AUG 20, 2018", "AUG 24, 2018", "AUG 17, 2018", "AUG 17, 2018", "AUG 16, 2018", "AUG 14, 2018", "AUG 13, 2018", "AUG 10, 2018", "AUG 9, 2018", "AUG 17, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 9, 2018", "AUG 8, 2018", "AUG 7, 2018", "AUG 7, 2018", "AUG 2, 2018", "AUG 2, 2018", "AUG 1, 2018", "AUG 1, 2018", "AUG 8, 2018", "JUL 27, 2018", "JUL 26, 2018", "JUL 26, 2018", "JUL 25, 2018", "JUL 25, 2018", "JUL 24, 2018", "JUL 23, 2018", "JUL 30, 2018", "JUL 8, 2018", "JUL 3, 2018", "JUL 2, 2018", "JUL 2, 2018", "JUL 2, 2018", "JUN 29, 2018", "JUN 29, 2018", "JUL 9, 2018", "JUN 29, 2018", "JUN 29, 2018", "JUN 29, 2018", "JUN 26, 2018", "JUN 25, 2018", "JUN 20, 2018", "JUN 20, 2018", "JUN 29, 2018", "JUN 12, 2018", "JUN 11, 2018", "JUN 8, 2018", "JUN 6, 2018", "JUN 5, 2018", "JUN 5, 2018", "JUN 1, 2018", "JUN 14, 2018", "MAY 31, 2018", "MAY 31, 2018", "MAY 31, 2018", "MAY 30, 2018", "MAY 28, 2018", "MAY 25, 2018", "MAY 24, 2018", "MAY 31, 2018", "MAY 21, 2018", "MAY 16, 2018", "MAY 15, 2018", "MAY 11, 2018", "MAY 11, 2018", "MAY 10, 2018", "MAY 9, 2018", "MAY 24, 2018", "MAY 8, 2018", "MAY 8, 2018", "MAY 2, 2018", "MAY 2, 2018", "APR 30, 2018", "APR 29, 2018", "APR 27, 2018", "MAY 9, 2018", "APR 26, 2018", "APR 26, 2018", "APR 24, 2018", "APR 24, 2018", "APR 18, 2018", "APR 16, 2018", "APR 13, 2018", "APR 26, 2018", "APR 12, 2018", "APR 12, 2018", "APR 10, 2018", "APR 9, 2018", "APR 6, 2018", "APR 5, 2018", "APR 4, 2018", "APR 13, 2018", "MAR 23, 2018", "MAR 23, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 15, 2018", "MAR 15, 2018", "MAR 13, 2018", "MAR 28, 2018", "MAR 9, 2018", "MAR 7, 2018", "MAR 6, 2018", "MAR 3, 2018", "MAR 2, 2018", "FEB 28, 2018", "FEB 28, 2018", "MAR 13, 2018", "FEB 21, 2018", "FEB 20, 2018", "FEB 19, 2018", "FEB 16, 2018", "FEB 16, 2018", "FEB 16, 2018", "FEB 16, 2018", "FEB 23, 2018", "FEB 21, 2018", "FEB 15, 2018", "FEB 15, 2018", "FEB 14, 2018", "FEB 13, 2018", "FEB 13, 2018", "FEB 15, 2018", "FEB 8, 2018", "FEB 8, 2018", "FEB 8, 2018", "FEB 8, 2018", "FEB 8, 2018", "FEB 7, 2018", "FEB 7, 2018", "FEB 12, 2018", "FEB 5, 2018", "FEB 3, 2018", "FEB 2, 2018", "FEB 1, 2018", "FEB 1, 2018", "FEB 1, 2018", "FEB 1, 2018", "FEB 5, 2018", "JAN 31, 2018", "JAN 31, 2018", "JAN 31, 2018", "JAN 31, 2018", "JAN 30, 2018", "JAN 29, 2018", "JAN 29, 2018", "FEB 1, 2018", "JAN 31, 2018", "JAN 26, 2018", "JAN 26, 2018", "JAN 25, 2018", "JAN 25, 2018", "JAN 25, 2018", "JAN 24, 2018", "JAN 29, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 18, 2018", "JAN 18, 2018", "JAN 18, 2018", "JAN 18, 2018", "JAN 18, 2018", "JAN 23, 2018", "JAN 17, 2018", "JAN 17, 2018", "JAN 16, 2018", "JAN 16, 2018", "JAN 15, 2018", "JAN 12, 2018", "JAN 12, 2018", "JAN 18, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 10, 2018", "JAN 10, 2018", "JAN 10, 2018", "JAN 10, 2018", "JAN 10, 2018", "JAN 10, 2018", "JAN 10, 2018", "JAN 11, 2018", "JAN 9, 2018", "JAN 9, 2018", "JAN 9, 2018", "JAN 8, 2018", "JAN 8, 2018", "JAN 8, 2018", "JAN 8, 2018", "JAN 9, 2018", "JAN 5, 2018", "JAN 4, 2018", "JAN 4, 2018", "JAN 3, 2018", "JAN 3, 2018", "JAN 3, 2018", "JAN 3, 2018", "JAN 6, 2018", "JAN 2, 2018", "JAN 2, 2018", "DEC 29, 2017", "DEC 29, 2017", "DEC 27, 2017", "DEC 27, 2017", "DEC 27, 2017", "JAN 3, 2018", "DEC 26, 2017", "DEC 26, 2017", "DEC 26, 2017", "DEC 26, 2017", "DEC 22, 2017", "DEC 22, 2017", "DEC 22, 2017", "DEC 27, 2017", "DEC 22, 2017", "DEC 22, 2017", "DEC 22, 2017", "DEC 21, 2017", "DEC 21, 2017", "DEC 21, 2017", "DEC 21, 2017", "DEC 22, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 19, 2017", "DEC 19, 2017", "DEC 13, 2017", "DEC 20, 2017", "DEC 11, 2017", "DEC 11, 2017", "DEC 11, 2017", "DEC 11, 2017", "DEC 10, 2017", "DEC 8, 2017", "DEC 8, 2017", "DEC 13, 2017", "DEC 5, 2017", "DEC 5, 2017", "DEC 3, 2017", "NOV 28, 2017", "NOV 28, 2017", "NOV 27, 2017", "NOV 26, 2017", "DEC 7, 2017", "NOV 22, 2017", "NOV 21, 2017", "NOV 20, 2017", "NOV 20, 2017", "NOV 20, 2017", "NOV 17, 2017", "NOV 15, 2017", "NOV 22, 2017", "NOV 9, 2017", "NOV 6, 2017", "NOV 3, 2017", "NOV 3, 2017", "NOV 1, 2017", "OCT 31, 2017", "OCT 31, 2017", "NOV 13, 2017", "OCT 31, 2017", "OCT 27, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 25, 2017", "OCT 31, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 25, 2017", "OCT 23, 2017", "OCT 23, 2017", "OCT 20, 2017", "OCT 20, 2017", "OCT 18, 2017", "OCT 18, 2017", "OCT 23, 2017", "OCT 16, 2017", "OCT 15, 2017", "OCT 13, 2017", "OCT 13, 2017", "OCT 13, 2017", "OCT 11, 2017", "OCT 11, 2017", "OCT 17, 2017", "OCT 10, 2017", "OCT 10, 2017", "OCT 9, 2017", "OCT 4, 2017", "OCT 3, 2017", "OCT 3, 2017", "SEP 29, 2017", "OCT 10, 2017", "SEP 27, 2017", "SEP 26, 2017", "SEP 25, 2017", "SEP 24, 2017", "SEP 20, 2017", "SEP 19, 2017", "SEP 18, 2017", "SEP 28, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 7, 2017", "SEP 6, 2017", "SEP 6, 2017", "SEP 5, 2017", "SEP 13, 2017", "SEP 1, 2017", "SEP 1, 2017", "AUG 31, 2017", "AUG 30, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 29, 2017", "SEP 5, 2017", "AUG 24, 2017", "AUG 23, 2017", "AUG 23, 2017", "AUG 22, 2017", "AUG 22, 2017", "AUG 22, 2017", "AUG 22, 2017", "AUG 25, 2017", "AUG 21, 2017", "AUG 17, 2017", "AUG 16, 2017", "AUG 16, 2017", "AUG 15, 2017", "AUG 14, 2017", "AUG 14, 2017", "AUG 22, 2017", "AUG 14, 2017", "AUG 11, 2017", "AUG 11, 2017", "AUG 11, 2017", "AUG 9, 2017", "AUG 8, 2017", "AUG 4, 2017", "AUG 14, 2017", "AUG 3, 2017", "AUG 2, 2017", "JUL 28, 2017", "JUL 28, 2017", "JUL 27, 2017", "JUL 27, 2017", "JUL 27, 2017", "AUG 3, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 27, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 24, 2017", "JUL 24, 2017", "JUL 24, 2017", "JUL 25, 2017", "JUL 24, 2017", "JUL 24, 2017", "JUL 21, 2017", "JUL 21, 2017", "JUL 21, 2017", "JUL 21, 2017", "JUL 21, 2017", "JUL 24, 2017", "JUL 21, 2017", "JUL 21, 2017", "JUL 20, 2017", "JUL 20, 2017", "JUL 20, 2017", "JUL 20, 2017", "JUL 20, 2017", "JUL 21, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 18, 2017", "JUL 18, 2017", "JUL 19, 2017", "JUL 15, 2017", "JUL 14, 2017", "JUL 14, 2017", "JUL 13, 2017", "JUL 13, 2017", "JUL 13, 2017", "JUL 12, 2017", "JUL 17, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 10, 2017", "JUL 10, 2017", "JUL 5, 2017", "JUL 3, 2017", "JUL 3, 2017", "JUL 12, 2017", "JUN 29, 2017", "JUN 28, 2017", "JUN 23, 2017", "JUN 23, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUN 20, 2017", "JUL 3, 2017", "JUN 14, 2017", "JUN 14, 2017", "JUN 14, 2017", "JUN 8, 2017", "JUN 8, 2017", "JUN 6, 2017", "JUN 6, 2017", "JUN 19, 2017", "JUN 5, 2017", "JUN 4, 2017", "JUN 3, 2017", "JUN 2, 2017", "JUN 2, 2017", "JUN 1, 2017", "MAY 31, 2017", "JUN 5, 2017", "MAY 30, 2017", "MAY 24, 2017", "MAY 24, 2017", "MAY 19, 2017", "MAY 18, 2017", "MAY 18, 2017", "MAY 18, 2017", "MAY 30, 2017", "MAY 17, 2017", "MAY 17, 2017", "MAY 17, 2017", "MAY 16, 2017", "MAY 14, 2017", "MAY 11, 2017", "MAY 9, 2017", "MAY 18, 2017", "MAY 3, 2017", "MAY 3, 2017", "MAY 1, 2017", "APR 29, 2017", "APR 28, 2017", "APR 27, 2017", "APR 27, 2017", "MAY 8, 2017", "APR 26, 2017", "APR 26, 2017", "APR 24, 2017", "APR 24, 2017", "APR 23, 2017", "APR 18, 2017", "APR 18, 2017", "APR 26, 2017", "APR 13, 2017", "APR 13, 2017", "APR 12, 2017", "APR 12, 2017", "APR 10, 2017", "APR 8, 2017", "APR 7, 2017", "APR 17, 2017", "APR 7, 2017", "APR 6, 2017", "APR 6, 2017", "APR 6, 2017", "APR 6, 2017", "APR 6, 2017", "APR 5, 2017", "APR 7, 2017", "APR 5, 2017", "APR 4, 2017", "APR 4, 2017", "APR 4, 2017", "APR 4, 2017", "APR 3, 2017", "APR 3, 2017", "APR 5, 2017", "APR 5, 2017", "MAR 31, 2017", "MAR 31, 2017", "MAR 30, 2017", "MAR 30, 2017", "MAR 29, 2017", "MAR 29, 2017", "APR 2, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 28, 2017", "MAR 28, 2017", "MAR 17, 2017", "MAR 16, 2017", "MAR 15, 2017", "MAR 10, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 6, 2017", "MAR 6, 2017", "MAR 6, 2017", "MAR 6, 2017", "MAR 6, 2017", "MAR 6, 2017", "MAR 8, 2017", "FEB 28, 2017", "FEB 27, 2017", "FEB 27, 2017", "FEB 22, 2017", "FEB 22, 2017", "FEB 21, 2017", "FEB 13, 2017", "MAR 1, 2017", "FEB 10, 2017", "FEB 9, 2017", "FEB 9, 2017", "JAN 31, 2017", "JAN 26, 2017", "JAN 26, 2017", "JAN 26, 2017", "FEB 12, 2017", "JAN 25, 2017", "JAN 25, 2017", "JAN 25, 2017", "JAN 25, 2017", "JAN 24, 2017", "JAN 24, 2017", "JAN 24, 2017", "JAN 25, 2017", "JAN 20, 2017", "JAN 19, 2017", "JAN 19, 2017", "JAN 18, 2017", "JAN 18, 2017", "JAN 17, 2017", "JAN 12, 2017", "JAN 23, 2017", "JAN 9, 2017", "JAN 9, 2017", "JAN 4, 2017", "JAN 3, 2017", "DEC 29, 2016", "DEC 28, 2016", "DEC 27, 2016", "JAN 11, 2017", "DEC 23, 2016", "DEC 23, 2016", "DEC 23, 2016", "DEC 22, 2016", "DEC 22, 2016", "DEC 20, 2016", "DEC 15, 2016", "DEC 27, 2016", "DEC 7, 2016", "DEC 7, 2016", "DEC 7, 2016", "NOV 30, 2016", "NOV 29, 2016", "NOV 29, 2016", "NOV 23, 2016", "DEC 13, 2016", "NOV 21, 2016", "NOV 16, 2016", "NOV 15, 2016", "NOV 14, 2016", "NOV 11, 2016", "NOV 10, 2016", "NOV 9, 2016", "NOV 22, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 1, 2016", "OCT 31, 2016", "OCT 27, 2016", "OCT 27, 2016", "NOV 9, 2016", "OCT 26, 2016", "OCT 25, 2016", "OCT 25, 2016", "OCT 24, 2016", "OCT 24, 2016", "OCT 24, 2016", "OCT 20, 2016", "OCT 26, 2016", "OCT 13, 2016", "OCT 13, 2016", "OCT 12, 2016", "OCT 5, 2016", "SEP 30, 2016", "SEP 27, 2016", "SEP 22, 2016", "OCT 19, 2016", "SEP 20, 2016", "SEP 16, 2016", "SEP 13, 2016", "SEP 12, 2016", "SEP 8, 2016", "SEP 5, 2016", "AUG 31, 2016", "SEP 21, 2016", "AUG 29, 2016", "AUG 25, 2016", "AUG 25, 2016", "AUG 22, 2016", "AUG 19, 2016", "AUG 18, 2016", "AUG 17, 2016", "AUG 30, 2016", "AUG 10, 2016", "AUG 2, 2016", "AUG 2, 2016", "JUL 28, 2016", "JUL 27, 2016", "JUL 27, 2016", "JUL 27, 2016", "AUG 16, 2016", "JUL 25, 2016", "JUL 23, 2016", "JUL 21, 2016", "JUL 21, 2016", "JUL 11, 2016", "JUL 8, 2016", "JUL 27, 2016", "JUL 26, 2016", "JUL 25, 2016", "JUN 27, 2016", "JUN 24, 2016", "JUN 23, 2016", "JUN 9, 2016", "JUN 9, 2016", "JUL 6, 2016", "JUN 1, 2016", "MAY 28, 2016", "MAY 25, 2016", "MAY 20, 2016", "MAY 19, 2016", "MAY 17, 2016", "MAY 17, 2016", "JUN 1, 2016", "MAY 3, 2016", "MAY 3, 2016", "APR 28, 2016", "APR 28, 2016", "APR 27, 2016", "APR 27, 2016", "APR 27, 2016", "MAY 9, 2016", "APR 25, 2016", "APR 22, 2016", "APR 22, 2016", "APR 18, 2016", "APR 15, 2016", "APR 15, 2016", "APR 13, 2016", "APR 25, 2016", "APR 7, 2016", "APR 7, 2016", "APR 6, 2016", "MAR 23, 2016", "MAR 21, 2016", "MAR 18, 2016", "MAR 16, 2016", "APR 11, 2016", "MAR 9, 2016", "MAR 9, 2016", "MAR 8, 2016", "MAR 4, 2016", "MAR 3, 2016", "MAR 2, 2016", "MAR 1, 2016", "MAR 10, 2016", "FEB 15, 2016", "FEB 12, 2016", "FEB 10, 2016", "FEB 9, 2016", "FEB 8, 2016", "FEB 5, 2016", "FEB 5, 2016", "FEB 17, 2016", "FEB 2, 2016", "JAN 29, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 27, 2016", "JAN 27, 2016", "JAN 26, 2016", "FEB 3, 2016", "JAN 21, 2016", "JAN 20, 2016", "JAN 18, 2016", "JAN 15, 2016", "JAN 13, 2016", "JAN 13, 2016", "JAN 12, 2016", "JAN 25, 2016", "JAN 11, 2016", "DEC 31, 2015", "DEC 29, 2015", "DEC 29, 2015", "DEC 29, 2015", "DEC 27, 2015", "DEC 26, 2015", "JAN 11, 2016", "DEC 22, 2015", "DEC 10, 2015", "DEC 10, 2015", "NOV 27, 2015", "NOV 25, 2015", "NOV 23, 2015", "NOV 22, 2015", "DEC 23, 2015", "NOV 19, 2015", "NOV 18, 2015", "NOV 18, 2015", "NOV 15, 2015", "NOV 7, 2015", "NOV 3, 2015", "NOV 1, 2015", "NOV 20, 2015", "OCT 29, 2015", "OCT 29, 2015", "OCT 28, 2015", "OCT 28, 2015", "OCT 28, 2015", "OCT 27, 2015", "OCT 26, 2015", "OCT 30, 2015", "OCT 14, 2015", "OCT 13, 2015", "OCT 9, 2015", "OCT 8, 2015", "OCT 7, 2015", "OCT 6, 2015", "OCT 2, 2015", "OCT 19, 2015", "SEP 30, 2015", "SEP 29, 2015", "SEP 28, 2015", "SEP 25, 2015", "SEP 25, 2015", "SEP 24, 2015", "SEP 23, 2015", "OCT 1, 2015", "SEP 18, 2015", "SEP 18, 2015", "SEP 17, 2015", "SEP 14, 2015", "AUG 24, 2015", "AUG 13, 2015", "AUG 12, 2015", "SEP 22, 2015", "AUG 10, 2015", "AUG 6, 2015", "AUG 5, 2015", "JUL 30, 2015", "JUL 29, 2015", "JUL 29, 2015", "JUL 29, 2015", "AUG 12, 2015", "JUL 29, 2015", "JUL 28, 2015", "JUL 15, 2015", "JUL 15, 2015", "JUL 9, 2015", "JUL 8, 2015", "JUL 3, 2015", "JUL 29, 2015", "JUN 24, 2015", "JUN 11, 2015", "JUN 10, 2015", "JUN 5, 2015", "JUN 2, 2015", "MAY 30, 2015", "MAY 18, 2015", "JUL 2, 2015", "MAY 14, 2015", "MAY 13, 2015", "MAY 13, 2015", "MAY 13, 2015", "MAY 13, 2015", "MAY 5, 2015", "APR 30, 2015", "MAY 15, 2015", "APR 30, 2015", "APR 29, 2015", "APR 29, 2015", "APR 29, 2015", "APR 29, 2015", "APR 29, 2015", "APR 28, 2015", "APR 30, 2015", "APR 28, 2015", "APR 27, 2015", "APR 17, 2015", "APR 16, 2015", "APR 15, 2015", "APR 15, 2015", "APR 10, 2015", "APR 28, 2015", "APR 1, 2015", "MAR 26, 2015", "MAR 25, 2015", "MAR 24, 2015", "MAR 23, 2015", "MAR 23, 2015", "MAR 23, 2015", "APR 7, 2015", "MAR 23, 2015", "MAR 19, 2015", "MAR 16, 2015", "MAR 11, 2015", "MAR 11, 2015", "MAR 5, 2015", "MAR 4, 2015", "MAR 23, 2015", "FEB 17, 2015", "FEB 16, 2015", "FEB 16, 2015", "FEB 14, 2015", "FEB 4, 2015", "JAN 30, 2015", "JAN 29, 2015", "FEB 26, 2015", "JAN 28, 2015", "JAN 27, 2015", "JAN 16, 2015", "JAN 14, 2015", "JAN 12, 2015", "JAN 2, 2015", "JAN 2, 2015", "JAN 28, 2015", "DEC 31, 2014", "DEC 30, 2014", "DEC 30, 2014", "DEC 29, 2014", "DEC 26, 2014", "DEC 24, 2014", "DEC 11, 2014", "JAN 2, 2015", "DEC 8, 2014", "DEC 8, 2014", "DEC 8, 2014", "DEC 3, 2014", "DEC 1, 2014", "DEC 1, 2014", "NOV 26, 2014", "DEC 10, 2014", "NOV 20, 2014", "NOV 12, 2014", "NOV 11, 2014", "NOV 6, 2014", "NOV 5, 2014", "NOV 5, 2014", "NOV 5, 2014", "NOV 21, 2014", "NOV 20, 2014", "NOV 12, 2014", "OCT 29, 2014", "OCT 28, 2014", "OCT 28, 2014", "OCT 27, 2014", "OCT 27, 2014", "NOV 1, 2014", "OCT 26, 2014", "OCT 24, 2014", "OCT 24, 2014", "OCT 24, 2014", "OCT 24, 2014", "OCT 24, 2014", "OCT 22, 2014", "OCT 27, 2014", "OCT 22, 2014", "OCT 21, 2014", "OCT 21, 2014", "OCT 21, 2014", "OCT 21, 2014", "OCT 21, 2014", "OCT 22, 2014", "OCT 20, 2014", "OCT 19, 2014", "OCT 15, 2014", "OCT 13, 2014", "OCT 13, 2014", "OCT 10, 2014", "OCT 9, 2014", "OCT 20, 2014", "OCT 7, 2014", "OCT 7, 2014", "OCT 2, 2014", "OCT 2, 2014", "OCT 1, 2014", "SEP 24, 2014", "SEP 22, 2014", "OCT 8, 2014", "OCT 7, 2014", "OCT 7, 2014", "SEP 5, 2014", "SEP 5, 2014", "AUG 28, 2014", "AUG 28, 2014", "SEP 19, 2014", "AUG 20, 2014", "AUG 13, 2014", "AUG 13, 2014", "AUG 11, 2014", "AUG 11, 2014", "AUG 6, 2014", "AUG 5, 2014", "AUG 28, 2014", "AUG 4, 2014", "JUL 30, 2014", "JUL 30, 2014", "JUL 29, 2014", "JUL 28, 2014", "JUL 28, 2014", "JUL 16, 2014", "AUG 5, 2014", "JUL 8, 2014", "JUL 3, 2014", "JUL 2, 2014", "JUL 2, 2014", "JUN 30, 2014", "JUN 27, 2014", "JUN 27, 2014", "JUL 14, 2014", "JUN 27, 2014", "JUN 27, 2014", "JUN 25, 2014", "JUN 25, 2014", "JUN 24, 2014", "JUN 24, 2014", "JUN 24, 2014", "JUN 27, 2014", "JUN 24, 2014", "JUN 24, 2014", "JUN 24, 2014", "JUN 24, 2014", "JUN 24, 2014", "JUN 24, 2014", "JUN 24, 2014", "JUN 24, 2014", "JUN 24, 2014", "JUN 24, 2014", "JUN 23, 2014", "JUN 20, 2014", "JUN 19, 2014", "JUN 17, 2014", "JUN 16, 2014", "JUN 24, 2014", "JUN 24, 2014", "JUN 5, 2014", "JUN 2, 2014", "MAY 30, 2014", "MAY 28, 2014", "MAY 22, 2014", "MAY 22, 2014", "JUN 16, 2014", "MAY 2, 2014", "MAY 2, 2014", "MAY 1, 2014", "APR 29, 2014", "APR 28, 2014", "APR 25, 2014", "APR 25, 2014", "MAY 5, 2014", "APR 24, 2014", "APR 24, 2014", "APR 24, 2014", "APR 23, 2014", "APR 23, 2014", "APR 23, 2014", "APR 22, 2014", "APR 24, 2014", "MAR 19, 2014", "MAR 7, 2014", "MAR 7, 2014", "MAR 3, 2014", "FEB 24, 2014", "JAN 30, 2014", "JAN 29, 2014", "APR 1, 2014", "MAR 19, 2014", "MAR 7, 2014", "MAR 7, 2014", "NOV 18, 2013", "NOV 1, 2013", "OCT 29, 2013", "OCT 21, 2013", "DEC 20, 2013", "SEP 30, 2013", "SEP 25, 2013", "SEP 20, 2013", "SEP 19, 2013", "SEP 16, 2013", "SEP 13, 2013", "SEP 12, 2013", "OCT 21, 2013", "AUG 16, 2013", "AUG 15, 2013", "JUL 30, 2013", "JUL 29, 2013", "JUL 26, 2013", "JUL 26, 2013", "JUL 26, 2013", "SEP 12, 2013", "JUL 19, 2013", "JUL 3, 2013", "JUN 21, 2013", "JUN 7, 2013", "JUN 7, 2013", "MAY 1, 2013", "MAY 1, 2013", "JUL 19, 2013", "JUL 19, 2013", "APR 23, 2013", "APR 22, 2013", "APR 22, 2013", "APR 22, 2013", "APR 19, 2013", "APR 19, 2013", "APR 30, 2013", "APR 19, 2013", "APR 19, 2013", "APR 19, 2013", "APR 19, 2013", "APR 18, 2013", "APR 17, 2013", "APR 16, 2013", "APR 19, 2013", "APR 8, 2013", "MAR 21, 2013", "MAR 14, 2013", "MAR 8, 2013", "MAR 6, 2013", "FEB 6, 2013", "JAN 30, 2013", "APR 15, 2013", "JAN 29, 2013", "JAN 25, 2013", "JAN 10, 2013", "DEC 16, 2012", "DEC 10, 2012", "NOV 15, 2012", "NOV 5, 2012", "JAN 30, 2013", "NOV 2, 2012", "OCT 9, 2012", "OCT 9, 2012", "OCT 8, 2012", "SEP 26, 2012", "AUG 1, 2012", "JUL 30, 2012", "NOV 2, 2012", "JUN 28, 2012", "JUN 8, 2012", "MAY 30, 2012", "MAY 29, 2012", "MAY 29, 2012", "MAY 14, 2012", "MAY 8, 2012", "JUN 29, 2012", "MAY 7, 2012", "MAY 7, 2012", "APR 27, 2012", "APR 20, 2012", "MAR 21, 2012", "FEB 29, 2012", "FEB 17, 2012", "MAY 8, 2012", "FEB 8, 2012", "FEB 3, 2012", "FEB 1, 2012", "JAN 20, 2012", "JAN 19, 2012", "DEC 29, 2011", "DEC 6, 2011", "FEB 13, 2012", "OCT 17, 2011", "OCT 17, 2011", "SEP 11, 2011", "JUL 22, 2011", "JUL 21, 2011", "MAY 23, 2011", "MAY 23, 2011", "NOV 9, 2011", "APR 28, 2011", "APR 25, 2011", "MAR 29, 2011", "MAR 29, 2011", "JUL 20, 2010", "APR 28, 2011"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/better-buy%3A-crispr-therapeutics-vs.-sangamo-therapeutics-2020-06-14", "https://www.nasdaq.com/articles/crispr-therapeutics-and-vertex-pharmaceuticals-deliever-new-ctx001-data-2020-06-12", "https://www.nasdaq.com/articles/ibb-vrtx-biib-ilmn%3A-large-outflows-detected-at-etf-2020-06-12", "https://www.nasdaq.com/articles/tuesday-sector-leaders%3A-technology-communications-healthcare-2020-06-09", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-fate-therapeutics-tiffany-moneygram-2020-06-09", "https://www.nasdaq.com/articles/worried-another-stock-market-crash-is-coming-3-things-you-should-do-right-now-2020-06-07", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-in-june-2020-06-06", "https://www.nasdaq.com/articles/2-healthcare-stocks-that-have-a-killer-advantage-2020-06-06", "https://www.nasdaq.com/articles/better-buy%3A-crispr-therapeutics-vs.-sangamo-therapeutics-2020-06-14", "https://www.nasdaq.com/articles/crispr-therapeutics-and-vertex-pharmaceuticals-deliever-new-ctx001-data-2020-06-12", "https://www.nasdaq.com/articles/ibb-vrtx-biib-ilmn%3A-large-outflows-detected-at-etf-2020-06-12", "https://www.nasdaq.com/articles/tuesday-sector-leaders%3A-technology-communications-healthcare-2020-06-09", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-fate-therapeutics-tiffany-moneygram-2020-06-09", "https://www.nasdaq.com/articles/worried-another-stock-market-crash-is-coming-3-things-you-should-do-right-now-2020-06-07", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-in-june-2020-06-06", "https://www.nasdaq.com/articles/2-healthcare-stocks-that-have-a-killer-advantage-2020-06-06", "https://www.nasdaq.com/articles/better-buy%3A-crispr-therapeutics-vs.-sangamo-therapeutics-2020-06-14", "https://www.nasdaq.com/articles/heres-why-you-might-not-want-to-buy-stocks-right-now-2020-05-24", "https://www.nasdaq.com/articles/noteworthy-etf-inflows%3A-mtum-bmy-abbv-vrtx-2020-05-21", "https://www.nasdaq.com/articles/2-top-biotech-picks-for-may-2020-05-20", "https://www.nasdaq.com/articles/3-great-stocks-to-buy-if-you-get-a-second-stimulus-check-2020-05-19", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-reaches-analyst-target-price-2020-05-18", "https://www.nasdaq.com/articles/2-top-gene-editing-stocks-to-watch-in-june-2020-05-16", "https://www.nasdaq.com/articles/monday-sector-leaders%3A-healthcare-technology-communications-2020-05-11", "https://www.nasdaq.com/articles/if-youd-invested-%2410000-in-modernas-ipo-heres-how-much-money-youd-have-now-2020-05-24", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-in-may-2020-05-10", "https://www.nasdaq.com/articles/modernas-potential-covid-19-vaccine-isnt-the-only-reason-its-worth-a-buy-2020-05-10", "https://www.nasdaq.com/articles/3-reasons-to-buy-vertex-pharmaceuticals-stock-right-now-2020-05-08", "https://www.nasdaq.com/articles/heres-my-top-stock-to-buy-in-may-2020-05-03", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-alexion-pharmaceuticals-2020-05-02", "https://www.nasdaq.com/articles/vertex%3A-kalydeco-gets-european-chmp-positive-opinion-for-cf-in-children-2020-05-01", "https://www.nasdaq.com/articles/interesting-vrtx-put-and-call-options-for-june-12th-2020-04-30", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-cellect-biotechnology-under-armour-amc-entertainment-2020-05", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tesla-valaris-qep-resources-2020-04-30", "https://www.nasdaq.com/articles/better-buy%3A-crispr-therapeutics-vs.-bluebird-bio-2020-04-30", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc-vrtx-q1-2020-earnings-call-transcript-2020-04-30", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc.-q1-adjusted-earnings-beat-estimates-2020-04-29", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-q1-20-earnings-conference-call-at-5%3A00-pm-et-2020-04-29", "https://www.nasdaq.com/articles/how-these-15-stock-suggestions-fared-against-the-market-2020-04-28", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-dxcm-nxpi-2020-04-28", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-etf-inflow-alert-2020-04-30", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-kohls-tanker-operators-oil-and-gas-companies-u.s.-casinos", "https://www.nasdaq.com/articles/first-week-of-june-19th-options-trading-for-vertex-pharmaceuticals-vrtx-2020-04-23", "https://www.nasdaq.com/articles/these-3-biotechs-had-successful-ipos-during-the-coronavirus-crisis.-are-they-buys-2020-04", "https://www.nasdaq.com/articles/noteworthy-etf-inflows%3A-ibb-vrtx-biib-regn-2020-04-22", "https://www.nasdaq.com/articles/whats-the-best-biotech-stock-to-buy-for-treating-sickle-cell-disease-2020-04-22", "https://www.nasdaq.com/articles/drug-trial-specialists-see-coronavirus-fueled-spike-in-demand-for-virtual-services-2020-0", "https://www.nasdaq.com/articles/vrtx-crosses-above-average-analyst-target-2020-04-17", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-regeneron-zoom-video-u.s.-oil-companies-apple-u.s.-insurers", "https://www.nasdaq.com/articles/2-great-stocks-you-can-buy-and-hold-forever-2020-04-16", "https://www.nasdaq.com/articles/should-you-buy-biotech-stocks-right-now-2020-04-15", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-in-april-2020-04-12", "https://www.nasdaq.com/articles/have-an-extra-%241000-buy-these-2-biotech-stocks-2020-04-10", "https://www.nasdaq.com/articles/where-will-vertex-pharmaceuticals-be-in-1-year-2020-04-10", "https://www.nasdaq.com/articles/wednesday-sector-laggards%3A-healthcare-consumer-products-2020-04-08", "https://www.nasdaq.com/articles/should-i-trade-my-growth-stocks-for-value-stocks-2020-04-03", "https://www.nasdaq.com/articles/drug-trial-specialists-see-coronavirus-fueled-spike-in-demand-for-virtual-services-2020-04", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-regeneron-pharmaceuticals-2020-04-01", "https://www.nasdaq.com/articles/do-clinical-trial-delays-mean-trouble-for-pharmaceutical-stocks-2020-04-01", "https://www.nasdaq.com/articles/ibb-vrtx-biib-ilmn%3A-etf-outflow-alert-2020-03-31", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-aal-vrtx-2020-03-30", "https://www.nasdaq.com/articles/4-reasons-drug-stocks-are-a-buy-right-now-2020-03-30", "https://www.nasdaq.com/articles/my-top-healthcare-stocks-to-buy-in-the-market-crash-2020-03-29", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-to-pause-some-clinical-trials-2020-03-27", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-now-2020-04-02", "https://www.nasdaq.com/articles/vertex-pharma-confirms-2020-business-outlook-supply-chain-continuity-2020-03-27", "https://www.nasdaq.com/articles/4-reasons-biotech-stocks-are-a-buy-right-now-2020-03-25", "https://www.nasdaq.com/articles/3-stocks-to-buy-to-make-your-coronavirus-lockdown-a-profitable-one-2020-03-24", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2020-03-23", "https://www.nasdaq.com/articles/coronavirus-crisis%3A-3-biotech-stocks-to-buy-right-now-2020-03-22", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-mar-ctxs-2020-03-18", "https://www.nasdaq.com/articles/sp-500-movers%3A-wcg-ctxs-2020-03-18", "https://www.nasdaq.com/articles/first-week-of-may-15th-options-trading-for-vertex-pharmaceuticals-vrtx-2020-03-27", "https://www.nasdaq.com/articles/first-week-of-may-1st-options-trading-for-vertex-pharmaceuticals-vrtx-2020-03-16", "https://www.nasdaq.com/articles/5-biotech-stocks-to-buy-for-a-strong-growth-prognosis-2020-03-11", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-large-outflows-detected-at-etf-2020-03-10", "https://www.nasdaq.com/articles/with-the-market-down-im-buying-these-3-stocks-2020-03-10", "https://www.nasdaq.com/articles/how-to-be-greedy-when-others-are-fearful-2020-03-10", "https://www.nasdaq.com/articles/vertex-pharma-says-no-coronavirus-impact-on-supply-chain-or-2020-outlook-2020-03-09", "https://www.nasdaq.com/articles/2-biotech-stocks-to-buy-as-coronavirus-fears-tank-the-market-2020-03-07", "https://www.nasdaq.com/articles/why-biogen-gw-pharmaceuticals-and-vertex-pharmaceuticals-stocks-jumped-today-2020-03-17", "https://www.nasdaq.com/articles/is-ishares-nasdaq-biotechnology-index-fund-a-buy-2020-03-05", "https://www.nasdaq.com/articles/3-biotech-stocks-that-are-coronavirus-safe-havens-2020-03-05", "https://www.nasdaq.com/articles/analysts-predict-13-upside-for-tqqq-2020-03-03", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-to-buy-in-march-2020-03-03", "https://www.nasdaq.com/articles/all-the-stocks-im-selling-if-the-coronavirus-keeps-spreading-2020-03-01", "https://www.nasdaq.com/articles/can-crispr-therapeutics-double-your-money-in-2020-2020-02-28", "https://www.nasdaq.com/articles/noteworthy-etf-inflows%3A-ibb-gild-vrtx-biib-2020-02-26", "https://www.nasdaq.com/articles/hematology-focused-biotech-imara-to-ipo-soon-2020-03-06", "https://www.nasdaq.com/articles/why-so-many-biotechs-are-scrambling-to-develop-a-drug-for-the-same-rare-disease-2020-02-23", "https://www.nasdaq.com/articles/better-buy%3A-crispr-therapeutics-vs.-intellia-2020-02-21", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-incyte-2020-02-19", "https://www.nasdaq.com/articles/stock-alert%3A-vrtx-trading-close-to-52-week-high-2020-02-19", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-etf-outflow-alert-2020-02-18", "https://www.nasdaq.com/articles/3-best-biotech-stocks-to-buy-for-the-next-decade-2020-02-16", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2020-02-10", "https://www.nasdaq.com/articles/what-happens-with-abbvie-if-its-allergan-buyout-is-blocked-2020-02-26", "https://www.nasdaq.com/articles/2-ultra-risky-stocks-that-could-make-you-filthy-rich-2020-02-06", "https://www.nasdaq.com/articles/where-will-vertex-pharmaceuticals-be-in-10-years-2020-02-02", "https://www.nasdaq.com/articles/is-vertex-pharmaceuticals-stock-still-a-strong-buy-2020-01-31", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc-vrtx-q4-2019-earnings-call-transcript-2020-01-31", "https://www.nasdaq.com/articles/vertex-pharma-vrtx-q4-results-trounce-estimates-sees-stronger-2020-2020-01-30", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-reports-q4-financial-earnings-beats-estimates-2020-01-30", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc.-q4-adjusted-earnings-beat-estimates-2020-01-30", "https://www.nasdaq.com/articles/3-biotech-companies-analyzed-2020-02-07", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-ibb-gild-vrtx-biib-2020-01-29", "https://www.nasdaq.com/articles/3-biotech-start-ups-that-could-soar-in-2020-2020-01-27", "https://www.nasdaq.com/articles/vertexs-%24950-million-bet-that-could-pay-off-big-time-for-investors-2020-01-26", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-galapagos-2020-01-25", "https://www.nasdaq.com/articles/march-6th-options-now-available-for-vertex-pharmaceuticals-vrtx-2020-01-23", "https://www.nasdaq.com/articles/2-ultra-expensive-biotech-stocks-still-worth-buying-2020-01-23", "https://www.nasdaq.com/articles/interesting-vrtx-put-and-call-options-for-march-20th-2020-01-22", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-q4-19-earnings-conference-call-at-4%3A30-pm-et-2020-01-30", "https://www.nasdaq.com/articles/3-top-biotech-picks-for-2020-2020-01-20", "https://www.nasdaq.com/articles/2-biotech-stocks-to-watch-in-2020-2020-01-17", "https://www.nasdaq.com/articles/are-biotech-stocks-due-for-a-correction-in-2020-2020-01-15", "https://www.nasdaq.com/articles/these-3-momentum-stocks-have-room-for-further-upside-says-jefferies-2020-01-14", "https://www.nasdaq.com/articles/vertex-pharma-to-present-at-the-j.p.-morgan-conference-webcast-at-2%3A30-pm-et-2020-01-13", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-large-inflows-detected-at-etf-2020-01-13", "https://www.nasdaq.com/articles/why-has-vertex-pharmaceuticals-stock-gained-30-in-the-last-quarter-2020-01-10", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2020-01-21", "https://www.nasdaq.com/articles/why-your-2020-resolution-should-be-to-buy-more-healthcare-stocks-2020-01-09", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-giii-vrtx-acm-2020-01-08", "https://www.nasdaq.com/articles/wednesday-sector-leaders%3A-healthcare-technology-communications-2020-01-08", "https://www.nasdaq.com/articles/monday-sector-leaders%3A-energy-healthcare-2020-01-06", "https://www.nasdaq.com/articles/3-high-growth-stocks-that-can-soar-2020-01-06", "https://www.nasdaq.com/articles/3-top-stocks-to-buy-in-january-2020-01-05", "https://www.nasdaq.com/articles/is-vertex-pharmaceuticals-stock-a-buy-2020-01-04", "https://www.nasdaq.com/articles/heres-why-crispr-therapeutics-stock-jumped-113.2-in-2019-2020-01-09", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-etf-outflow-alert-2020-01-03", "https://www.nasdaq.com/articles/5-stocks-to-buy-in-january-2019-12-30", "https://www.nasdaq.com/articles/the-3-best-healthcare-stocks-to-buy-for-2020-2019-12-29", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-rpg-keys-adsk-vrtx-2019-12-23", "https://www.nasdaq.com/articles/why-2020-should-be-the-biggest-year-yet-for-crispr-gene-editing-stocks-2019-12-22", "https://www.nasdaq.com/articles/why-longer-term-investors-should-buy-amarin-stock-on-weakness-2019-12-19", "https://www.nasdaq.com/articles/5-biotech-stocks-to-buy-for-a-strong-growth-prognosis-2019-12-18", "https://www.nasdaq.com/articles/better-buy%3A-crispr-therapeutics-vs.-editas-2020-01-04", "https://www.nasdaq.com/articles/heres-why-proteostasis-therapeutics-stock-plummeted-today-2019-12-17", "https://www.nasdaq.com/articles/ibb-gild-vrtx-ilmn%3A-etf-outflow-alert-2019-12-13", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-to-buy-in-december-2019-12-08", "https://www.nasdaq.com/articles/despite-massive-gains-this-year-this-biotech-stock-is-a-risky-bet-2019-12-06", "https://www.nasdaq.com/articles/heres-why-vertex-pharmaceuticals-rose-13.4-in-november-2019-12-04", "https://www.nasdaq.com/articles/heres-why-crispr-therapeutics-jumped-42.2-in-november-2019-12-03", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-in-december-2019-12-01", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-alexion-pharmaceuticals-2019-12-18", "https://www.nasdaq.com/articles/ibb-gild-vrtx-ilmn%3A-large-outflows-detected-at-etf-2019-11-27", "https://www.nasdaq.com/articles/crispr-vs.-gene-therapy-round-1%3A-what-investors-need-to-know-2019-11-26", "https://www.nasdaq.com/articles/2-small-cap-biotechs-that-soared-last-week-2019-11-25", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-to-buy-now-2019-11-24", "https://www.nasdaq.com/articles/more-crispr-stock-catalysts-ahead-2019-11-23", "https://www.nasdaq.com/articles/is-amarins-fish-oil-pill-on-track-to-become-a-blockbuster-2019-11-22", "https://www.nasdaq.com/articles/sp-500-analyst-moves%3A-vrtx-2019-11-22", "https://www.nasdaq.com/articles/5-new-drug-approvals-the-fda-gave-top-priority-2019-11-29", "https://www.nasdaq.com/articles/check-out-these-5-fast-growing-stocks-to-buy-2019-11-20", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-19-2019%3A-mdconvsmyovcrspvrtxkrtx-2019-11-19", "https://www.nasdaq.com/articles/heres-why-crispr-stocks-are-soaring-today-2019-11-19", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-19-2019%3A-myovcrspvrtxkrtx-2019-11-19", "https://www.nasdaq.com/articles/drug-approvals-upbeat-earnings-help-vertex-pharmaceuticals-stock-jump-20-in-a-month-2019", "https://www.nasdaq.com/articles/the-best-biotech-stock-to-buy-right-now-2019-11-17", "https://www.nasdaq.com/articles/heres-why-solid-biosciences-collapsed-today-2019-11-12", "https://www.nasdaq.com/articles/heres-why-crispr-therapeutics-stock-is-falling-today-2019-11-21", "https://www.nasdaq.com/articles/2-beaten-down-biotech-stocks-that-could-make-you-rich-2019-11-11", "https://www.nasdaq.com/articles/3-top-stocks-to-buy-in-november-2019-11-10", "https://www.nasdaq.com/articles/why-the-opioid-crisis-makes-vertex-pharmaceuticals-a-buy-2019-11-06", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-ibb-celg-gild-vrtx-2019-11-04", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc-vrtx-q3-2019-earnings-call-transcript-2019-10-31", "https://www.nasdaq.com/articles/2-top-healthcare-stocks-every-investor-should-own-2019-10-31", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc.-q3-adjusted-earnings-beat-estimates-2019-10-30", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2019-11-12", "https://www.nasdaq.com/articles/3-reasons-crispr-therapeutics-stock-can-reach-record-highs-again-2019-10-30", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-gains-fda-approval-for-cystic-fibrosis-drug-2019-10-28", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-incyte-2019-10-27", "https://www.nasdaq.com/articles/5-top-healthcare-etfs-2019-10-26", "https://www.nasdaq.com/articles/5-biotech-stocks-to-buy-for-a-strong-growth-prognosis-2019-10-25", "https://www.nasdaq.com/articles/2-things-just-happened-that-make-vertex-pharmaceuticals-stock-a-screaming-buy-2019-10-25", "https://www.nasdaq.com/articles/first-trust-nyse-arca-biotechnology-index-fund-experiences-big-outflow-2019-10-24", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-whr-vrtx-cbs-2019-10-30", "https://www.nasdaq.com/articles/implied-rpg-analyst-target-price%3A-%24132-2019-10-24", "https://www.nasdaq.com/articles/vertex-in-deal-with-nhs-england-for-access-to-all-licensed-cf-medicines-2019-10-24", "https://www.nasdaq.com/articles/5-healthcare-stocks-to-buy-2019-10-22", "https://www.nasdaq.com/articles/odonate-on-the-move-with-contessa-fda-snubs-clsd-its-a-yes-for-azn-vrtx-2019-10-22", "https://www.nasdaq.com/articles/2-high-growth-stocks-to-buy-right-now-2019-10-17", "https://www.nasdaq.com/articles/ibb-celg-vrtx-ilmn%3A-large-outflows-detected-at-etf-2019-10-15", "https://www.nasdaq.com/articles/10-high-quality-high-growth-stocks-to-buy-2019-10-11", "https://www.nasdaq.com/articles/3-reasons-biomarin-pharmaceutical-stock-is-a-buy-right-now-2019-10-24", "https://www.nasdaq.com/articles/3-reasons-vertex-pharmaceuticals-is-poised-for-a-big-year-2019-10-08", "https://www.nasdaq.com/articles/check-out-these-5-fast-growing-stocks-to-buy-2019-10-04", "https://www.nasdaq.com/articles/interesting-vrtx-put-and-call-options-for-november-22nd-2019-10-03", "https://www.nasdaq.com/articles/forget-vertex-pharmaceuticals-crispr-therapeutics-is-a-better-biotech-growth-stock-2019-10", "https://www.nasdaq.com/articles/a-biotech-set-to-dominate-the-next-20-years-2019-10-01", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-right-now-2019-10-01", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-ibb-celg-vrtx-ilmn-2019-09-27", "https://www.nasdaq.com/articles/5-large-cap-stocks-with-growth-in-the-tank-2019-10-08", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-galapagos-2019-09-22", "https://www.nasdaq.com/articles/2-pharma-stocks-you-should-buy-now-2019-09-21", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-breaks-above-200-day-moving-average-bullish-for-vrtx-2019-09-20", "https://www.nasdaq.com/articles/first-week-of-january-2022-options-trading-for-vertex-pharmaceuticals-vrtx-2019-09-18", "https://www.nasdaq.com/articles/3-top-stocks-you-can-buy-and-hold-for-the-next-decade-2019-09-16", "https://www.nasdaq.com/articles/is-ishares-nasdaq-biotechnology-index-fund-a-buy-2019-09-15", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2019-09-11", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-to-buy-right-now-2019-09-23", "https://www.nasdaq.com/articles/wednesday-sector-laggards%3A-utilities-healthcare-2019-09-04", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-%24950-million-bet-on-curing-type-1-diabetes-could-have-an", "https://www.nasdaq.com/articles/3-healthcare-stocks-that-have-a-killer-advantage-2019-09-01", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-right-now-2019-08-28", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-ibb-gild-celg-vrtx-2019-08-28", "https://www.nasdaq.com/articles/3-big-stock-charts-for-tuesday%3A-technipfmc-plc-vertex-pharmaceuticals-and-constellation", "https://www.nasdaq.com/articles/check-out-these-5-fast-growing-stocks-to-buy-2019-08-22", "https://www.nasdaq.com/articles/dont-blink-or-youll-miss-vertexs-next-move-and-its-bound-to-be-a-good-one-2019-09-05", "https://www.nasdaq.com/articles/ibb-celg-vrtx-ilmn%3A-etf-outflow-alert-2019-08-20", "https://www.nasdaq.com/articles/interesting-vrtx-put-and-call-options-for-april-2020-2019-08-20", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-alexion-pharmaceuticals-2019-08-11", "https://www.nasdaq.com/articles/the-10-largest-cap-growth-stocks-2019-08-09", "https://www.nasdaq.com/articles/vertex-has-significant-financial-firepower-2019-08-06", "https://www.nasdaq.com/articles/will-this-asteroid-heading-toward-vertex-pharmaceuticals-make-impact-2019-08-04", "https://www.nasdaq.com/articles/thursday-sector-leaders%3A-utilities-healthcare-2019-08-01", "https://www.nasdaq.com/articles/analysts-anticipate-12-upside-for-qqew-2019-08-22", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc-vrtx-q2-2019-earnings-call-transcript-2019-08-01", "https://www.nasdaq.com/articles/is-intellia-therapeutics-a-buy-2019-07-31", "https://www.nasdaq.com/articles/interesting-vrtx-put-and-call-options-for-september-20th-2019-07-31", "https://www.nasdaq.com/articles/september-6th-options-now-available-for-vertex-pharmaceuticals-vrtx-2019-07-29", "https://www.nasdaq.com/articles/pfizer-closes-in-on-a-major-spinoff-2019-07-29", "https://www.nasdaq.com/articles/3-perfect-10-biotech-companies-to-buy-2019-07-25", "https://www.nasdaq.com/articles/where-will-crispr-therapeutics-be-in-5-years-2019-07-25", "https://www.nasdaq.com/articles/vrtx-makes-bullish-cross-above-critical-moving-average-2019-08-01", "https://www.nasdaq.com/articles/5-biotech-stocks-to-buy-for-a-strong-growth-prognosis-2019-07-23", "https://www.nasdaq.com/articles/look-under-the-hood%3A-qqxt-has-10-upside-2019-07-22", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-ibb-gild-celg-vrtx-2019-07-19", "https://www.nasdaq.com/articles/2-supercharged-growth-stocks-id-buy-right-now-2019-07-18", "https://www.nasdaq.com/articles/august-30th-options-now-available-for-vertex-pharmaceuticals-vrtx-2019-07-15", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-for-the-2nd-half-of-2019-2019-07-14", "https://www.nasdaq.com/articles/3-big-stock-charts-for-friday%3A-hollyfrontier-activision-blizzard-and-vertex", "https://www.nasdaq.com/articles/is-vertex-pharmaceuticals-a-buy-2019-07-23", "https://www.nasdaq.com/articles/vrtx-crosses-above-key-moving-average-level-2019-07-09", "https://www.nasdaq.com/articles/august-23rd-options-now-available-for-vertex-pharmaceuticals-vrtx-2019-07-08", "https://www.nasdaq.com/articles/9-health-care-stocks-for-your-portfolio-2019-07-03", "https://www.nasdaq.com/articles/how-to-invest-in-biotech-stocks-2019-07-02", "https://www.nasdaq.com/articles/3-growth-stocks-to-buy-and-hold-for-the-next-50-years-2019-06-29", "https://www.nasdaq.com/articles/august-9th-options-now-available-for-vertex-pharmaceuticals-vrtx-2019-06-27", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2019-06-25", "https://www.nasdaq.com/articles/heres-why-crispr-gene-editing-stocks-rose-as-much-as-32.4-in-june-2019-07-10", "https://www.nasdaq.com/articles/3-stocks-that-could-double-your-money-2019-06-22", "https://www.nasdaq.com/articles/health-care-sector-update-for-06-21-2019%3A-vrtxctltctrvgcgweed.to-2019-06-21", "https://www.nasdaq.com/articles/check-out-these-5-fast-growing-stocks-to-buy-today-2019-06-20", "https://www.nasdaq.com/articles/vrtx-makes-bullish-cross-above-critical-moving-average-2019-06-18", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-gild-biib-vrtx-2019-06-17", "https://www.nasdaq.com/articles/3-cheap-drug-stocks-you-can-buy-right-now-2019-06-16", "https://www.nasdaq.com/articles/7-top-rated-biotech-stocks-to-invest-in-today-2019-06-14", "https://www.nasdaq.com/articles/the-10-biggest-biotech-stocks-2019-06-25", "https://www.nasdaq.com/articles/5-most-valuable-pipeline-drugs-development-and-stocks-poised-profit-2019-06-12", "https://www.nasdaq.com/articles/3-healthcare-stocks-id-buy-right-now-2019-06-09", "https://www.nasdaq.com/articles/gene-therapy-vs.-gene-editing%3A-which-better-tackling-muscular-dystrophy-2019-06-09", "https://www.nasdaq.com/articles/health-care-sector-update-for-06-07-2019%3A-xforcrspvrtxljpcmrtxamgn-2019-06-07", "https://www.nasdaq.com/articles/friday-sector-leaders%3A-healthcare-services-2019-06-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-06-07-2019%3A-crspvrtxljpcmrtxamgn-2019-06-07", "https://www.nasdaq.com/articles/heres-why-crispr-therapeutics-rose-much-18.7-today-2019-06-07", "https://www.nasdaq.com/articles/3-big-stock-charts-for-friday%3A-symantec-vertex-pharmaceuticals-and-nektar-therapeutics", "https://www.nasdaq.com/articles/3-top-gene-therapy-stocks-that-could-soar-2019-05-30", "https://www.nasdaq.com/articles/3-big-biotech-stocks-warren-buffett-might-2019-05-26", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-intu-ha-vrtx-2019-05-23", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-galapagos-2019-05-19", "https://www.nasdaq.com/articles/5-growthy-biotech-stocks-to-buy-despite-the-scrutiny-2019-05-13", "https://www.nasdaq.com/articles/heres-my-top-stock-buy-may-2019-05-12", "https://www.nasdaq.com/articles/ibb-biib-vrtx-ilmn%3A-large-outflows-detected-etf-2019-05-07", "https://www.nasdaq.com/articles/july-26th-options-now-available-vertex-pharmaceuticals-vrtx-2019-06-06", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-galapagos-2019-05-02", "https://www.nasdaq.com/articles/5-things-you-need-know-vertex-pharmaceuticals-q1-earnings-update-2019-05-02", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc-vrtx-q1-2019-earnings-call-transcript-2019-05-01", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc.-q1-adjusted-earnings-beat-estimates-2019-04-30", "https://www.nasdaq.com/articles/vertex-pharma%3A-fda-approves-expanded-indication-kalydeco-quick-facts-2019-04-30", "https://www.nasdaq.com/articles/health-care-stocks%3A-buy-them-while-theyre-down-2019-04-30", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2019-04-28", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-looks-jump-18000-patients-68000-2019-05-02", "https://www.nasdaq.com/articles/2-best-biotech-buyout-plays-2019-04-23", "https://www.nasdaq.com/articles/5-top-pharmaceutical-stocks-buy-2019-2019-04-19", "https://www.nasdaq.com/articles/5-top-biotech-stocks-buy-2019-2019-04-19", "https://www.nasdaq.com/articles/5-top-healthcare-stocks-buy-2019-2019-04-19", "https://www.nasdaq.com/articles/sum-pieces-qqxt-could-be-worth-58-2019-04-18", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-becomes-oversold-vrtx-2019-04-17", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-tndm-vrtx-lly-2019-04-17", "https://www.nasdaq.com/articles/everything-you-need-know-about-investing-healthcare-2019-04-24", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2019-04-17", "https://www.nasdaq.com/articles/vertex-crisprs-gene-editing-drug-gets-fdas-fast-track-tag-2019-04-17-0", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-tndm-vrtx-lly-2019-04-17-0", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-16-2019%3A-crsp-vrtx-unh-jnj-pfe-abt-mrk-amgn-2019-04-16", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-could-conceivably-succeed-too-well-2019-04-09", "https://www.nasdaq.com/articles/5-stocks-age-miracles-2019-04-09", "https://www.nasdaq.com/articles/the-10-fastest-growing-stocks-to-invest-in-right-now-2019-04-09", "https://www.nasdaq.com/articles/vrtx-makes-notable-cross-below-critical-moving-average-2019-04-17", "https://www.nasdaq.com/articles/check-out-these-5-fast-growing-stocks-to-buy-today-2019-04-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-intc-algn-2019-04-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-intc-algn-2019-04-05-0", "https://www.nasdaq.com/articles/vertex-appoints-charles-wagner-new-cfo-quick-facts-2019-04-02", "https://www.nasdaq.com/articles/ibb-gild-celg-vrtx-large-outflows-detected-etf-2019-04-01", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2019-03-31", "https://www.nasdaq.com/articles/better-buy-crispr-therapeutics-vs-sangamo-therapeutics-2019-03-28", "https://www.nasdaq.com/articles/check-out-these-7-fast-growing-stocks-to-buy-today-2019-04-05", "https://www.nasdaq.com/articles/may-3rd-options-now-available-vertex-pharmaceuticals-vrtx-2019-03-25", "https://www.nasdaq.com/articles/better-buy-vertex-pharmaceuticals-vs-regeneron-pharmaceuticals-2019-03-24", "https://www.nasdaq.com/articles/first-week-vrtx-may-17th-options-trading-2019-03-22", "https://www.nasdaq.com/articles/first-week-vrtx-october-18th-options-trading-2019-03-21", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-regn-gets-fda-nod-for-dupixent-other-pipeline-news-2019-03-13", "https://www.nasdaq.com/articles/celg-vs.-vrtx%3A-which-stock-is-the-better-value-option-2019-03-13", "https://www.nasdaq.com/articles/peek-under-hood-sphq-has-10-upside-2019-03-11", "https://www.nasdaq.com/articles/proteostasis-plunges-on-weak-data-from-cystic-fibrosis-study-2019-03-26", "https://www.nasdaq.com/articles/why-is-vertex-vrtx-down-0.7-since-last-earnings-report-2019-03-07", "https://www.nasdaq.com/articles/vertexs-vx-445-triple-combo-cystic-fibrosis-trials-succeed-2019-03-07", "https://www.nasdaq.com/articles/top-research-reports-amazon-berkshire-hathaway-thermo-fisher-2019-03-07", "https://www.nasdaq.com/articles/4-low-priced-stocks-under-%2410-for-2019-2019-03-06", "https://www.nasdaq.com/articles/vertex-cystic-fibrosis-triple-combo-therapy-succeeds-important-trials-2019-03-06", "https://www.nasdaq.com/articles/vertexs-cystic-fibrosis-therapy-meets-goal-late-stage-studies-2019-03-06", "https://www.nasdaq.com/articles/3-hot-stocks-buy-march-2019-03-05", "https://www.nasdaq.com/articles/why-vertexs-dilemma-makes-it-best-biotech-stock-buy-now-2019-03-10", "https://www.nasdaq.com/articles/5-pharmaceutical-stocks-big-moats-and-bridges-2019-02-28", "https://www.nasdaq.com/articles/3-arguments-and-against-buying-gw-pharmaceuticals-2019-02-27", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-once-cmta-soar-on-merger-news-other-pipeline-updates-2019-02-27", "https://www.nasdaq.com/articles/crispr-therapeutics-up-as-dosing-starts-in-thalassemia-study-2019-02-26", "https://www.nasdaq.com/articles/health-care-sector-update-02252019-foldoncecrspakcaionsnvs-2019-02-25", "https://www.nasdaq.com/articles/health-care-sector-update-02252019-oncecrspakcaionsnvs-2019-02-25", "https://www.nasdaq.com/articles/could-vertex-pharmaceuticals-be-millionaire-maker-stock-2019-02-24", "https://www.nasdaq.com/articles/5-top-stocks-buy-march-2019-03-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-intercept-gilead-vertex-alkermes-and-clovis-2019-02-21", "https://www.nasdaq.com/articles/top-stock-reports-nike-3m-vertex-2019-02-21", "https://www.nasdaq.com/articles/should-you-invest-invesco-dynamic-biotechnology-genome-etf-pbe-2019-02-20", "https://www.nasdaq.com/articles/3-most-profitable-drugmakers-sp-500-are-they-buys-2019-02-17", "https://www.nasdaq.com/articles/heres-why-crispr-therapeutics-rose-135-january-2019-02-11", "https://www.nasdaq.com/articles/groupon-grpn-to-report-q4-earnings%3A-whats-in-the-cards-2019-02-11", "https://www.nasdaq.com/articles/best-biotech-stock-market-2019-02-10", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-nike-3m-vertex-pepsico-and-verisk-2019-02-22", "https://www.nasdaq.com/articles/factors-likely-influence-ciscos-csco-earnings-q2-2019-02-08", "https://www.nasdaq.com/articles/factors-expected-to-influence-akamais-akam-q4-earnings-2019-02-08", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-vertex-celgene-alkermes-and-aveo-2019-02-07", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-new-drug-same-great-growth-story-2019-02-07", "https://www.nasdaq.com/articles/vertex-vrtx-q4-earnings-beat-on-solid-cf-products-sales-2019-02-06", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-q4-2018-earnings-conference-call-transcript-2019-02-06", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-celgene-tops-in-q4-gilead-disappoints-alks-aveo-sink-2019-02-06", "https://www.nasdaq.com/articles/check-out-these-7-fast-growing-stocks-to-buy-today-2019-02-08", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc-q4-adjusted-earnings-beat-estimates-2019-02-05", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-q4-18-earnings-conference-call-430-pm-et-2019-02-05", "https://www.nasdaq.com/articles/after-hours-earnings-report-february-5-2019-dis-cb-su-vrtx-all-ea-apc-dlr-mchp-cern-paa", "https://www.nasdaq.com/articles/sp-500-movers-wy-clx-2019-02-04", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-lbtya-2019-02-04", "https://www.nasdaq.com/articles/regeneron-regn-to-report-q4-earnings%3A-is-a-beat-in-store-2019-02-04", "https://www.nasdaq.com/articles/qorvo-qrvo-to-report-q3-earnings%3A-whats-in-the-cards-2019-02-04", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-q4-earnings-and-revenues-top-estimates-2019-02-05", "https://www.nasdaq.com/articles/march-22nd-options-now-available-vertex-pharmaceuticals-vrtx-2019-01-31", "https://www.nasdaq.com/articles/will-gilead-gild-q4-earnings-disappoint-on-weak-hcv-sales-2019-01-31", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-vertex-vrtx-this-earnings-season-2019-01-30", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-earnings-expected-to-grow%3A-should-you-buy-2019-01-29", "https://www.nasdaq.com/articles/vertexs-kalydeco-wins-health-canada-nod-to-treat-cf-in-kids-2019-01-29", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-celgene-celg-in-q4-earnings-2019-01-29", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2019-01-29", "https://www.nasdaq.com/articles/6-biotech-stocks-watch-now-2019-02-01", "https://www.nasdaq.com/articles/merck-kgaa-gives-vertex-rights-to-two-gene-editing-compounds-2019-01-25", "https://www.nasdaq.com/articles/vertex-terminates-coo-ian-smith-on-code-of-conduct-violation-2019-01-24", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-reports-next-week%3A-wall-street-expects-earnings-growth-2019-01", "https://www.nasdaq.com/articles/celg-or-vrtx%3A-which-is-the-better-value-stock-right-now-2019-01-23", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-amgen-vertex-get-ec-nod-for-label-expansion-of-drugs-2019-01-23", "https://www.nasdaq.com/articles/better-buy-crispr-therapeutics-vs-editas-medicine-2019-01-23", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-fires-coo-ian-smith-2019-01-23", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-buy-2019-01-26", "https://www.nasdaq.com/articles/vertex-pharma-terminates-interim-cfos-employment-code-violations-2019-01-23", "https://www.nasdaq.com/articles/vertexs-orkambi-wins-eu-nod-to-treat-cystic-fibrosis-in-kids-2019-01-22", "https://www.nasdaq.com/articles/should-you-sell-crispr-therapeutics-following-analyst-downgrade-2019-01-22", "https://www.nasdaq.com/articles/why-vertex-vrtx-is-poised-to-beat-earnings-estimates-again-2019-01-21", "https://www.nasdaq.com/articles/vertex-ec-approves-orkambi-treat-children-cf-aged-2-5-years-old-2019-01-21", "https://www.nasdaq.com/articles/after-hours-most-active-jan-16-2019-invh-amd-cvs-tak-xom-mu-ge-foxa-ctl-qqq-sbux-vrtx-2019", "https://www.nasdaq.com/articles/3-biotech-stocks-watch-2019-2019-01-12", "https://www.nasdaq.com/articles/vertex-pharma-boots-out-coo-personal-behavior-violations-2019-01-23", "https://www.nasdaq.com/articles/vrtx-march-1st-options-begin-trading-2019-01-10", "https://www.nasdaq.com/articles/moderna-mrna-announces-pipeline-progress-shares-rise-2019-01-09", "https://www.nasdaq.com/articles/5-things-expect-vertex-pharmaceuticals-2019-2019-01-08", "https://www.nasdaq.com/articles/vertex-crisprs-sickle-disease-drug-gets-fdas-fast-track-tag-2019-01-07", "https://www.nasdaq.com/articles/better-buy-crispr-therapeutics-vs-vertex-pharmaceuticals-2019-01-06", "https://www.nasdaq.com/articles/vertex-joins-forces-with-arbor-to-build-gene-editing-therapies-2019-01-04", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-vrtx-2019-01-03", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-vrtx-exas-win-2019-01-11", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-aduro-vertex-evofem-and-incyte-2018-12-20", "https://www.nasdaq.com/articles/analysts-expect-qqxt-hit-58-2018-12-20", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-652841-down-10842-points-2018-12-20", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-pipeline-updates-from-vrtx-amgn-adro-teams-up-with-lly-2018-12-19", "https://www.nasdaq.com/articles/vertexs-vrtx-3rd-study-on-pain-drug-meets-primary-endpoint-2018-12-19", "https://www.nasdaq.com/articles/3-biotechs-potential-blockbusters-near-finish-line-2018-12-18", "https://www.nasdaq.com/articles/why-dova-pharmaceuticals-nosediving-today-2018-12-17", "https://www.nasdaq.com/articles/year-review-best-ceos-ipos-and-more-2018-12-27", "https://www.nasdaq.com/articles/should-you-invest-in-the-invesco-dynamic-biotechnology-genome-etf-pbe-2018-12-13", "https://www.nasdaq.com/articles/notable-thursday-option-activity-pdfs-vrtx-wdc-2018-12-13", "https://www.nasdaq.com/articles/3-highest-growth-stocks-todays-market-2018-12-07", "https://www.nasdaq.com/articles/better-buy-vertex-pharmaceuticals-vs-regeneron-pharmaceuticals-2018-12-01", "https://www.nasdaq.com/articles/why-crispr-therapeutics-stock-65-so-far-2018-2018-11-30-0", "https://www.nasdaq.com/articles/why-crispr-therapeutics-stock-65-so-far-2018-2018-11-30", "https://www.nasdaq.com/articles/4-strong-buy-stocks-oppenheimer-likes-right-now-2018-11-29", "https://www.nasdaq.com/articles/5-drug-biotech-stocks-with-promise-to-sustain-bull-run-in-2019-2018-12-14", "https://www.nasdaq.com/articles/vertex-looks-capture-rest-its-multibillion-dollar-market-2018-11-28", "https://www.nasdaq.com/articles/vrtx-crosses-above-key-moving-average-level-2018-11-27", "https://www.nasdaq.com/articles/nasdaq-100-movers-shpg-vrtx-2018-11-27", "https://www.nasdaq.com/articles/sp-500-movers-utx-vrtx-2018-11-27", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-708270-85-points-2018-11-27", "https://www.nasdaq.com/articles/health-care-sector-update-11272018-dvavrtxacadgthx-2018-11-27", "https://www.nasdaq.com/articles/health-care-sector-update-11272018-vrtxhalogthxacad-2018-11-27", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-pipeline-updates-from-celg-vrtx-zfgn-plunges-on-hold-news-2018-11", "https://www.nasdaq.com/articles/first-week-vrtx-july-2019-options-trading-2018-11-21", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilds-drug-wins-nod-in-china-arena-up-on-licensing-deal-2018-11-21", "https://www.nasdaq.com/articles/10-stocks-are-screaming-buys-right-now-2018-11-21", "https://www.nasdaq.com/articles/should-you-invest-invesco-dynamic-biotechnology-genome-etf-pbe-2018-11-21", "https://www.nasdaq.com/articles/vertex-vrtx-gets-positive-chmp-opinion-for-orkambi-in-kids-2018-11-19", "https://www.nasdaq.com/articles/celldex-cldx-q3-earnings-beat-estimates-revenues-miss-2018-11-09", "https://www.nasdaq.com/articles/spectrum-sppi-earnings-and-sales-beat-estimates-in-q3-2018-11-09", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-avgo-vrtx-tif-2018-11-27", "https://www.nasdaq.com/articles/jazz-pharma-jazz-beats-on-q3-earnings-lowers-sales-view-2018-11-08", "https://www.nasdaq.com/articles/ironwood-irwd-q3-earnings-revenues-miss-shares-down-2018-11-08", "https://www.nasdaq.com/articles/vivus-vvus-q3-loss-narrower-than-expected-revenues-up-y-y-2018-11-02", "https://www.nasdaq.com/articles/gerons-gern-q3-earnings-beat-revenues-miss-shares-down-2018-11-02", "https://www.nasdaq.com/articles/sp-500-analyst-moves-vrtx-2018-11-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-amgen-vertex-pharmaceuticals-celgene", "https://www.nasdaq.com/articles/should-you-invest-in-the-invesco-dynamic-biotechnology-genome-etf-pbe-2018-10-30", "https://www.nasdaq.com/articles/perrigo-prgo-beats-on-q3-earnings-cuts-view-shares-down-2018-11-08", "https://www.nasdaq.com/articles/better-buy-vertex-pharmaceuticals-incorporated-vs-incyte-corporation-2018-10-28", "https://www.nasdaq.com/articles/abbvie-takes-aim-vertex-pharmaceuticals-incorporated-2018-10-27", "https://www.nasdaq.com/articles/vertex-vrtx-q3-earnings-and-revenues-surpass-estimates-2018-10-25", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc-vrtx-q3-2018-earnings-conference-call-transcript-2018-10-24", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-q3-earnings-and-revenues-surpass-estimates-2018-10-24", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-24-2018-msft-v-tsla-vrtx-lvs-afl-f-now-orly-algn-amd", "https://www.nasdaq.com/articles/biotech-stocks-earnings-lineup-for-oct-24%3A-vrtx-alxn-srpt-2018-10-23", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-waits-hit-triple-2018-10-29", "https://www.nasdaq.com/articles/whats-in-store-for-anika-therapeutics-anik-in-q3-earnings-2018-10-22", "https://www.nasdaq.com/articles/why-proteostasis-therapeutics-tumbled-232-friday-2018-10-19", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-q3-earnings-preview%3A-whats-shaping-up-2018-10-17", "https://www.nasdaq.com/articles/celg-vs.-vrtx%3A-which-stock-should-value-investors-buy-now-2018-10-17", "https://www.nasdaq.com/articles/jj-jnj-to-set-the-ball-rolling-for-pharma-q3-earnings-2018-10-11", "https://www.nasdaq.com/articles/why-crispr-therapeutics-stock-heading-higher-today-2018-10-11", "https://www.nasdaq.com/articles/why-the-earnings-surprise-streak-could-continue-for-vertex-vrtx-2018-10-10", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-vertex-vrtx-this-earnings-season-2018-10-22", "https://www.nasdaq.com/articles/should-you-invest-in-the-invesco-dynamic-biotechnology-genome-etf-pbe-2018-10-08", "https://www.nasdaq.com/articles/7-fast-growing-stocks-to-buy-today-2018-10-05", "https://www.nasdaq.com/articles/3-biotech-stocks-virtual-monopolies-2018-10-03", "https://www.nasdaq.com/articles/3-biotech-stocks-with-rising-estimates-in-the-past-month-2018-09-28", "https://www.nasdaq.com/articles/better-buy-vertex-pharmaceuticals-incorporated-vs-galapagos-nv-2018-09-28", "https://www.nasdaq.com/articles/guide-crispr-stocks-latest-apple-fed-gdp-news-free-lunch-2018-09-27", "https://www.nasdaq.com/articles/10-stocks-are-screaming-buys-right-now-2018-09-19", "https://www.nasdaq.com/articles/better-buy-crispr-therapeutics-ag-vs-editas-2018-10-09", "https://www.nasdaq.com/articles/notable-friday-option-activity-dis-algn-vrtx-2018-09-14", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-september-2018-09-12", "https://www.nasdaq.com/articles/lilly-lly-hits-52-week-high-can-the-run-continue-2018-09-10", "https://www.nasdaq.com/articles/vertex-completes-enrollment-in-triple-combination-studies-2018-09-07", "https://www.nasdaq.com/articles/pbe-ilmn-biib-vrtx-etf-inflow-alert-2018-09-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-puma-biotechnology-mannkind-united-therapeutics", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-amgn-pbyi-get-ec-nod-for-their-drugs-mnkd-soars-2018-09-05", "https://www.nasdaq.com/articles/crispr-therapeutics-ag-buy-2018-09-16", "https://www.nasdaq.com/articles/vertex-inks-reimbursement-agreement-for-orkambi-in-australia-2018-09-04", "https://www.nasdaq.com/articles/3-biotech-stocks-could-soar-next-week-2018-09-02", "https://www.nasdaq.com/articles/3-stocks-could-put-netflixs-returns-shame-2018-09-01", "https://www.nasdaq.com/articles/vertex-inks-deal-with-genomics-to-make-serious-disease-drugs-2018-08-31", "https://www.nasdaq.com/articles/vertex-vrtx-hits-fresh-high%3A-is-there-still-room-to-run-2018-08-30", "https://www.nasdaq.com/articles/why-is-vertex-vrtx-up-0.1-since-last-earnings-report-2018-08-24", "https://www.nasdaq.com/articles/3-relatively-safe-ways-invest-gene-editing-2018-08-24", "https://www.nasdaq.com/articles/forget-crispr-therapeutics-vertex-pharmaceuticals-incorporated-better-biotech-stock-2018", "https://www.nasdaq.com/articles/interesting-vrtx-put-and-call-options-october-5th-2018-08-23", "https://www.nasdaq.com/articles/4-biotech-stocks-investors-can-bet-post-solid-q2-earnings-2018-08-23", "https://www.nasdaq.com/articles/mallinckrodts-stannsoporfin-gets-complete-response-letter-2018-08-23", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-label-expansion-of-regenerons-eylea-vertexs-kalydeco-2018-08-22", "https://www.nasdaq.com/articles/looking-for-a-growth-stock-why-it-is-time-to-focus-on-vertex-pharmaceuticals-vrtx-2018-08", "https://www.nasdaq.com/articles/zacks.com-highlights%3A-illumina-vertex-pharmaceuticals-surmodics-and-mcdermott", "https://www.nasdaq.com/articles/novo-nordisk-buys-ziylo-to-develop-glucose-responsive-insulin-2018-08-20", "https://www.nasdaq.com/articles/notable-friday-option-activity-wday-vrtx-de-2018-08-24", "https://www.nasdaq.com/articles/4-winning-stocks-solid-efficiency-level-2018-08-17", "https://www.nasdaq.com/articles/should-vertex-pharmaceuticals-vrtx-be-on-your-radar-now-2018-08-17", "https://www.nasdaq.com/articles/vertexs-cystic-fibrosis-drug-gets-fda-nod-for-children-2018-08-16", "https://www.nasdaq.com/articles/bayer-plunges-as-monsanto-fined-%24289m-in-roundup-lawsuit-2018-08-14", "https://www.nasdaq.com/articles/7-fast-growing-stocks-to-buy-today-2018-08-13", "https://www.nasdaq.com/articles/spectrum-sppi-earnings-and-sales-miss-estimates-in-q2-2018-08-10", "https://www.nasdaq.com/articles/endo-endp-beats-on-q2-earnings-sales-raises-guidance-2018-08-09", "https://www.nasdaq.com/articles/lilly-lly-hits-52-week-high-can-the-run-continue-2018-08-17", "https://www.nasdaq.com/articles/perrigo-prgo-beats-on-q2-earnings-cuts-view-shares-down-2018-08-09", "https://www.nasdaq.com/articles/sarepta-srpt-q2-loss-narrows-exondys-51-drives-sales-2018-08-09", "https://www.nasdaq.com/articles/infinity-infi-posts-narrower-than-expected-loss-in-q2-2018-08-09", "https://www.nasdaq.com/articles/horizon-pharma-hznp-q2-earnings-sales-beat-shares-rise-2018-08-09", "https://www.nasdaq.com/articles/mallinckrodt-mnk-beats-on-q2-earnings-and-sales-ups-view-2018-08-08", "https://www.nasdaq.com/articles/catalyst-cprx-posts-narrower-than-expected-loss-in-q2-2018-08-08", "https://www.nasdaq.com/articles/jazz-pharmas-jazz-stock-down-despite-q2-earnings-beat-2018-08-08", "https://www.nasdaq.com/articles/crispr-therapeutics-stock-grossly-overvalued-2018-08-09", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-august-2018-08-08", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-q2-loss-wider-than-expected-2018-08-07", "https://www.nasdaq.com/articles/ironwood-irwd-q2-earnings-revenues-miss-shares-down-2018-08-07", "https://www.nasdaq.com/articles/medicines-company-mdco-q2-loss-narrows-revenues-tank-y-y-2018-08-02", "https://www.nasdaq.com/articles/ophthotech-opht-q2-loss-narrows-zimura-progress-on-track-2018-08-02", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-celgene-amgen-vertex-impress-in-q2-gileads-ceo-to-exit-2018-08-01", "https://www.nasdaq.com/articles/geron-gern-q2-loss-in-line-revenues-up-y-y-shares-down-2018-08-01", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-regeneron-shines-blue-surges-once-plunges-2018-08-08", "https://www.nasdaq.com/articles/3-reasons-why-vertex-pharmaceuticals-stock-isnt-nearly-expensive-it-looks-2018-07-27", "https://www.nasdaq.com/articles/vertex-vrtx-q2-earnings-and-revenues-surpass-estimates-2018-07-26", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-q2-2018-earnings-conference-call-transcript-2018-07-26", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-333-follow-through-indicator", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-25-2018-fb-v-pypl-gild-qcom-su-mdlz-lvs-vrtx-f-now-algn", "https://www.nasdaq.com/articles/4-of-the-best-u.s.-stocks-to-buy-today-for-long-term-growth-2018-07-24", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-vertex-vrtx-this-earnings-season-2018-07-23", "https://www.nasdaq.com/articles/heres-why-vertex-pharmaceuticals-earnings-are-growing-faster-revenue-2018-07-30", "https://www.nasdaq.com/articles/why-bluebird-bios-shares-have-tumbled-119-2018-so-far-2018-07-08", "https://www.nasdaq.com/articles/10-underappreciated-biotech-stocks-buy-2018-07-03", "https://www.nasdaq.com/articles/company-news-for-jul-2-2018-2018-07-02", "https://www.nasdaq.com/articles/vertexs-shares-rally-as-a-rivals-cf-candidate-disappoints-2018-07-02", "https://www.nasdaq.com/articles/4-drug-and-biotech-stocks-awaiting-fda-decisions-july-2018-07-02", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-incorporated-stock-surged-14-today-2018-06-29", "https://www.nasdaq.com/articles/bad-news-delivers-decisive-blow-galapagos-nv-2018-06-29", "https://www.nasdaq.com/articles/10-stocks-that-are-screaming-buys-right-now-2018-07-09", "https://www.nasdaq.com/articles/sp-500-movers-stz-vrtx-2018-06-29", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-751030-662-points-2018-06-29", "https://www.nasdaq.com/articles/fridays-etf-movers-fbt-fm-2018-06-29", "https://www.nasdaq.com/articles/biotech-has-most-valuable-pipeline-asset-world-stock-buy-2018-06-26", "https://www.nasdaq.com/articles/interesting-vrtx-put-and-call-options-august-17th-2018-06-25", "https://www.nasdaq.com/articles/2-high-flying-biotech-stocks-even-more-room-grow-2018-06-20", "https://www.nasdaq.com/articles/5-experimental-new-drugs-could-be-worth-47-billion-2018-06-20", "https://www.nasdaq.com/articles/nasdaq-100-movers-lbtya-vrtx-2018-06-29", "https://www.nasdaq.com/articles/10-stocks-that-are-screaming-buys-right-now-2018-06-12", "https://www.nasdaq.com/articles/nasdaq-100-movers-amat-meli-2018-06-11", "https://www.nasdaq.com/articles/nows-time-buy-these-3-stocks-2018-06-08", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-regeneron-celgene-amgen-impress-at-asco-2018-06-06", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-enters-oversold-territory-2018-06-05", "https://www.nasdaq.com/articles/buy-these-2-biotech-stocks-dip-after-fda-delay-2018-06-05", "https://www.nasdaq.com/articles/zacks-investment-ideas-feature-highlights%3A-crispr-intellia-therapeutics-editas-and-vertex", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-vrtx-2018-06-14", "https://www.nasdaq.com/articles/crispr-therapeutics-stock-bad-news-buy-2018-05-31", "https://www.nasdaq.com/articles/should-you-buy-dip-crispr-therapeutics-2018-05-31", "https://www.nasdaq.com/articles/health-care-sector-update-05312018-sesnasndcrspvrtx-2018-05-31", "https://www.nasdaq.com/articles/what-makes-crispr-stock-better-rest-2018-05-30", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-down-1.2-since-earnings-report%3A-can-it-rebound-2018-05-28", "https://www.nasdaq.com/articles/3-stocks-could-put-alibabas-returns-shame-2018-05-25", "https://www.nasdaq.com/articles/july-6th-options-now-available-vertex-pharmaceuticals-vrtx-2018-05-24", "https://www.nasdaq.com/articles/vertex-crisprs-sickle-disease-candidate-put-on-hold-by-fda-2018-05-31", "https://www.nasdaq.com/articles/ibb-biib-celg-vrtx-etf-outflow-alert-2018-05-21", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-general-dynamics-enbridge-csx-humana-and-vertex-2018-05", "https://www.nasdaq.com/articles/top-research-reports-general-dynamics-enbridge-csx-corporation-2018-05-15", "https://www.nasdaq.com/articles/crispr%3A-3-strong-buy-biotechs-trying-to-edit-our-genes-2018-05-11", "https://www.nasdaq.com/articles/vrtx-crosses-above-key-moving-average-level-2018-05-11", "https://www.nasdaq.com/articles/ibb-celg-biib-vrtx-etf-inflow-alert-2018-05-10", "https://www.nasdaq.com/articles/10-stocks-are-screaming-buys-right-now-2018-05-09", "https://www.nasdaq.com/articles/genome-editing-next-biotech-breakthrough-2018-05-24", "https://www.nasdaq.com/articles/7-fast-growing-stocks-to-buy-today-2018-05-08", "https://www.nasdaq.com/articles/heres-my-top-stock-buy-may-2018-05-08", "https://www.nasdaq.com/articles/ibb-celg-biib-vrtx-etf-outflow-alert-2018-05-02", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-vrtx-post-solid-results-gild-disappoints-in-q1-2018-05-02", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-takes-detour-around-fdas-roadblock-2018-04-30", "https://www.nasdaq.com/articles/5-things-youll-want-know-vertex-pharmaceuticals-q1-conference-call-2018-04-29", "https://www.nasdaq.com/articles/vertex-vrtx-q1-earnings-beat-on-strong-cf-products-sales-2018-04-27", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-may-2018-05-09", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-300-follow-through-indicator", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-26-2018-msft-amzn-intc-sbux-bidu-syk-vrtx-wdc-dfs-ftv", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-vertex-vrtx-this-earnings-season-2018-04-24", "https://www.nasdaq.com/articles/why-earnings-season-could-be-great-for-vertex-pharmaceuticals-vrtx-2018-04-24", "https://www.nasdaq.com/articles/3-growth-stocks-could-put-facebooks-returns-shame-2018-04-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-agios-pharmaceuticals-biomarin-pharmaceutical-vertex", "https://www.nasdaq.com/articles/pharma-ma-active-week-4-potential-buyout-targets-2018-04-13", "https://www.nasdaq.com/articles/notable-thursday-option-activity-lvs-sq-vrtx-2018-04-26", "https://www.nasdaq.com/articles/ibb-gild-biib-vrtx-etf-outflow-alert-2018-04-12", "https://www.nasdaq.com/articles/is-powershares-dynamic-biotechnology-genome-portfolio-pbe-a-hot-etf-right-now-2018-04-12", "https://www.nasdaq.com/articles/novartis-and-other-drug-stocks-fda-catalysts-april-2018-04-10", "https://www.nasdaq.com/articles/we-did-math-mgk-can-go-129-2018-04-09", "https://www.nasdaq.com/articles/10-healthcare-stocks-stave-market-flu-2018-04-06", "https://www.nasdaq.com/articles/10-stocks-are-screaming-buys-right-now-2018-04-05", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-biib-vrtx-ilmn-2018-04-04", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-april-2018-04-13", "https://www.nasdaq.com/articles/top-research-reports-oracle-vale-general-mills-2018-03-23", "https://www.nasdaq.com/articles/10-triple-stocks-second-quarter-2018-03-23", "https://www.nasdaq.com/articles/3-highest-growth-stocks-market-today-2018-03-19", "https://www.nasdaq.com/articles/does-crispr-therapeutics-ag-deserve-massive-rally-2018-03-19", "https://www.nasdaq.com/articles/7-things-vertex-pharmaceuticals-ceo-just-said-will-probably-make-you-want-buy-stock-2018", "https://www.nasdaq.com/articles/why-crispr-therapeutics-slipped-10-thursday-2018-03-15", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-bbh-celg-biib-vrtx-2018-03-13", "https://www.nasdaq.com/articles/first-week-vrtx-may-18th-options-trading-2018-03-28", "https://www.nasdaq.com/articles/implied-esgu-analyst-target-price-66-2018-03-09", "https://www.nasdaq.com/articles/10-stocks-are-screaming-buys-right-now-2018-03-07", "https://www.nasdaq.com/articles/tuesday-sector-laggards-utilities-healthcare-2018-03-06", "https://www.nasdaq.com/articles/why-investors-are-paying-premium-these-3-biotech-stocks-2018-03-03", "https://www.nasdaq.com/articles/7-fast-growing-stocks-to-buy-today-2018-03-02", "https://www.nasdaq.com/articles/ibb-regn-vrtx-alxn-large-outflows-detected-etf-2018-02-28", "https://www.nasdaq.com/articles/biotech-stock-round-up%3A-celgene-suffers-setback-gilead-teams-up-with-sangamo-2018-02-28", "https://www.nasdaq.com/articles/3-biotech-stocks-with-rising-earnings-estimates-post-q4-2018-03-13", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-total-marriott-pge-and-vertex-2018-02-21", "https://www.nasdaq.com/articles/top-analyst-report-amgen-total-sa-marriott-2018-02-20", "https://www.nasdaq.com/articles/3-high-growth-stocks-could-soar-2018-02-19", "https://www.nasdaq.com/articles/3-stocks-could-put-amazons-future-returns-shame-2018-02-16", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-scores-important-win-2018-02-16", "https://www.nasdaq.com/articles/stocks-watch-alkermes-sees-relative-strength-rating-rise-85-2018-02-16", "https://www.nasdaq.com/articles/alkermes-gets-ibd-stock-rating-upgrade-2018-02-16", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-733739-12730-points-2018-02-23", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-total-marriott-pge-and-vertex-2018-02-21", "https://www.nasdaq.com/articles/portola-pharmaceuticals-getting-closer-key-technical-benchmark-2018-02-15", "https://www.nasdaq.com/articles/alder-biopharmaceuticals-shows-rising-relative-strength-still-shy-key-benchmark-2018-02-15", "https://www.nasdaq.com/articles/3-high-growth-stocks-are-just-getting-started-2018-02-14", "https://www.nasdaq.com/articles/vertexs-third-cystic-fibrosis-treatment-gets-fda-approval-2018-02-13", "https://www.nasdaq.com/articles/now-good-time-buy-vertex-pharmaceuticals-2018-02-13", "https://www.nasdaq.com/articles/3-great-acquisition-targets-gilead-sciences-and-1-iffy-candidate-2018-02-15", "https://www.nasdaq.com/articles/heres-what-pushed-intellia-therapeutics-inc-337-january-2018-02-08", "https://www.nasdaq.com/articles/march-29th-options-now-available-vertex-pharmaceuticals-vrtx-2018-02-08", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-02-08", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-wells-fargo-caterpillar-schlumberger-vertex-and", "https://www.nasdaq.com/articles/why-crispr-therapeutics-ag-stock-bolted-higher-january-2018-02-08", "https://www.nasdaq.com/articles/regn-vs.-alxn%3A-which-stock-is-poised-for-better-q4-earnings-2018-02-07", "https://www.nasdaq.com/articles/top-stock-reports-wells-fargo-caterpillar-schlumberger-2018-02-07", "https://www.nasdaq.com/articles/abbvie-or-vertex-pharmaceuticals-better-buy-now-2018-02-12", "https://www.nasdaq.com/articles/monday-sector-laggards-energy-healthcare-2018-02-05", "https://www.nasdaq.com/articles/3-top-orphan-drug-stocks-buy-now-2018-02-03", "https://www.nasdaq.com/articles/omeros-trying-close-key-technical-measure-2018-02-02", "https://www.nasdaq.com/articles/vertex-vrtx-q4-earnings-beat-on-strong-cf-products-sales-2018-02-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-abbvie-4q-results-impress-ablynx-be-acquired-sanofi-2018-02-01", "https://www.nasdaq.com/articles/what-vertex-pharmaceuticals-just-said-about-its-future-2018-02-01", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-picks-between-sirloin-steak-and-filet-mignon-2018-02-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-sanofi-seattle-genetics-abbvie-celgene-and-vertex-2018", "https://www.nasdaq.com/articles/vertex-vrtx-other-drug-stocks-fda-catalysts-february-2018-01-31", "https://www.nasdaq.com/articles/vertex-beats-views-closes-cystic-fibrosis-treatments-2018-01-31", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-31-2018-msft-fb-t-pypl-qcom-mdlz-ebay-vrtx-afl-now-avb", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-333-follow-through-0", "https://www.nasdaq.com/articles/drug-biotech-stocks-q4-earnings-due-on-jan-31%3A-lly-vrtx-2018-01-30", "https://www.nasdaq.com/articles/vertex-vrtx-to-report-q4-earnings%3A-whats-in-the-cards-2018-01-29", "https://www.nasdaq.com/articles/gilead-sciences-take-two-interactive-hit-buys-after-vertex-breakout-2018-01-29", "https://www.nasdaq.com/articles/la-jolla-pharmaceutical-meets-80-plus-relative-strength-rating-benchmark-2018-02-01", "https://www.nasdaq.com/articles/3-biotech-stocks-jaw-dropping-growth-potential-2018-01-28", "https://www.nasdaq.com/articles/rpg-vrtx-lrcx-cnc-large-inflows-detected-etf-2018-01-26", "https://www.nasdaq.com/articles/quality-fund-support-crucial-stocks-success-2018-01-26", "https://www.nasdaq.com/articles/vertex-vrtx-stock-up-70-in-a-years-time%3A-heres-why-2018-01-25", "https://www.nasdaq.com/articles/innoviva-clears-technical-benchmark-hitting-80-plus-rs-rating-2018-01-25", "https://www.nasdaq.com/articles/stocks-showing-market-leadership-concert-pharmaceuticals-earns-93-rs-rating-2018-01-25", "https://www.nasdaq.com/articles/first-week-march-16th-options-trading-vertex-pharmaceuticals-vrtx-2018-01-24", "https://www.nasdaq.com/articles/stock-futures-fall-treasury-yields-climb-why-these-7-earnings-stand-out-2018-01-29", "https://www.nasdaq.com/articles/whats-in-the-cards-for-novartis-nvs-this-earnings-season-2018-01-22", "https://www.nasdaq.com/articles/celgene-celg-q4-preview%3A-will-it-beat-on-earnings-again-2018-01-22", "https://www.nasdaq.com/articles/amgen-gets-fda-nod-to-add-endeavor-data-on-kyprolis-label-2018-01-18", "https://www.nasdaq.com/articles/3-top-ranked-drug-stocks-are-broker-favorites-2018-01-18-0", "https://www.nasdaq.com/articles/3-top-ranked-drug-stocks-are-broker-favorites-2018-01-18", "https://www.nasdaq.com/articles/stocks-rising-relative-strength-biogen-2018-01-18", "https://www.nasdaq.com/articles/3-biotech-stocks-start-healthy-18-will-rally-last-2018-01-18", "https://www.nasdaq.com/articles/heres-whats-driving-crispr-therapeutics-ag-higher-today-2018-01-23", "https://www.nasdaq.com/articles/blackrock-pier-one-imports-alkermes-vertex-pharmaceuticals-and-agenus-highlighted-as-zacks", "https://www.nasdaq.com/articles/biotech-stock-roundup-juno-surges-acquisition-rumor-concert-down-patent-news-2018-01-17", "https://www.nasdaq.com/articles/3-biotech-stocks-start-healthy-in-18%3A-will-the-rally-last-2018-01-16", "https://www.nasdaq.com/articles/stocks-showing-market-leadership-voyager-therapeutics-earns-91-rs-rating-2018-01-16", "https://www.nasdaq.com/articles/concert-pharmaceuticals-plunges-on-patent-petition-setback-2018-01-15", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-celgene-amgen-exelixis-alexion-and-vertex-2018-01-12", "https://www.nasdaq.com/articles/atara-biotherapeutics-joins-elite-club-stocks-rs-ratings-over-90-2018-01-12", "https://www.nasdaq.com/articles/rpg-vrtx-cnc-phm-large-outflows-detected-etf-2018-01-18", "https://www.nasdaq.com/articles/vertexs-cystic-fibrosis-drug-okd-for-pediatric-use-in-eu-2018-01-11", "https://www.nasdaq.com/articles/biogen-trying-close-key-technical-measure-2018-01-11", "https://www.nasdaq.com/articles/omeros-scores-relative-strength-rating-upgrade-hits-key-threshold-2018-01-11", "https://www.nasdaq.com/articles/stocks-showing-improving-market-leadership-agios-pharmaceuticals-earns-81-rs-rating-2018", "https://www.nasdaq.com/articles/stocks-watch-halozyme-therapeutics-sees-rs-rating-rise-92-2018-01-11", "https://www.nasdaq.com/articles/alder-biopharmaceuticals-meets-80-plus-relative-strength-rating-benchmark-2018-01-11", "https://www.nasdaq.com/articles/heron-therapeutics-joins-elite-club-stocks-rs-ratings-over-90-2018-01-11", "https://www.nasdaq.com/articles/can-biotech-keep-last-years-momentum-alive-in-2018-2018-01-11", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-regn-vrtx-ilmn-2018-01-10", "https://www.nasdaq.com/articles/health-care-sector-update-01102018-jnj-pfe-abt-mrk-amgn-aphb-lpcn-gkos-avdl-vrtx-alks-sndx", "https://www.nasdaq.com/articles/biotech-stock-roundup-celgene-acquire-impact-jp-morgan-healthcare-conference-focus-2018-01", "https://www.nasdaq.com/articles/supernus-pharmaceuticals-earns-relative-strength-rating-upgrade-hits-key-threshold-2018-01", "https://www.nasdaq.com/articles/stocks-showing-market-leadership-array-biopharma-earns-91-rs-rating-2018-01-10", "https://www.nasdaq.com/articles/portola-pharmaceuticals-reaches-80-plus-relative-strength-rating-benchmark-2018-01-10", "https://www.nasdaq.com/articles/dow-returns-new-years-rally-2018-01-10", "https://www.nasdaq.com/articles/stocks-rising-relative-price-strength-regenxbio-2018-01-11", "https://www.nasdaq.com/articles/10-things-expect-vertex-pharmaceuticals-2018-2018-01-09", "https://www.nasdaq.com/articles/avexis-joins-rank-stocks-rs-ratings-over-90-2018-01-09", "https://www.nasdaq.com/articles/ptc-therapeutics-clears-key-benchmark-hitting-80-plus-rs-rating-2018-01-09", "https://www.nasdaq.com/articles/galapagos-reports-topline-data-from-osteoarthritis-study-2018-01-08", "https://www.nasdaq.com/articles/amgens-amgn-xgeva-gets-fda-approval-for-multiple-myeloma-2018-01-08", "https://www.nasdaq.com/articles/stocks-showing-market-leadership-crispr-therapeutics-earns-92-rs-rating-2018-01-08", "https://www.nasdaq.com/articles/stocks-generating-improved-relative-strength-supernus-pharmaceuticals-2018-01-08", "https://www.nasdaq.com/articles/2018-jp-morgan-healthcare-conference-roundup-2018-01-09", "https://www.nasdaq.com/articles/why-crispr-therapeutics-ag-stock-rising-today-2018-01-05", "https://www.nasdaq.com/articles/heres-what-pushed-crispr-therapeutics-ag-236-december-2018-01-04", "https://www.nasdaq.com/articles/3-best-performing-healthcare-stocks-sp-500-2017-2018-01-04", "https://www.nasdaq.com/articles/nasdaq-100-movers-intc-expe-2018-01-03", "https://www.nasdaq.com/articles/will-these-2-large-cap-biotechs-be-on-investor-radar-in-18-2018-01-03", "https://www.nasdaq.com/articles/stocks-generating-improved-relative-strength-biogen-2018-01-03", "https://www.nasdaq.com/articles/ptc-therapeutics-shows-market-leadership-jump-84-rs-rating-2018-01-03", "https://www.nasdaq.com/articles/3-big-biotech-stocks-buy-january-2018-01-06", "https://www.nasdaq.com/articles/these-4-sp-500-stocks-doubled-2017-2018-01-02", "https://www.nasdaq.com/articles/why-these-2-biotechs-could-outperform-amid-hyper-competition-2018-01-02", "https://www.nasdaq.com/articles/flexion-therapeutics-getting-closer-key-technical-measure-2017-12-29", "https://www.nasdaq.com/articles/supernus-pharmaceuticals-shows-rising-price-performance-jump-81-rs-rating-2017-12-29", "https://www.nasdaq.com/articles/another-reason-2018-might-not-be-banner-year-biotech-mergers-2017-12-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-biib-celg-hit-pipeline-news-acquisition-deals-ignyta-sucampo-2017-12", "https://www.nasdaq.com/articles/innoviva-sees-rs-rating-rise-74-2017-12-27", "https://www.nasdaq.com/articles/la-jolla-pharmaceutical-hits-80-plus-relative-strength-rating-benchmark-2018-01-03", "https://www.nasdaq.com/articles/ptc-therapeutics-clears-key-benchmark-hitting-80-plus-rs-rating-2017-12-26", "https://www.nasdaq.com/articles/stocks-showing-improving-market-leadership-voyager-therapeutics-earns-84-rs-rating-2017-12", "https://www.nasdaq.com/articles/array-biopharma-shows-rising-price-performance-jump-85-rs-rating-2017-12-26", "https://www.nasdaq.com/articles/stocks-showing-market-leadership-exelixis-earns-93-rs-rating-2017-12-26", "https://www.nasdaq.com/articles/qa-vertex-chief-talks-about-companys-transformational-year-2017-12-22", "https://www.nasdaq.com/articles/10-top-sp-500-stocks-2017-2017-12-22", "https://www.nasdaq.com/articles/innoviva-earns-relative-strength-rating-upgrade-2017-12-22", "https://www.nasdaq.com/articles/ibd-rating-upgrades-pacira-pharmaceuticals-shows-improved-relative-price-strength-2017-12", "https://www.nasdaq.com/articles/editas-medicine-joins-elite-club-stocks-rs-ratings-over-90-2017-12-22", "https://www.nasdaq.com/articles/array-biopharma-trying-close-key-technical-benchmark-2017-12-22", "https://www.nasdaq.com/articles/corcept-therapeutics-shows-rising-price-performance-jump-95-rs-rating-2017-12-22", "https://www.nasdaq.com/articles/3-great-stocks-your-ira-2017-12-21", "https://www.nasdaq.com/articles/stocks-showing-rising-market-leadership-voyager-therapeutics-earns-83-rs-rating-2017-12-21", "https://www.nasdaq.com/articles/acceleron-pharma-hits-80-plus-relative-strength-rating-benchmark-2017-12-21", "https://www.nasdaq.com/articles/regenxbio-shows-rising-price-performance-jump-93-rs-rating-2017-12-21", "https://www.nasdaq.com/articles/acceleron-pharma-joins-rank-stocks-rs-ratings-over-90-2017-12-22", "https://www.nasdaq.com/articles/stocks-showing-improving-market-leadership-exelixis-earns-83-rs-rating-2017-12-20", "https://www.nasdaq.com/articles/stocks-watch-portola-pharmaceuticals-sees-relative-strength-rating-jump-94-2017-12-20", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-shows-market-leadership-jump-81-rs-rating-2017-12-20", "https://www.nasdaq.com/articles/heron-therapeutics-earns-relative-strength-rating-upgrade-hits-key-benchmark-2017-12-20", "https://www.nasdaq.com/articles/5-hot-stocks-driving-nasdaq-etf-rally-2017-12-19", "https://www.nasdaq.com/articles/stocks-showing-improved-relative-strength-acceleron-pharma-2017-12-19", "https://www.nasdaq.com/articles/proteostasis-stock-surges-on-positive-data-from-cf-studies-2017-12-13", "https://www.nasdaq.com/articles/biotech-stock-roundup-label-expansion-exelixiss-cabometyx-fda-nod-sparks-gene-therapy-2017", "https://www.nasdaq.com/articles/nasdaq-100-movers-orly-bmrn-2017-12-11", "https://www.nasdaq.com/articles/4-drug-biotech-stocks-that-could-be-buyout-targets-in-2018-2017-12-11", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc-vrtx-ceo-president-jeffrey-m-leiden-sold-177-million-shares", "https://www.nasdaq.com/articles/5-best-stocks-sp-500-2017-2017-12-11", "https://www.nasdaq.com/articles/3-growth-stocks-id-buy-right-now-2017-12-10", "https://www.nasdaq.com/articles/vertex-kalydeco-study-successful-in-children-aged-1-2-years-2017-12-08", "https://www.nasdaq.com/articles/3-top-stocks-to-boost-your-portfolio-in-2018-2017-12-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-ash-data-focus-gilead-buy-cell-design-labs-2017-12-13", "https://www.nasdaq.com/articles/agree-buy-vertex-pharmaceuticals-110-earn-104-using-options-2017-12-05", "https://www.nasdaq.com/articles/building-circle-competency-2017-12-05", "https://www.nasdaq.com/articles/5-top-biotech-stocks-buy-now-2017-12-03", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-starbucks-nike-manulife-intuit-and-vertex-2017-11-28", "https://www.nasdaq.com/articles/new-pharma-etf-pill-what-investors-need-know-2017-11-28", "https://www.nasdaq.com/articles/top-analyst-reports-starbucks-nike-manulife-2017-11-27", "https://www.nasdaq.com/articles/3-stocks-could-put-amazons-returns-shame-2017-11-26", "https://www.nasdaq.com/articles/implied-analyst-12-month-target-xlv-2017-12-07", "https://www.nasdaq.com/articles/sage-therapeutics-shows-rising-price-performance-jump-91-rs-rating-2017-11-22", "https://www.nasdaq.com/articles/3-stocks-have-doubled-and-still-have-room-grow-2017-11-21", "https://www.nasdaq.com/articles/sp-500-movers-vrtx-dlph-2017-11-20", "https://www.nasdaq.com/articles/galapagos-cf-candidate-shows-potential-in-phase-ii-study-2017-11-20", "https://www.nasdaq.com/articles/galapagos-pops-vertexs-detriment-can-it-compete-2017-11-20", "https://www.nasdaq.com/articles/biotechs-trading-lower-in-q4-on-macro-uncertainty-tepid-q3-2017-11-17", "https://www.nasdaq.com/articles/biotech-stock-roundup-dynavax-vaccine-gets-fda-nod-loxo-inks-deal-bayer-2017-11-15", "https://www.nasdaq.com/articles/zynerba-pharmaceuticals-joins-rank-stocks-rs-ratings-over-90-2017-11-22", "https://www.nasdaq.com/articles/biotech-stock-roundup-regeneron-delivers-strong-q3-results-cellectis-clinical-hold-lifted", "https://www.nasdaq.com/articles/how-pieces-add-fxh-headed-77-2017-11-06", "https://www.nasdaq.com/articles/these-3-stocks-look-expensive-are-actually-cheap-2017-11-03", "https://www.nasdaq.com/articles/vertex-pops-analyst-questions-whether-rival-has-viable-drug-2017-11-03", "https://www.nasdaq.com/articles/biotech-stock-roundup-celgene-amgen-gilead-hit-q3-results-vertex-beats-all-fronts-2017-11", "https://www.nasdaq.com/articles/biogen-sees-relative-strength-rating-climb-75-2017-10-31", "https://www.nasdaq.com/articles/sarepta-therapeutics-clears-key-benchmark-hitting-90-plus-rs-rating-2017-10-31", "https://www.nasdaq.com/articles/vertex-gets-chmp-recommendation-for-orkambi-label-expansion-2017-11-13", "https://www.nasdaq.com/articles/intra-cellular-therapies-earns-relative-strength-rating-upgrade-2017-10-31", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-one-eye-earnings-one-pipeline-2017-10-27", "https://www.nasdaq.com/articles/vertex-vrtx-beats-on-q3-earnings-sales-raises-2017-view-2017-10-26", "https://www.nasdaq.com/articles/bristol-myers-more-bad-medicine-market-2017-10-26", "https://www.nasdaq.com/articles/5-biotech-stocks-that-are-getting-battered-too-hard-for-comfort-2017-10-26", "https://www.nasdaq.com/articles/adamas-pharmaceuticals-clears-technical-benchmark-hitting-80-plus-rs-rating-2017-10-26", "https://www.nasdaq.com/articles/rsi-alert-vertex-pharmaceuticals-vrtx-now-oversold-2017-10-25", "https://www.nasdaq.com/articles/stocks-flashing-renewed-technical-strength-adamas-pharmaceuticals-2017-10-31", "https://www.nasdaq.com/articles/three-biotech-firms-top-third-quarter-views-only-one-pops-2017-10-25", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-400-follow-through-indicator", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-25-2017-amgn-su-lvs-nxpi-vrtx-psa-afl-dlr-now-wcn-abx", "https://www.nasdaq.com/articles/drug-biotech-stocks-q3-earnings-on-oct-25%3A-amgn-gsk-vrtx-2017-10-24", "https://www.nasdaq.com/articles/why-earnings-season-could-be-great-for-vertex-pharmaceuticals-vrtx-2017-10-24", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-now-2017-10-24", "https://www.nasdaq.com/articles/aimmune-therapeutics-scores-relative-strength-rating-upgrade-2017-10-24", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-tops-q3-earnings-gileads-car-t-drug-gets-fda-nod-2017-10-25", "https://www.nasdaq.com/articles/ibds-no-1-group-under-pressure-these-6-key-earnings-loom-sp-500-futures-2017-10-23", "https://www.nasdaq.com/articles/is-celgene-celg-poised-for-a-beat-this-earnings-season-2017-10-23", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-vertex-vrtx-in-q3-earnings-2017-10-20", "https://www.nasdaq.com/articles/4-most-efficient-stocks-buy-now-2017-10-20", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-novo-vertex-pharmaceuticals-celgene-and-ligand", "https://www.nasdaq.com/articles/whats-in-the-cards-for-novartis-nvs-this-earnings-season-2017-10-18", "https://www.nasdaq.com/articles/foolish-take-best-performing-sp-500-stock-year-2017-10-23", "https://www.nasdaq.com/articles/nasdaq-100-movers-jbht-wynn-2017-10-16", "https://www.nasdaq.com/articles/1-stock-youve-been-overlooking-your-roth-ira-2017-10-15", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-usg-and-j.-jill-highlighted-as-zacks-bull-and-bear-of-the-day-2017", "https://www.nasdaq.com/articles/rhenman-partners-asset-management-ab-buys-arena-pharmaceuticals-inc-vertex-2017-10-13", "https://www.nasdaq.com/articles/bull-day-vertex-pharmaceuticals-vrtx-2017-10-13", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-abbott-abt-this-earnings-season-2017-10-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgens-imlygic-data-promising-regeneron-scores-win-pcsk9-lawsuit", "https://www.nasdaq.com/articles/innovative-pipelines-regulatory-catalysts-drive-pharma-stocks-2017-10-17", "https://www.nasdaq.com/articles/5-pharma-biotech-stocks-could-be-big-winners-q3-earnings-2017-10-10", "https://www.nasdaq.com/articles/why-the-earnings-streak-will-continue-for-vertex-pharmaceuticals-vrtx-2017-10-10", "https://www.nasdaq.com/articles/forget-teva-teva-buy-these-5-drug-stocks-instead-2017-10-09", "https://www.nasdaq.com/articles/biotech-stock-roundup-endocyte-shoots-deal-amgen-abbvie-settle-humira-litigation-2017-10", "https://www.nasdaq.com/articles/fex-trow-hpe-vrtx-large-outflows-detected-etf-2017-10-03", "https://www.nasdaq.com/articles/3-top-ranked-big-biotech-stocks-to-buy-now-2017-10-03", "https://www.nasdaq.com/articles/stocks-open-mixed-musk-talks-mars-zogenix-soars-drug-news-2017-09-29", "https://www.nasdaq.com/articles/amgen-label-expansion-application-for-prolia-accepted-by-fda-2017-10-10", "https://www.nasdaq.com/articles/top-stock-reports-goldman-sachs-pepsico-and-johnson-johnson-2017-09-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-reiterates-2017-outlook-intercept-hit-ocaliva-safety-issues", "https://www.nasdaq.com/articles/3-highest-growth-stocks-market-today-2017-09-25", "https://www.nasdaq.com/articles/3-monster-biotech-stocks-making-2017-09-24", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-first-cancer-biosimilar-halo-deals-raised-outlook-2017-09-20", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-ishares-core-sp-500-etf-vertex-pharmaceuticals-align", "https://www.nasdaq.com/articles/5-top-performing-stocks-driving-sp-500-etf-higher-2017-09-18", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-gilead-sciences-cystic-fibrosis-2017-09-28", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-fex-vrtx-pypl-trow-2017-09-12", "https://www.nasdaq.com/articles/nasdaq-100-movers-alxn-payx-2017-09-12", "https://www.nasdaq.com/articles/2-views-vertex-pharmaceuticals-stock-short-term-vs-long-term-2017-09-12", "https://www.nasdaq.com/articles/notable-thursday-option-activity-oxy-vrtx-aig-2017-09-07", "https://www.nasdaq.com/articles/nasdaq-100-biotechnology-beyond-pure-tech-still-pure-innovation-2017-09-06", "https://www.nasdaq.com/articles/biotech-stock-roundup-cellectis-down-clinical-hold-insmed-soars-positive-data-2017-09-06", "https://www.nasdaq.com/articles/4-biotech-stocks-more-doubled-year-2017-09-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-alexion-cut-jobs-streamline-operations-kura-cancer-data-2017-09-13", "https://www.nasdaq.com/articles/4-biotech-stocks-that-more-than-doubled-this-year-2017-09-01", "https://www.nasdaq.com/articles/dont-sell-facebook-inc-fb-stock-just-because-its-losing-the-teen-crowd-2017-09-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-car-t-focus-gilead-kite-deal-incyte-baricitinib-update-2017-08-31", "https://www.nasdaq.com/articles/xbi-exel-alxn-vrtx-etf-inflow-alert-2017-08-30", "https://www.nasdaq.com/articles/why-micron-technology-inc.-mu-stock-suddenly-looks-so-sunny-2017-08-29", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-down-5.2-since-earnings-report%3A-can-it-rebound-2017-08-29", "https://www.nasdaq.com/articles/3-reasons-to-be-cautious-on-vertex-pharmaceuticals-incorporated-vrtx-stock-2017-08-29", "https://www.nasdaq.com/articles/3-growth-stocks-21st-century-2017-09-05", "https://www.nasdaq.com/articles/4-highest-growth-stocks-biotech-today-2017-08-24", "https://www.nasdaq.com/articles/commit-buy-vertex-pharmaceuticals-100-earn-45-using-options-2017-08-23", "https://www.nasdaq.com/articles/biotech-stock-roundup-eu-label-expansion-alexion-biib-facing-drug-price-probe-2017-08-23", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-xbi-exel-alxn-vrtx-2017-08-22", "https://www.nasdaq.com/articles/nasdaq-100-movers-myl-vrtx-2017-08-22", "https://www.nasdaq.com/articles/trade-of-the-day%3A-freeport-mcmoran-inc-fcx-stock-is-rally-ready-2017-08-22", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-629748-8435-points-2017-08-22", "https://www.nasdaq.com/articles/vertexs-cystic-fibrosis-combo-gets-priority-review-in-u.s.-2017-08-25", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-vrtx-stock-is-too-expensive-2017-08-21", "https://www.nasdaq.com/articles/3-best-stocks-healthcare-2017-08-17", "https://www.nasdaq.com/articles/biotech-stock-roundup-regeneron-drops-rsv-antibody-gilead-hiv-drug-gets-priority-review", "https://www.nasdaq.com/articles/3-stocks-could-put-alibabas-returns-shame-2017-08-16", "https://www.nasdaq.com/articles/why-gilead-sciences-might-not-make-oncology-acquisition-2017-08-15", "https://www.nasdaq.com/articles/3-big-stock-charts-for-monday%3A-nvidia-corporation-nvda-micron-technology-inc.-mu-and", "https://www.nasdaq.com/articles/is-tjx-companies-inc-tjx-stock-ready-to-shine-again-2017-08-14", "https://www.nasdaq.com/articles/tuesday-sector-leaders-technology-communications-healthcare-2017-08-22", "https://www.nasdaq.com/articles/3-strong-buy-biotech-stocks-you-should-watch-2017-08-14", "https://www.nasdaq.com/articles/hot-fidelity-fund-owns-stocks-tencent-jump-stock-market-2017-08-11", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-625656-3969-points-2017-08-11", "https://www.nasdaq.com/articles/friday-sector-leaders-technology-communications-healthcare-2017-08-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-q2-earnings-regeneron-kite-more-fibrogen-ipf-data-2017-08-09", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-incorporated-vrtx-will-keep-rolling-higher-2017-08-08", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vs-regeneron-pharmaceuticals-which-company-reported-better-earnings", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-incorporated-vrtx-stock-isnt-worth-the-risk-2017-08-14", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-skyrocketed-178-july-2017-08-03", "https://www.nasdaq.com/articles/biotech-stock-roundup-q2-earnings-gilead-celg-more-dynavax-panel-vote-2017-08-02", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-fex-vrtx-lrcx-bg-2017-07-28", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-chugs-along-2017-07-28", "https://www.nasdaq.com/articles/pharma-stocks-to-watch-for-earnings-on-jul-28%3A-abbv-mrk-2017-07-27", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-farmers-merchants-bancorp-advanced-energy-industries-nvr", "https://www.nasdaq.com/articles/vertex-vrtx-q2-earnings-top-on-solid-cystic-fibrosis-sales-2017-07-27", "https://www.nasdaq.com/articles/should-you-buy-vertex-pharmaceuticals-incorporated-vrtx-stock-3-pros-3-cons-2017-08-03", "https://www.nasdaq.com/articles/5-top-efficient-stocks-buy-winning-portfolio-2017-07-26", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-400-follow-through-0", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-26-2017-fb-gild-pypl-su-lvs-vrtx-psa-lrcx-ew-dfs-abx-now", "https://www.nasdaq.com/articles/drug-stocks-q2-earnings-releases-on-jul-26%3A-gild-vrtx-gsk-2017-07-25", "https://www.nasdaq.com/articles/whats-in-the-cards-for-geron-gern-this-earnings-season-2017-07-25", "https://www.nasdaq.com/articles/can-intercept-icpt-beat-estimates-this-earnings-season-2017-07-25", "https://www.nasdaq.com/articles/will-radius-health-rdus-disappoint-this-earnings-season-2017-07-25", "https://www.nasdaq.com/articles/thursday-sector-laggards-healthcare-technology-communications-2017-07-27", "https://www.nasdaq.com/articles/dst-systems-dst-q2-earnings%3A-is-a-surprise-in-store-2017-07-25", "https://www.nasdaq.com/articles/xilinx-xlnx-to-post-q1-earnings%3A-whats-in-the-cards-2017-07-25", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-vrtx-might-surprise-this-earnings-season-2017-07-25", "https://www.nasdaq.com/articles/top-stock-picks-week-july-24th-2017-07-25", "https://www.nasdaq.com/articles/whats-in-the-cards-for-exelixis-exel-in-q2-earnings-2017-07-24", "https://www.nasdaq.com/articles/is-celgene-celg-poised-for-a-beat-this-earnings-season-2017-07-24", "https://www.nasdaq.com/articles/top-ranked-momentum-stocks-to-buy-for-july-24th-2017-07-24", "https://www.nasdaq.com/articles/gigamon-gimo-to-report-q2-earnings%3A-whats-in-the-cards-2017-07-25", "https://www.nasdaq.com/articles/equifax-efx-to-post-q2-earnings%3A-whats-in-the-cards-2017-07-24", "https://www.nasdaq.com/articles/whats-in-the-offing-for-f5-networks-ffiv-in-q3-earnings-2017-07-24", "https://www.nasdaq.com/articles/whats-in-the-offing-for-bristol-myers-bmy-in-q2-earnings-2017-07-21", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc-vrtx-ceo-president-jeffrey-m-leiden-sold-349-million-shares", "https://www.nasdaq.com/articles/vertex-pharma-a10-networks-microsoft-visa-and-ebay-highlighted-as-zacks-bull-and-bear-of", "https://www.nasdaq.com/articles/can-merck-mrk-pull-off-a-surprise-this-earnings-season-2017-07-21", "https://www.nasdaq.com/articles/seres-therapeutics-mcrb-catches-eye%3A-stock-gains-9.2-2017-07-21", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-vertex-pharmaceuticals-agco-owens-corning-five9-and-axcelis", "https://www.nasdaq.com/articles/5-stock-picks-with-earnings-beat-potential-2017-07-21", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-vertex-vrtx-in-q2-earnings-2017-07-21", "https://www.nasdaq.com/articles/sarepta-srpt-q2-loss-narrows-ups-exondys-51-sales-view-2017-07-20", "https://www.nasdaq.com/articles/trade-philip-morris-international-inc.-pm-stock-while-its-up-in-smoke-2017-07-20", "https://www.nasdaq.com/articles/buy-vertex-pharmaceuticals-incorporated-vrtx-stock-like-its-20-gain-never-happened-2017-07", "https://www.nasdaq.com/articles/company-news-for-july-20-2017-2017-07-20", "https://www.nasdaq.com/articles/is-gilead-gild-poised-for-a-beat-this-earnings-season-2017-07-20", "https://www.nasdaq.com/articles/bull-day-vertex-pharma-vrtx-2017-07-21", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-apple-jpmorgan-celgene-paypal-and-vertex", "https://www.nasdaq.com/articles/nasdaq-100-movers-csx-vrtx-2017-07-19", "https://www.nasdaq.com/articles/sp-500-movers-ntrs-vrtx-2017-07-19", "https://www.nasdaq.com/articles/vertex-vrtx-triple-combination-cf-studies-data-positive-2017-07-19", "https://www.nasdaq.com/articles/pre-market-most-active-jul-19-2017-mt-vrtx-rad-bfr-sni-ms-baba-sny-tvix-mu-qqq-fb-2017-07", "https://www.nasdaq.com/articles/biotech-stock-roundup-vertex-boosted-cf-data-fda-nod-gilead-puma-drugs-2017-07-19", "https://www.nasdaq.com/articles/micron-technology-inc.-mu-stock-is-about-to-break-out-2017-07-19", "https://www.nasdaq.com/articles/heres-why-vertex-pharmaceuticals-vrtx-soared-today-2017-07-19", "https://www.nasdaq.com/articles/what-happened-stock-market-today-2017-07-19", "https://www.nasdaq.com/articles/market-close-report-historical-high-reached-nasdaq-composite-index-closes-638504-2017-07", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-stock-soaring-heres-why-its-still-not-too-late-buy-2017-07-19", "https://www.nasdaq.com/articles/health-care-sector-update-07192017-vrtxaezscycc-2017-07-19", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-incorporated-stock-soaring-today-2017-07-19", "https://www.nasdaq.com/articles/forget-gw-pharmaceuticals-these-2-stocks-are-better-buys-2017-07-18", "https://www.nasdaq.com/articles/top-stock-reports-apple-jpmorgan-celgene-2017-07-18", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-wednesday%3A-vertex-pharmaceuticals-incorporated-vrtx-csx-corporation", "https://www.nasdaq.com/articles/why-youre-smart-buy-vertex-pharmaceuticals-stock-2017-07-15", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-crescent-point-energy-vertex-pharmaceuticals-sodastream", "https://www.nasdaq.com/articles/can-novartis-nvs-spring-a-surprise-this-earnings-season-2017-07-14", "https://www.nasdaq.com/articles/amgens-myeloma-drug-improves-overall-survival-in-phase-iii-2017-07-13", "https://www.nasdaq.com/articles/5-companies-consistently-beat-earnings-estimates-2017-07-13", "https://www.nasdaq.com/articles/thursday-sector-laggards-healthcare-technology-communications-2017-07-13", "https://www.nasdaq.com/articles/biotech-stock-roundup-arena-shoots-study-data-celg-inks-immuno-oncology-deal-2017-07-12", "https://www.nasdaq.com/articles/wall-streets-5-hottest-biotech-stocks-right-now-2017-07-17", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-sanderson-farms-american-woodmark-vertex-pharmaceuticals", "https://www.nasdaq.com/articles/5-top-multibagger-biotech-stocks-buy-2nd-half-2017-07-11", "https://www.nasdaq.com/articles/bib-biib-regn-vrtx-etf-outflow-alert-2017-07-10", "https://www.nasdaq.com/articles/5-efficient-stocks-buy-winning-portfolio-2017-07-10", "https://www.nasdaq.com/articles/nasdaq-100s-3-best-stocks-2017s-first-half-2017-07-05", "https://www.nasdaq.com/articles/3-reasons-why-gilead-sciences-shouldnt-buy-vertex-pharmaceuticals-2017-07-03", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-reaches-analyst-target-price-2017-07-03", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-vertex-pharmaceuticals-alimera-sciences-enzo-biochem", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-running-out-steam-or-taking-breather-2017-06-29", "https://www.nasdaq.com/articles/will-oil-prices-spoil-tesla-incs-tsla-model-3-party-2017-06-28", "https://www.nasdaq.com/articles/heres-why-investors-are-glued-to-vertex-pharma-vrtx-stock-2017-06-23", "https://www.nasdaq.com/articles/3-growth-stocks-could-soar-more-tesla-2017-06-23", "https://www.nasdaq.com/articles/fresh-capital-be-injected-biotech-stocks-5-must-buys-2017-06-21", "https://www.nasdaq.com/articles/biotech-stock-roundup-clovis-soars-rubraca-data-seattle-hit-study-halt-2017-06-21", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-etsy-live-nation-entertainment-salesforce.com-vertex", "https://www.nasdaq.com/articles/3-best-sp-stocks-2017s-first-half-2017-07-03", "https://www.nasdaq.com/articles/the-spdr-sp-biotech-etf-xbi-is-on-breakout-watch-2017-06-14", "https://www.nasdaq.com/articles/what-are-good-stocks-invest-now-2017-06-14", "https://www.nasdaq.com/articles/wednesday-sector-leaders-healthcare-utilities-2017-06-14", "https://www.nasdaq.com/articles/3-growth-stocks-june-2017-06-08", "https://www.nasdaq.com/articles/weekly-cfo-sells-highlight-2017-06-08", "https://www.nasdaq.com/articles/3-highest-growth-stocks-market-today-2017-06-06", "https://www.nasdaq.com/articles/top-health-stocks-buy-now-2017-06-06", "https://www.nasdaq.com/articles/5-toxic-stocks-to-discard-or-play-short-for-profit-2017-06-19", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc-vrtx-ceo-president-jeffrey-m-leiden-sold-19-million-shares-2017", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-if-youve-never-bought-biotech-stock-2017-06-04", "https://www.nasdaq.com/articles/3-stocks-vertex-pharmaceuticals-return-potential-2017-06-03", "https://www.nasdaq.com/articles/sds-pbe-big-etf-inflows-2017-06-02", "https://www.nasdaq.com/articles/vrtx-crosses-above-average-analyst-target-2017-06-02", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xbi-vrtx-exas-regn-2017-06-01", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-619852-down-467-points-2017-05-31", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-salesforce.com-vertex-pharmaceuticals-live-nation", "https://www.nasdaq.com/articles/why-is-vertex-vrtx-up-2.1-since-the-last-earnings-report-2017-05-30", "https://www.nasdaq.com/articles/agree-buy-vertex-pharmaceuticals-80-earn-49-annualized-using-options-2017-05-24", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-regeneron-ra-drug-amgen-hit-study-data-2017-05-24", "https://www.nasdaq.com/articles/xbi-vrtx-regn-exas-large-inflows-detected-etf-2017-05-19", "https://www.nasdaq.com/articles/concert-pharma-falls-after-clinical-hold-on-hair-loss-drug-2017-05-18", "https://www.nasdaq.com/articles/vertex-ups-kalydeco-sales-view-as-fda-okays-label-expansion-2017-05-18", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-covanta-holding-ptc-etsy-vertex-pharmaceuticals-and-live", "https://www.nasdaq.com/articles/3-stocks-smartest-investors-are-buying-right-now-2017-05-30", "https://www.nasdaq.com/articles/love-high-growth-here-are-3-stocks-consider-2017-05-17", "https://www.nasdaq.com/articles/5-toxic-stocks-to-steer-clear-of-or-play-short-right-now-2017-05-17", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-inks-deal-boost-pipeline-sangamo-soars-pfizer-deal-2017-05-17", "https://www.nasdaq.com/articles/why-is-vertex-pharma-vrtx-stock-soaring-this-year-2017-05-16", "https://www.nasdaq.com/articles/3-best-stocks-personalized-medicine-2017-05-14", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-xbi-exas-vrtx-ions-2017-05-11", "https://www.nasdaq.com/articles/i-still-cant-believe-gilead-sciences-inc-spent-148-billion-shareholder-rewards-2017-05-09", "https://www.nasdaq.com/articles/doomed-trump-presidency-would-be-terrifying-development-pharmaceutical-stocks-2017-05-18", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-xbi-vrtx-ions-srpt-2017-05-03", "https://www.nasdaq.com/articles/the-3-best-comeback-stocks-to-buy-in-2017-2017-05-03", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-solid-sales-prepping-next-generation-2017-05-01", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-now-2017-04-29", "https://www.nasdaq.com/articles/vertex-vrtx-q1-earnings-top-cf-products-sales-strong-2017-04-28", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-400-follow-through-1", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-27-2017-msft-amzn-googl-intc-sbux-bidu-afl-vrtx-wdc-rsg", "https://www.nasdaq.com/articles/heres-why-vertex-pharmaceuticals-incorporated-gained-8-april-2017-05-08", "https://www.nasdaq.com/articles/whats-in-store-for-nivalis-nvls-this-earnings-season-2017-04-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-gains-strong-q1-nash-data-gilead-drug-2017-04-26", "https://www.nasdaq.com/articles/whats-in-store-for-vertex-vrtx-this-earnings-season-2017-04-24", "https://www.nasdaq.com/articles/3-healthcare-bargain-stocks-you-can-buy-right-now-2017-04-24", "https://www.nasdaq.com/articles/3-stocks-growth-investors-should-love-2017-04-23", "https://www.nasdaq.com/articles/xbi-vrtx-bivv-exel-large-inflows-detected-etf-2017-04-18", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-ptc-covanta-holding-live-nation-entertainment-incyte-and", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-xbi-vrtx-bivv-nbix-2017-04-26", "https://www.nasdaq.com/articles/retirement-accounts-benefit-columbia-funds-tech-bets-2017-04-13", "https://www.nasdaq.com/articles/top-research-reports-today-msft-blk-noc-2017-04-13", "https://www.nasdaq.com/articles/therapeuticsmd-falls-on-likely-delay-in-tx-004hr-approval-2017-04-12", "https://www.nasdaq.com/articles/biotech-stock-roundup-geron-gains-interim-data-oncomed-slumps-pipeline-setback-2017-04-12", "https://www.nasdaq.com/articles/3-best-performing-stocks-march-2017-04-10", "https://www.nasdaq.com/articles/whats-next-corbus-pharmaceuticals-after-its-controversial-cystic-fibrosis-results-2017-04", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-esperion-therapeutics-vertex-pharmaceuticals-nektar", "https://www.nasdaq.com/articles/5-toxic-stocks-to-shun-or-play-short-right-now-2017-04-17", "https://www.nasdaq.com/articles/friday-sector-leaders-healthcare-financial-2017-04-07", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-shares-march-higher-can-it-continue-2017-04-06", "https://www.nasdaq.com/articles/3-best-worst-performing-drug-stocks-q1-2017-04-06", "https://www.nasdaq.com/articles/3-top-stocks-buy-q2-2017-04-06", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-vrtx-enr-psmt-2017-04-06", "https://www.nasdaq.com/articles/stocks-watch-market-weakness-2017-04-06", "https://www.nasdaq.com/articles/amgen-files-for-xgeva-label-expansion-to-include-myeloma-2017-04-05", "https://www.nasdaq.com/articles/3-great-stocks-sale-buy-today-2017-04-07", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-best-biotech-stock-2017-04-05", "https://www.nasdaq.com/articles/sanofis-sny-diabetes-drug-toujeo-lowers-hypoglycemia-risk-2017-04-04", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-rocketed-211-higher-march-2017-04-04", "https://www.nasdaq.com/articles/5-stocks-that-outperformed-the-sp-500-in-q1-2017-04-04", "https://www.nasdaq.com/articles/5-stocks-that-chaperoned-nasdaq-to-double-digit-gains-in-q1-2017-04-04", "https://www.nasdaq.com/articles/astrazenecas-azn-lung-cancer-drug-gets-full-fda-approval-2017-04-03", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-disney-texas-instruments-lockheed-martin-bank-of-new", "https://www.nasdaq.com/articles/biotech-stock-roundup-acorda-down-court-ruling-patent-challenge-celg-drug-2017-04-05", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-best-biotech-stock-2017-04-05", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-591174-down-260-points-2017-03-31", "https://www.nasdaq.com/articles/top-research-reports-today-dis-txn-lmt-2017-03-31", "https://www.nasdaq.com/articles/company-news-for-march-30-2017-2017-03-30", "https://www.nasdaq.com/articles/vrtx-crosses-above-average-analyst-target-2017-03-30", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-15-alliqua-biomedical-shares-slide-2017-03-29", "https://www.nasdaq.com/articles/heres-why-vertex-pharmaceuticals-flying-high-today-2017-03-29", "https://www.nasdaq.com/articles/3-big-healthcare-stocks-wall-street-predicts-will-grow-fastest-2017-04-02", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-vrtx-2017-03-29", "https://www.nasdaq.com/articles/sp-500-movers-ffiv-vrtx-2017-03-29", "https://www.nasdaq.com/articles/pre-market-most-active-mar-29-2017-exar-ath-tnxp-snap-mt-asx-nok-vrtx-qqq-vod-xiv-aapl", "https://www.nasdaq.com/articles/buy-wells-fargo-co-wfc-stock-on-any-dips-2017-03-29", "https://www.nasdaq.com/articles/biotech-stock-roundup-regeneron-tesaro-drugs-approved-vertex-scores-big-study-2017-03-29", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-wednesday%3A-rh-rh-vertex-pharmaceuticals-incorporated-vrtx-and-ollies", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-589755-2241-points-2017-03-29", "https://www.nasdaq.com/articles/vertex-combo-data-on-kalydecovx-661-positive-in-phase-iii-2017-03-29", "https://www.nasdaq.com/articles/health-care-sector-update-03292017-vrtxtnxprttr-2017-03-29", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-tsla-2017-03-28", "https://www.nasdaq.com/articles/nasdaq-composite-index-closes-1164-points-week-rising-3rd-straight-day-2017-03-28", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-vrtx-gild-hd-2017-03-17", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-covanta-holding-etsy-ptc-incyte-and-vertex-pharmaceuticals", "https://www.nasdaq.com/articles/5-toxic-stocks-to-dump-or-play-short-to-make-gains-2017-03-15", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-march-2017-03-10", "https://www.nasdaq.com/articles/mid-afternoon-market-update-rh-gains-after-strong-q4-results-quorum-health-shares-plummet", "https://www.nasdaq.com/articles/vertex-to-buy-concerts-cystic-fibrosis-candidate-for-%24160m-2017-03-07", "https://www.nasdaq.com/articles/mid-day-market-update-dow-falls-80-points-concert-pharma-shares-spike-higher-2017-03-06", "https://www.nasdaq.com/articles/why-concert-pharmaceuticals-stock-soaring-today-2017-03-06", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-deutsche-bank-plans-raise-capital-2017-03-06", "https://www.nasdaq.com/articles/probable-reason-behind-vertex-pharmaceuticals-5-jump-february-2017-03-06", "https://www.nasdaq.com/articles/health-care-sector-update-03062017-cncevtrxtgtxions-2017-03-06", "https://www.nasdaq.com/articles/mid-afternoon-market-update-gopro-slides-following-goldman-sachs-downgrade-tg-therapeutics", "https://www.nasdaq.com/articles/biotech-stock-roundup-trump-tweet-hits-biotech-stocks-concert-gains-vertex-deal-2017-03-08", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-abercrombie-fitch-live-nation-entertainment-vertex", "https://www.nasdaq.com/articles/5-toxic-stocks-to-abandon-or-play-short-right-now-2017-02-27", "https://www.nasdaq.com/articles/vrtx-makes-bullish-cross-above-critical-moving-average-2017-02-27", "https://www.nasdaq.com/articles/first-week-vrtx-october-20th-options-trading-2017-02-22", "https://www.nasdaq.com/articles/how-high-can-corbus-pharmaceuticals-stock-go-2017-02-22", "https://www.nasdaq.com/articles/market-close-report-historical-high-reached-nasdaq-composite-index-closes-586595-2017-02", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-ets-incyte-abercrombie-fitch-vertex-pharmaceuticals-and", "https://www.nasdaq.com/articles/biotech-stock-roundup-kite-soars-car-t-data-exel-immuno-oncology-deals-2017-03-01", "https://www.nasdaq.com/articles/biotech-etfs-powered-q4-earnings-2017-02-10", "https://www.nasdaq.com/articles/5-toxic-stocks-to-dump-or-play-short-for-gains-2017-02-09", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-stock-surged-higher-january-2017-02-09", "https://www.nasdaq.com/articles/top-analyst-reports-alphabet-citigroup-chevron-others-2017-01-31", "https://www.nasdaq.com/articles/vertex-pharmas-vrtx-q4-earnings-sales-beat-stock-up-2017-01-26", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-turns-profit-2017-01-26", "https://www.nasdaq.com/articles/health-care-sector-update-01262017-vrtxavgrentl-2017-01-26", "https://www.nasdaq.com/articles/gilead-sciences-getting-ready-massive-acquisition-2017-02-12", "https://www.nasdaq.com/articles/what-lies-in-store-for-pfizer-pfe-this-earnings-season-2017-01-25", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-redhill-biopharma-cempra-vertex-pharmaceuticals-acorda", "https://www.nasdaq.com/articles/biotech-stock-roundup-synergy-drug-gets-fda-nod-abbvie-gild-hcv-drugs-under-eu-review-2017", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-25-2017-t-qcom-lvs-mck-ebay-cci-wdc-vrtx-lrcx-xlnx", "https://www.nasdaq.com/articles/why-vertex-vrtx-might-surprise-this-earnings-season-2017-01-24", "https://www.nasdaq.com/articles/will-these-5-drug-stocks-be-big-winners-q4-earnings-season-2017-01-24", "https://www.nasdaq.com/articles/can-abbvie-abbv-spring-a-surprise-this-earnings-season-2017-01-24", "https://www.nasdaq.com/articles/will-eli-lillys-lly-earnings-surpass-estimates-in-q4-2017-01-25", "https://www.nasdaq.com/articles/4-drug-stocks-poised-to-surprise-this-earnings-season-2017-01-20", "https://www.nasdaq.com/articles/3-beaten-down-biotech-stocks-you-can-buy-right-now-2017-01-19", "https://www.nasdaq.com/articles/vertex-pharma-vrtx-q4-earnings%3A-stock-likely-to-beat-2017-01-19", "https://www.nasdaq.com/articles/concert-offers-update-on-cystic-fibrosis-drug-stock-down-2017-01-18", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-vrtx-could-be-positioned-for-a-surge-2017-01-18", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-stock-sank-42-2016-2017-01-17", "https://www.nasdaq.com/articles/merck-kgaa-vertex-announce-tie-up-for-oncology-programs-2017-01-12", "https://www.nasdaq.com/articles/concerts-cnce-ctp-656-gets-orphan-drug-status-in-u.s.-2017-01-23", "https://www.nasdaq.com/articles/5-ways-vertex-pharmaceuticals-plans-grow-2017-and-beyond-2017-01-09", "https://www.nasdaq.com/articles/vertex-pharma-issues-disappointing-2017-orkambi-outlook-2017-01-09", "https://www.nasdaq.com/articles/biotech-stock-roundup-inotek-plunges-pipeline-setback-kite-files-ind-study-initiation-2017", "https://www.nasdaq.com/articles/is-vertex-pharma-vrtx-poised-for-a-turnaround-in-2017-2017-01-03", "https://www.nasdaq.com/articles/regeneron-vs-vertex-which-stock-better-pick-2016-12-29", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-biogenionis-drug-seattle-genetics-hit-clinical-hold-2016-12", "https://www.nasdaq.com/articles/stock-market-news-for-december-27-2016-2016-12-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-ariad-be-acquired-52b-vertex-outlook-falls-short-2017-01-11", "https://www.nasdaq.com/articles/nasdaq-100-movers-ctas-ntes-2016-12-23", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-abercrombie-fitch-live-nation-entertainment-herc-holdings", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-546269-1527-points-2016-12-23", "https://www.nasdaq.com/articles/are-these-3-stocks-biggest-comeback-opportunities-2017-2016-12-22", "https://www.nasdaq.com/articles/5-toxic-stocks-to-remove-from-your-portfolio-or-play-short-2016-12-22", "https://www.nasdaq.com/articles/first-week-vrtx-february-2017-options-trading-2016-12-20", "https://www.nasdaq.com/articles/we-did-math-pbe-can-go-52-2016-12-15", "https://www.nasdaq.com/articles/3-precision-medicine-stocks-buy-january-2016-12-27", "https://www.nasdaq.com/articles/worst-american-stocks-2016-2016-12-07", "https://www.nasdaq.com/articles/biotech-stock-roundup-actelion-remains-ma-spotlight-ash-data-focus-2016-12-07", "https://www.nasdaq.com/articles/why-celgene-corporation-celg-nu-skin-enterprises-inc.-nus-and-pioneer-energy-services-corp", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-532368-down-5624-points-2016-11-30", "https://www.nasdaq.com/articles/nasdaq-100-movers-bmrn-nflx-2016-11-29", "https://www.nasdaq.com/articles/nivalis-nvls-cystic-fibrosis-study-misses-primary-endpoint-2016-11-29", "https://www.nasdaq.com/articles/biotech-stock-roundup-acorda-stops-ampyra-pswd-development-crl-spectrums-qapzola-2016-11", "https://www.nasdaq.com/articles/these-growth-stocks-could-double-2017-2016-12-13", "https://www.nasdaq.com/articles/5-toxic-stocks-to-get-rid-of-or-play-short-right-now-2016-11-21", "https://www.nasdaq.com/articles/biotech-stock-roundup-biotech-stocks-soar-election-results-gilead-hbv-drug-approved-2016", "https://www.nasdaq.com/articles/ibb-regn-alxn-vrtx-etf-inflow-alert-2016-11-15", "https://www.nasdaq.com/articles/peek-under-hood-spyx-has-10-upside-2016-11-14", "https://www.nasdaq.com/articles/nasdaq-100-movers-alxn-nvda-2016-11-11", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-stock-slipped-13-october-2016-11-10", "https://www.nasdaq.com/articles/why-these-biotechs-are-soaring-today-2016-11-09", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-allegheny-technologies-salesforce.com-united-states-steel", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-amgen-vertex-valeant-pharmaceuticals-international", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-cabot-oil-gas-zayo-group-holdings-etsy-live-nation", "https://www.nasdaq.com/articles/health-care-sector-update-11072016-hznp-vrtx-2016-11-07", "https://www.nasdaq.com/articles/3-value-stocks-near-52-week-lows-worth-buying-2016-11-01", "https://www.nasdaq.com/articles/nivalis-nvls-q3-earnings-preview%3A-can-the-stock-surprise-2016-10-31", "https://www.nasdaq.com/articles/peek-into-drug-stocks-earnings-on-oct-28%3A-abbv-imgn-2016-10-27", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-pushes-forward-drug-combinations-and-reports-earnings", "https://www.nasdaq.com/articles/vrtx-crosses-above-key-moving-average-level-2016-11-09", "https://www.nasdaq.com/articles/vertexs-vrtx-q3-loss-wider-than-expected-sales-miss-2016-10-26", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-556-follow-through-indicator", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-25-2016-aapl-cb-cni-esrx-cof-ew-dfs-eqr-vrtx-bxp-bcr", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-tmus-2016-10-24", "https://www.nasdaq.com/articles/sp-500-movers-col-qrvo-2016-10-24", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-530983-5243-points-2016-10-24", "https://www.nasdaq.com/articles/vertex-vrtx-q3-earnings%3A-whats-in-store-for-the-stock-2016-10-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-clinical-holds-hit-inovio-aduro-vertex-q3-results-miss-estimates", "https://www.nasdaq.com/articles/math-shows-qus-can-go-69-2016-10-13", "https://www.nasdaq.com/articles/what-makes-vertex-pharmaceuticals-vrtx-a-strong-sell-2016-10-13", "https://www.nasdaq.com/articles/biotech-stock-roundup-alnylam-slumps-revusiran-update-tesaro-impresses-esmo-2016-10-12", "https://www.nasdaq.com/articles/biotech-stock-roundup-summit-soars-sarepta-deal-regeneron-presents-data-2016-10-05", "https://www.nasdaq.com/articles/vertex-orkambis-label-expanded-in-u.s.-outlook-revised-2016-09-30", "https://www.nasdaq.com/articles/3-critical-fda-decisions-you-cant-afford-miss-2016-09-27", "https://www.nasdaq.com/articles/nasdaq-100-movers-bmrn-bbby-2016-09-22", "https://www.nasdaq.com/articles/biotech-stock-roundup-ariad-down-drug-pricing-tweet-regeneron-study-clinical-hold-2016-10", "https://www.nasdaq.com/articles/first-week-vrtx-november-18th-options-trading-2016-09-20", "https://www.nasdaq.com/articles/nasdaq-100-movers-expe-wdc-2016-09-16", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-spectrum-pharmaceuticals-amgen-abbvie-and-vertex", "https://www.nasdaq.com/articles/3-drug-stocks-could-benefit-key-fda-events-sep-2016-2016-09-12", "https://www.nasdaq.com/articles/3-growth-stocks-could-double-2016-09-08", "https://www.nasdaq.com/articles/drug-stocks-remain-focus-pricing-debate-continues-2016-09-05", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-covanta-holding-zeltiq-aesthetics-capital-senior-living", "https://www.nasdaq.com/articles/biotech-stock-roundup-tobira-soars-acquisition-deal-fda-says-yes-sarepta-dmd-drug-2016-09", "https://www.nasdaq.com/articles/nasdaq-100-movers-gild-tmus-2016-08-29", "https://www.nasdaq.com/articles/stock-market-news-for-august-25-2016-2016-08-25", "https://www.nasdaq.com/articles/sp-500-analyst-moves-vrtx-2016-08-25", "https://www.nasdaq.com/articles/sp-500-movers-mro-regn-2016-08-22", "https://www.nasdaq.com/articles/p-s-s-st-heres-what-fidelity-has-been-buying-and-selling-2016-08-19", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-vertex-aurinia-aveo-and-amgen-2016-08-18", "https://www.nasdaq.com/articles/biotech-stock-roundup-vertex-slips-study-halt-aurinia-plunges-lupus-data-2016-08-17", "https://www.nasdaq.com/articles/5-toxic-stocks-to-steer-clear-of-before-its-too-late-2016-08-30", "https://www.nasdaq.com/articles/these-2-catalysts-lifted-vertex-pharmaceuticals-incorporated-13-july-2016-08-10", "https://www.nasdaq.com/articles/nivalis-nvls-reports-wider-than-expected-loss-in-q2-2016-08-02", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-prepares-more-growth-2016-08-02", "https://www.nasdaq.com/articles/vertex-vrtx-posts-narrower-q2-loss-revenues-fall-short-2016-07-28", "https://www.nasdaq.com/articles/nivalis-nvls%3A-can-the-stock-surprise-this-earnings-season-2016-07-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-q2-results-impress-gilead-hcv-franchise-under-pressure-2016", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-667-follow-through-indicator", "https://www.nasdaq.com/articles/vertex-vrtx-stop-vx-661-ivacaftor-study-stock-down-2016-08-16", "https://www.nasdaq.com/articles/vertex-vrtx-report-q2-earnings-surprise-store-2016-07-25", "https://www.nasdaq.com/articles/i-just-bought-these-4-fast-growing-biotech-stocks-2016-07-23", "https://www.nasdaq.com/articles/sorry-you-cant-buy-hot-biotech-least-not-directly-2016-07-21", "https://www.nasdaq.com/articles/7-biotech-stocks-to-watch-for-runaway-gains-2016-07-21", "https://www.nasdaq.com/articles/implied-qqxt-analyst-target-price-46-2016-07-11", "https://www.nasdaq.com/articles/friday-sector-laggards-utilities-healthcare-2016-07-08", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-27-2016-fb-amgn-mck-psa-su-nxpi-orly-pxd-abx-vrtx-mar-o", "https://www.nasdaq.com/articles/5-drug-stocks-earnings-on-jul-27%3A-amgn-vrtx-more-2016-07-26", "https://www.nasdaq.com/articles/vertex-vrtx-report-q2-earnings-surprise-store-2016-07-25", "https://www.nasdaq.com/articles/dump-these-5-toxic-stocks-to-avoid-portfolio-bleeding-2016-06-27", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-wake-brexit-vote-2016-06-24", "https://www.nasdaq.com/articles/how-former-market-darling-became-undervalued-stock-2016-06-23", "https://www.nasdaq.com/articles/5-toxic-stocks-to-discard-from-your-portfolio-right-now-2016-06-09", "https://www.nasdaq.com/articles/why-galapagos-nv-shares-soared-305-may-2016-06-09", "https://www.nasdaq.com/articles/can-vertex-pharmaceuticals-incorporated-bounce-back-its-289-drop-2016-07-06", "https://www.nasdaq.com/articles/biotech-stock-roundup-sarepta-shoots-fda-delay-ionis-falls-pipeline-news-2016-06-01", "https://www.nasdaq.com/articles/last-weeks-best-healthcare-etf-2016-05-28", "https://www.nasdaq.com/articles/biotech-stock-roundup-xenoport-soars-acquisition-deal-abbvie-crohns-disease-drug-fares", "https://www.nasdaq.com/articles/heavy-hitter-just-stepped-cystic-fibrosis-plate-2016-05-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-pfizer-buy-anacor-52b-pipeline-setbacks-aduro-trevena-2016-05-19", "https://www.nasdaq.com/articles/nasdaq-100-movers-alxn-stx-2016-05-17", "https://www.nasdaq.com/articles/nivalis-starts-dosing-in-second-phase-ii-cystic-fibrosis-study-2016-05-17", "https://www.nasdaq.com/articles/vertex-vrtx-orkambi-snda-accepted-with-priority-review-2016-06-01", "https://www.nasdaq.com/articles/forget-bluebird-bio-inc-these-3-stocks-are-better-buys-2016-05-03", "https://www.nasdaq.com/articles/vanguard-boosts-stake-incyte-st-quarter-2016-05-03", "https://www.nasdaq.com/articles/will-vertex-vrtx-stock-decline-1q-earnings-miss-2016-04-28", "https://www.nasdaq.com/articles/orkambi-2016-blockbuster-vertex-pharmaceuticals-incorporated-thinks-so-2016-04-28", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-tops-q1-earnings-sarepta-catalyst-plunge-regulatory-news-2016", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-750-follow-through-indicator", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-27-2016-fb-txn-orly-avb-vrtx-mar-amp-sndk-bcr-gg-efx", "https://www.nasdaq.com/articles/look-under-hood-csm-has-12-upside-2016-05-09", "https://www.nasdaq.com/articles/big-drug-stocks-report-week-lly-gsk-vrtx-bmy-abbv-2016-04-25", "https://www.nasdaq.com/articles/vertex-vrtx-report-q1-earnings-surprise-store-2016-04-22", "https://www.nasdaq.com/articles/top-5-stocks-boasting-earnings-acceleration-2016-04-22", "https://www.nasdaq.com/articles/sp-500-movers-chk-has-2016-04-18", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-nvda-2016-04-15", "https://www.nasdaq.com/articles/fridays-etf-unusual-volume-iyh-2016-04-15", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-advisory-panels-say-yes-intercept-no-clovis-2016-04-13", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-vertex-pharmaceuticals-flir-systems-medtronic-cirrus", "https://www.nasdaq.com/articles/nasdaq-100-movers-ebay-bbby-2016-04-07", "https://www.nasdaq.com/articles/how-pieces-add-spxe-targets-47-2016-04-07", "https://www.nasdaq.com/articles/nasdaq-100-movers-wdc-vrtx-2016-04-06", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-nvda-2016-03-23", "https://www.nasdaq.com/articles/3-biggest-challenges-facing-raptor-pharmaceuticals-corp-stock-2016-03-21", "https://www.nasdaq.com/articles/do-you-own-any-these-top-sector-funds-2016-03-18", "https://www.nasdaq.com/articles/biotech-stock-roundup-gw-pharma-soars-epidiolex-data-gileads-zydelig-trouble-2016-03-16", "https://www.nasdaq.com/articles/why-vertex-pharmaceuticals-incorporated-stock-dipped-11-march-2016-04-11", "https://www.nasdaq.com/articles/instant-analysis-vertex-pharmaceuticals-inc-wins-another-approval-2016-03-09", "https://www.nasdaq.com/articles/biotech-stock-roundup-abbvies-imbruvica-label-expanded-celldex-slumps-study-update-2016-03", "https://www.nasdaq.com/articles/nivalis-nvls-provides-update-on-cystic-fibrosis-candidate-2016-03-08", "https://www.nasdaq.com/articles/what-does-trumps-healthcare-plan-mean-investors-2016-03-04", "https://www.nasdaq.com/articles/these-3-biotechs-are-growing-fast-which-best-buy-today-2016-03-03", "https://www.nasdaq.com/articles/biotech-stock-roundup-gilead-hiv-drug-approved-baxalta-immuno-oncology-deal-2016-03-02", "https://www.nasdaq.com/articles/concerts-early-stage-cystic-fibrosis-drug-shows-promise-2016-03-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-abbvie-vertex-celldex-and-celgene-2016-03-10", "https://www.nasdaq.com/articles/3-biotechs-could-snap-back-and-soar-even-higher-2016-02-15", "https://www.nasdaq.com/articles/3-reasons-vertex-stock-could-fall-2016-02-12", "https://www.nasdaq.com/articles/biotech-stock-roundup-alexion-regeneron-miss-estimates-setback-cti-biopharma-2016-02-10", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc-dropped-26-january-heres-why-2016-02-09", "https://www.nasdaq.com/articles/vertex-vrtx-down-crl-kalydeco-label-expansion-2016-02-08", "https://www.nasdaq.com/articles/health-care-sector-update-02052016-jnj-pfe-abt-mrk-amgn-immu-vrtx-2016-02-05", "https://www.nasdaq.com/articles/health-care-sector-update-02052016-vrtx-dhrm-2016-02-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-incyte-down-jakafi-update-intercept-buyout-target-2016-02-17", "https://www.nasdaq.com/articles/ignore-regeneron-pharmaceuticals-inc-here-are-3-better-buys-right-now-2016-02-02", "https://www.nasdaq.com/articles/whats-in-store-for-nivalis-nvls-this-earnings-season-2016-01-29", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-ford-tops-q4-views-2016-01-28", "https://www.nasdaq.com/articles/vertex-vrtx-posts-narrower-4q-loss-maintains-outlook-2016-01-28", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-750-follow-through-0", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-27-2016-fb-qcom-txn-mck-lvs-ebay-cci-vrtx-dfs-amp-sndk", "https://www.nasdaq.com/articles/will-2016-be-vertexs-best-year-yet-2016-01-26", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incs-q4-revenues-surge-new-drug-2016-02-03", "https://www.nasdaq.com/articles/regeneron-pharmaceuticals-inc-stock-bargain-or-rip-2016-01-21", "https://www.nasdaq.com/articles/biotech-stock-roundup-sarepta-plunges-briefing-documents-acorda-buy-biotie-2016-01-20", "https://www.nasdaq.com/articles/nivalis-n91115-gets-orphan-drug-status-for-cystic-fibrosis-2016-01-18", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-jumps%3A-stock-moves-up-5.8-2016-01-15", "https://www.nasdaq.com/articles/biotech-stock-roundup-baxalta-shire-combine-jpm-healthcare-conference-focus-2016-01-13", "https://www.nasdaq.com/articles/3-biotechs-major-catalysts-incoming-2016-01-13", "https://www.nasdaq.com/articles/biotech-etfs-snap-back-after-undercutting-sept-lows-2016-01-12", "https://www.nasdaq.com/articles/will-higher-expenses-hurt-vertexs-vrtx-4q-earnings-2016-01-25", "https://www.nasdaq.com/articles/vertex-vrtx-gives-2016-view-orkambi-view-come-later-2016-01-11", "https://www.nasdaq.com/articles/agree-purchase-vertex-pharmaceuticals-80-earn-84-using-options-2015-12-31", "https://www.nasdaq.com/articles/tuesdays-etf-unusual-volume-iwy-2015-12-29", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-vrtx-2015-12-29", "https://www.nasdaq.com/articles/nasdaq-100-movers-nxpi-nclh-2015-12-29", "https://www.nasdaq.com/articles/3-stocks-huge-growth-opportunities-2015-12-27", "https://www.nasdaq.com/articles/3-new-drugs-ready-explode-2016-2015-12-26", "https://www.nasdaq.com/articles/nasdaq-100-movers-lbtya-adi-2016-01-11", "https://www.nasdaq.com/articles/best-3-biotech-stocks-2016-2015-12-22", "https://www.nasdaq.com/articles/pbe-bmrn-incy-vrtx-large-outflows-detected-etf-2015-12-10", "https://www.nasdaq.com/articles/interesting-vrtx-put-and-call-options-january-2016-2015-12-10", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biomarin-amgen-vertex-gilead-biogen-and-repros-2015-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-kalobios-soars-shkreli-steps-fda-panel-not-convinced-about-biomarin", "https://www.nasdaq.com/articles/vertexs-vrtx-orkambi-approved-in-eu-for-cystic-fibrosis-2015-11-23", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-december-2015-11-22", "https://www.nasdaq.com/articles/biotech-stock-roundup-kalobios-removes-ceo-shkreli-actelion-pah-drug-approved-2015-12-23", "https://www.nasdaq.com/articles/instant-analysis-vertex-pharmaceuticals-scores-2-regulatory-wins-2015-11-19", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-moved-16-higher-october-heres-why-2015-11-18", "https://www.nasdaq.com/articles/biotech-stock-roundup-clovis-plunges-label-expansion-gileads-harvoni-2015-11-18", "https://www.nasdaq.com/articles/5-drugs-are-face-prescription-drug-reform-2015-11-15", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-26-billion-bet-crispr-2015-11-07", "https://www.nasdaq.com/articles/5-exciting-biotech-stocks-to-buy-on-november-upswing-2015-11-03", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-profit-horizon-2015-11-01", "https://www.nasdaq.com/articles/instant-analysis-vertex-pharmaceuticals-grabs-important-regulatory-win-2015-11-20", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-breaks-above-200-day-moving-average-bullish-vrtx-2015-10-29", "https://www.nasdaq.com/articles/vertex-vrtx-posts-narrower-q3-loss-ups-kalydeco-view-2015-10-29", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-tops-estimates-fda-approves-alexions-strensiq-2015-10-28", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-778-follow-through-indicator", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-28-2015-amgn-psa-su-vrtx-wmb-orly-nxpi-mar-wpz-eqix", "https://www.nasdaq.com/articles/will-orkambi-help-vertex-vrtx-post-lower-loss-q3-2015-10-27", "https://www.nasdaq.com/articles/health-care-sector-update-10262015-rdhl-tbph-vrtx-2015-10-26", "https://www.nasdaq.com/articles/nivalis-nvls%3A-a-surprise-in-store-this-earnings-season-2015-10-30", "https://www.nasdaq.com/articles/stock-market-news-for-october-14-2015-2015-10-14", "https://www.nasdaq.com/articles/want-lower-drug-prices-these-3-proposals-wont-help-you-2015-10-13", "https://www.nasdaq.com/articles/vertex-vrtx-provides-updates-on-cystic-fibrosis-pipeline-2015-10-09", "https://www.nasdaq.com/articles/vertexs-kalydeco-gets-priority-review-for-expanded-use-2015-10-08", "https://www.nasdaq.com/articles/3-large-cap-biotech-stocks-whose-valuations-should-make-you-skeptical-2015-10-07", "https://www.nasdaq.com/articles/nasdaq-100-movers-ilmn-viab-2015-10-06", "https://www.nasdaq.com/articles/double-dose-bad-news-rocks-vertex-pharmaceuticals-september-2015-10-02", "https://www.nasdaq.com/articles/vertex-turns-heat-cystic-fibrosis-challengers-2015-10-19", "https://www.nasdaq.com/articles/biotech-stock-roundup-pricing-concerns-hit-biotech-stocks-eu-nod-regenerons-praluent-2015", "https://www.nasdaq.com/articles/nasdaq-100-movers-disca-yhoo-2015-09-29", "https://www.nasdaq.com/articles/stock-market-news-for-september-28-2015-2015-09-28", "https://www.nasdaq.com/articles/double-dose-good-news-vertex-pharmaceuticals-incorporated-investors-2015-09-25", "https://www.nasdaq.com/articles/interesting-vrtx-put-and-call-options-november-20th-2015-09-25", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-now-oversold-vrtx-2015-09-24", "https://www.nasdaq.com/articles/shareholders-breathe-easier-concert-pharmaceuticals-rockets-higher-23-2015-09-23", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-regeneron-vertex-gilead-biogen-and-celgene-2015-10-01", "https://www.nasdaq.com/articles/nasdaq-100-movers-vip-adbe-2015-09-18", "https://www.nasdaq.com/articles/vrtx-makes-notable-cross-below-critical-moving-average-2015-09-18", "https://www.nasdaq.com/articles/could-these-2-biopharmas-be-real-apples-gilead-sciences-eye-2015-09-17", "https://www.nasdaq.com/articles/health-care-sector-update-09142015-sgen-tbph-vrtx-2015-09-14", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-breaks-below-200-day-moving-average-notable-vrtx-2015-08-24", "https://www.nasdaq.com/articles/vrtx-october-2nd-options-begin-trading-2015-08-13", "https://www.nasdaq.com/articles/first-trust-nyse-arca-biotechnology-index-fund-experiences-big-inflow-2015-08-12", "https://www.nasdaq.com/articles/5-biotech-stocks-hit-hard-hillary-clintons-tweet-2015-09-22", "https://www.nasdaq.com/articles/nasdaq-100-movers-jd-vrtx-2015-08-10", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-vertex-regeneron-baxalta-and-vivus-press-releases", "https://www.nasdaq.com/articles/biotech-stock-roundup-baxalta-rejects-shire-bid-amgens-beat-raise-quarter-analyst-blog", "https://www.nasdaq.com/articles/vertex-posts-wider-yy-loss-raises-kalydeco-outlook-analyst-blog-2015-07-30", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-down-tecfidera-issues-regenerons-praluent-gets-fda-nod", "https://www.nasdaq.com/articles/secret-vertex-pharmaceuticals-success-2015-07-29", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-rolls-along-2015-07-29", "https://www.nasdaq.com/articles/nasdaq-100-movers-yhoo-biib-2015-08-12", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-29-2015-fb-met-mck-wmb-su-psa-vrtx-wpz-orly-nxpi-bax-mar", "https://www.nasdaq.com/articles/will-vertex-vrtx-surprise-lower-loss-q2-analyst-blog-2015-07-28", "https://www.nasdaq.com/articles/nasdaq-100-movers-aal-celg-2015-07-15", "https://www.nasdaq.com/articles/sp-500-movers-yum-celg-2015-07-15", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-vertex-biogen-applied-genetic-gilead-and-alexion-press", "https://www.nasdaq.com/articles/biotech-stock-roundup-vertex-cf-drug-approved-biogen-strikes-deal-gene-therapy-analyst", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-cf-drug-orkambi-gets-fda-nod-analyst-blog-2015-07-03", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-667-follow-through-0", "https://www.nasdaq.com/articles/biotech-stock-roundup-biomarin-jumps-dwarfism-data-vical-plunges-vaccine-data-analyst-blog", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-regeneron-vertex-celgene-seattle-genetics-and-sage", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-panel-recommends-regenerons-praluent-sage-gains-data-analyst", "https://www.nasdaq.com/articles/iwp-intu-vrtx-mhfi-etf-outflow-alert-2015-06-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-wynn-2015-06-02", "https://www.nasdaq.com/articles/highest-paid-ceos-biotech-2015-05-30", "https://www.nasdaq.com/articles/3-types-risks-facing-biotech-stocks-2015-05-18", "https://www.nasdaq.com/articles/vertex-investors-sigh-fda-approval-2015-07-02", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-vip-2015-05-14", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-orkambi-wins-fda-panel-backing-analyst-blog-2015-05-13", "https://www.nasdaq.com/articles/health-care-sector-update-05132015-vrtxfcscrmd-2015-05-13", "https://www.nasdaq.com/articles/biotech-stock-roundup-alexion-buy-synageva-fda-panel-backs-vertexs-orkambi-analyst-blog", "https://www.nasdaq.com/articles/nasdaq-100-movers-mat-vip-2015-05-13", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-nflx-2015-05-05", "https://www.nasdaq.com/articles/iwp-kr-nflx-vrtx-etf-outflow-alert-2015-04-30", "https://www.nasdaq.com/articles/sp-500-movers-gmcr-nflx-2015-05-15", "https://www.nasdaq.com/articles/vertex-posts-wider-1q-loss-affirms-kalydeco-outlook-analyst-blog-2015-04-30", "https://www.nasdaq.com/articles/3-stable-large-cap-biotech-stocks-to-buy-now-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-waiting-exhale-2015-04-29", "https://www.nasdaq.com/articles/whats-behind-vertex-pharmaceuticals-incorporateds-disappointing-q1-2015-04-29", "https://www.nasdaq.com/articles/earnings-reaction-history-vertex-pharmaceuticals-incorporated-750-follow-through-1", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-29-2015-bidu-su-wmb-vrtx-wpz-mar-nxpi-lnc-eqix-mac-ar-o", "https://www.nasdaq.com/articles/will-biomarin-bmrn-top-earnings-again-on-vimzim-sales-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-celladon-kite-pharma-pharmacyclics-and-vertex", "https://www.nasdaq.com/articles/will-vertex-vrtx-surprise-with-a-lower-loss-in-q1-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/will-united-therapeutics-uthr-miss-this-earnings-season-analyst-blog-2015-04-27", "https://www.nasdaq.com/articles/biotech-investors-shouldnt-miss-these-stocks-this-earnings-earnings-esp-2015-04-17", "https://www.nasdaq.com/articles/3-potential-blockbuster-drugs-could-be-approved-years-end-2015-04-16", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-wdc-2015-04-15", "https://www.nasdaq.com/articles/biotech-stock-roundup-favorable-briefing-documents-mdcos-kengreal-alexion-soliris-label", "https://www.nasdaq.com/articles/health-care-sector-update-04102015-arna-vrtx-anip-2015-04-10", "https://www.nasdaq.com/articles/will-celgene-celg-beat-q1-earnings-on-strong-sales-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/stock-market-news-for-april-01-2015-market-news-2015-04-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-prothena-vertex-gilead-and-amgen-press-releases", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-soars-alzheimers-data-gilead-hcv-drugs-label-update-analyst", "https://www.nasdaq.com/articles/vertex-falls-on-disappointing-kalydecovx-661-combo-data-analyst-blog-2015-03-24", "https://www.nasdaq.com/articles/pre-market-most-active-mar-23-2015-sto-gsk-gild-aapl-vrtx-imgn-rdsb-qqq-fb-rdsa-sdrl-nvs", "https://www.nasdaq.com/articles/health-care-sector-update-03232015-kmda-evdy-vrtx-2015-03-23", "https://www.nasdaq.com/articles/health-care-sector-update-03232015-vrtxcapnmeip-2015-03-23", "https://www.nasdaq.com/articles/sp-500-movers-gm-fdx-2015-04-07", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-vip-2015-03-23", "https://www.nasdaq.com/articles/vertexs-kalydeco-gets-fda-nod-for-additional-indication-analyst-blog-2015-03-19", "https://www.nasdaq.com/articles/nasdaq-100-movers-wynn-avgo-2015-03-16", "https://www.nasdaq.com/articles/biotech-stock-roundup-abbvie-buy-pharmacyclics-fda-approves-first-biosimilar-analyst-blog", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-march-2015-03-11", "https://www.nasdaq.com/articles/nasdaq-100-movers-aal-myl-2015-03-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-orexigen-soars-contrave-data-amgen-scores-study-analyst-blog-2015-03", "https://www.nasdaq.com/articles/sp-500-movers-vrtx-gnw-2015-03-23", "https://www.nasdaq.com/articles/surprise-we-still-need-drugmakers-develop-revolutionary-hepatitis-c-drugs-2015-02-17", "https://www.nasdaq.com/articles/3-upcoming-fda-decisions-were-most-excited-about-2015-02-16", "https://www.nasdaq.com/articles/could-be-biggest-advance-hepatitis-c-gilead-sciences-sovaldi-2015-02-16", "https://www.nasdaq.com/articles/case-you-missed-it-theres-new-fastest-growing-drug-world-2015-02-14", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-impresses-4q-results-gilead-abbvie-hcv-drugs-focus-analyst", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-slumps%3A-vrtx-falls-5.9-in-session-tale-of-the-tape-2015-01-30", "https://www.nasdaq.com/articles/vertex-posts-wider-4q-loss-affirms-kalydeco-outlook-analyst-blog-2015-01-29", "https://www.nasdaq.com/articles/biotech-stock-roundup-pharmacyclics-buyout-rumors-celgene-drug-label-expanded-analyst-blog", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-28-2015-fb-qcom-lvs-vrtx-ggp-amp-avb-lrcx-slg-tsco-now", "https://www.nasdaq.com/articles/will-vertex-vrtx-surprise-lower-loss-q4-analyst-blog-2015-01-27", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-going-get-fat-cystic-fibrosis-pie-2015-01-16", "https://www.nasdaq.com/articles/how-much-could-abbvie-inc-make-selling-its-hepatitis-c-drug-year-2015-01-14", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-kalydeco-remains-in-focus-in-2015-analyst-blog-2015-01-12", "https://www.nasdaq.com/articles/nasdaq-100-movers-tsla-vrtx-2015-01-02", "https://www.nasdaq.com/articles/sp-500-movers-dnr-vrtx-2015-01-02", "https://www.nasdaq.com/articles/no-surprises-vertex-pharmaceuticals-incorporated-yet-2015-01-28", "https://www.nasdaq.com/articles/market-drug-just-got-19-bigger-you-havent-seen-anything-yet-2014-12-31", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-past-gilead-2014-analyst-blog-2014-12-30", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-kalydeco-label-expanded-in-the-u.s.-analyst-blog-2014-12-30", "https://www.nasdaq.com/articles/gilead-sciences-inc-value-stock-following-its-tumble-2014-12-29", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-vo-vrtx-avgo-mco-2014-12-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-abbvies-hcv-treatment-approved-immunogen-plunges-data-analyst-blog", "https://www.nasdaq.com/articles/why-gilead-sciences-and-abbvie-care-about-tiny-company-2014-12-11", "https://www.nasdaq.com/articles/friday-sector-leaders-healthcare-utilities-2015-01-02", "https://www.nasdaq.com/articles/sp-500-movers-nbr-celg-2014-12-08", "https://www.nasdaq.com/articles/nasdaq-100-movers-vip-celg-2014-12-08", "https://www.nasdaq.com/articles/time-buy-dip-gilead-sciences-inc-stock-2014-12-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-avanir-be-acquired-japanese-firm-biogen-scores-alzheimers-study", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-iwp-kr-vrtx-cci-2014-12-01", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-52-week-high-driven-by-kalydeco-analyst-blog-2014-12-01", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-biomarin-to-acquire-prosensa-abbvie-hcv-therapy-closer-to-eu", "https://www.nasdaq.com/articles/biotech-stock-roundup-cubist-be-acquired-merck-bluebird-shoots-ash-data-analyst-blog-2014", "https://www.nasdaq.com/articles/nasdaq-100-movers-gmcr-dltr-2014-11-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-gilead-abbvie-score-liver-meeting-dendreon-files-bankruptcy-analyst", "https://www.nasdaq.com/articles/stock-market-news-for-november-11-2014-market-news-2014-11-11", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-seeks-approval-cf-combination-analyst-blog-2014-11-06", "https://www.nasdaq.com/articles/trend-making-gilead-sciences-inc-worry-2014-11-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-regenerons-eylea-stumbles-geron-lifting-clinical-hold-analyst-blog", "https://www.nasdaq.com/articles/sp-500-analyst-moves-vrtx-2014-11-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-adsk-2014-11-21", "https://www.nasdaq.com/articles/nasdaq-100-movers-gmcr-dltr-2014-11-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-gilead-abbvie-score-liver-meeting-dendreon-files-bankruptcy-analyst", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-posts-narrower-than-expected-loss-analyst-blog-2014-10-29", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-plays-earnings-waiting-game-2014-10-28", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-28-2014-fb-gild-esrx-mck-apc-afl-vrtx-eqr-amp-wdc-mar", "https://www.nasdaq.com/articles/should-you-buy-vertex-pharmaceuticals-vrtx-ahead-of-earnings-tale-of-the-tape-2014-10-27", "https://www.nasdaq.com/articles/will-aegerion-aegr-disappoint-this-earnings-season-analyst-blog-2014-10-27", "https://www.nasdaq.com/articles/5-staggering-statistics-about-fastest-growing-drug-world-2014-11-01", "https://www.nasdaq.com/articles/5-most-expensive-drugs-world-2014-10-26", "https://www.nasdaq.com/articles/will-pfizer-pfe-disappoint-this-earnings-season-analyst-blog-2014-10-24", "https://www.nasdaq.com/articles/will-ligand-pharmaceuticals-beat-q3-earnings-estimates-analyst-blog-2014-10-24", "https://www.nasdaq.com/articles/will-amgen-amgn-disappoint-in-the-q3-earnings-season-analyst-blog-2014-10-24", "https://www.nasdaq.com/articles/will-vertex-pharmaceuticals-vrtx-post-a-lower-q3-loss-analyst-blog-2014-10-24", "https://www.nasdaq.com/articles/will-gilead-gild-miss-earnings-on-high-operating-costs-analyst-blog-2014-10-24", "https://www.nasdaq.com/articles/johnson-johnsons-worst-nightmare-becoming-reality-2014-10-22", "https://www.nasdaq.com/articles/will-express-scripts-esrx-beat-q3-earnings-estimates-analyst-blog-2014-10-27", "https://www.nasdaq.com/articles/will-agenus-agen-incur-wider-than-expected-q3-loss-analyst-blog-2014-10-22", "https://www.nasdaq.com/articles/5-best-biotech-stocks-buy-now-2014-10-21", "https://www.nasdaq.com/articles/pacific-biosciences-to-incur-narrower-than-expected-q3-loss-analyst-blog-2014-10-21", "https://www.nasdaq.com/articles/will-biomarin-bmrn-disappoint-this-earnings-season-analyst-blog-2014-10-21", "https://www.nasdaq.com/articles/will-alexion-alxn-earnings-suffer-due-to-higher-costs-analyst-blog-2014-10-21", "https://www.nasdaq.com/articles/celgene-celg-q3-earnings-to-be-overrun-by-expenses-analyst-blog-2014-10-21", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-kalydeco-wins-fda-panel-backing-analyst-blog-2014-10-22", "https://www.nasdaq.com/articles/will-biogen-idec-biib-pull-a-surprise-this-earnings-season-analyst-blog-2014-10-20", "https://www.nasdaq.com/articles/180-million-people-have-disease-yet-few-are-aware-it-2014-10-19", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilead-nabs-fda-nod-for-combo-hcv-drug-auxilium-accepts-endo-offer", "https://www.nasdaq.com/articles/gilead-sciences-inc-stocks-green-light-sparks-offensive-2014-10-13", "https://www.nasdaq.com/articles/nasdaq-100-movers-tsla-vrtx-2014-10-13", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-updates-on-kalydeco-studies-analyst-blog-2014-10-10", "https://www.nasdaq.com/articles/why-you-shouldnt-bet-against-vertex-pharmaceuticals-vrtx-stock-tale-of-the-tape-2014-10-09", "https://www.nasdaq.com/articles/will-glaxosmithkline-gsk-earnings-suffer-on-china-probe-analyst-blog-2014-10-20", "https://www.nasdaq.com/articles/vertex-pharmaceticals-insiders-sell-537645-shares-month-2014-10-07", "https://www.nasdaq.com/articles/most-important-number-you-need-know-buying-gilead-sciences-inc-stock-2014-10-07", "https://www.nasdaq.com/articles/sp-500-movers-vrtx-myl-2014-10-02", "https://www.nasdaq.com/articles/nasdaq-100-movers-vip-myl-2014-10-02", "https://www.nasdaq.com/articles/nasdaq-100-movers-adp-vod-2014-10-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-auxilium-acquisition-target-amgen-submits-another-bla-analyst-blog", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-jumps%3A-stock-rises-6.6-tale-of-the-tape-2014-09-22", "https://www.nasdaq.com/articles/biotech-stock-roundup-sunesis-tanks-study-results-chimerix-ebola-update-analyst-blog-2014", "https://www.nasdaq.com/articles/vertex-pharmaceticals-insiders-sell-537645-shares-month-2014-10-07", "https://www.nasdaq.com/articles/most-important-number-you-need-know-buying-gilead-sciences-inc-stock-2014-10-07", "https://www.nasdaq.com/articles/sp-500-movers-kors-vrtx-2014-09-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-gild-vrtx-2014-09-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-vip-vrtx-2014-08-28", "https://www.nasdaq.com/articles/guggenheim-sp-500-equal-weight-etf-experiences-big-inflow-2014-08-28", "https://www.nasdaq.com/articles/nasdaq-100-movers-mu-amzn-2014-09-19", "https://www.nasdaq.com/articles/biotech-stock-roundup-achillion-scores-mid-stage-study-gileads-sovaldi-remains-focus", "https://www.nasdaq.com/articles/stock-market-today-equities-rally-despite-poor-retail-earnings-stocks-news-2014-08-13", "https://www.nasdaq.com/articles/wednesdays-etf-unusual-volume-pbp-2014-08-13", "https://www.nasdaq.com/articles/sp-500-movers-vrtx-kmi-2014-08-11", "https://www.nasdaq.com/articles/nasdaq-100-movers-ilmn-tsla-2014-08-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-plans-job-cuts-regenerons-eylea-continues-impress-analyst-blog", "https://www.nasdaq.com/articles/fxd-ryh-big-etf-inflows-2014-08-05", "https://www.nasdaq.com/articles/has-gilead-sciences-incs-star-drug-already-peaked-2014-08-28", "https://www.nasdaq.com/articles/nasdaq-100-movers-ctrx-vrtx-2014-08-04", "https://www.nasdaq.com/articles/nasdaq-100-movers-grmn-regn-2014-07-30", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-posts-wider-q2-loss-maintains-view-analyst-blog-2014-07-30", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-29-2014-axp-amgn-apc-esrx-afl-eqr-amp-vrtx-mar-bxp-fisv", "https://www.nasdaq.com/articles/should-you-buy-vertex-pharmaceuticals-vrtx-ahead-of-earnings-tale-of-the-tape-2014-07-28", "https://www.nasdaq.com/articles/will-vertex-pharmaceuticals-vrtx-loss-be-below-estimates-analyst-blog-2014-07-28", "https://www.nasdaq.com/articles/biotech-stock-roundup-abbvie-woos-shire-revised-offer-sarepta-slips-eteplirsen-data", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-kalydeco-label-expanded-in-eu-analyst-blog-2014-08-05", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-inc-vrtx-new-analyst-report-zacks-equity-research-zacks-equity", "https://www.nasdaq.com/articles/merck-gilead-lead-race-eradicate-hepatitis-c-2014-07-03", "https://www.nasdaq.com/articles/biotech-stock-roundup-vertex-jumps-phase-iii-data-mannkind-scores-fda-approval-analyst", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-up-on-kalydeco-snda-submission-analyst-blog-2014-07-02", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-kalydeco-wins-positive-eu-opinion-analyst-blog-2014-06-30", "https://www.nasdaq.com/articles/sector-update-health-care-2014-06-27", "https://www.nasdaq.com/articles/sector-update-health-care-shares-fairly-flat-pre-market-2014-06-27", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-myl-2014-07-14", "https://www.nasdaq.com/articles/sector-update-healthcare-stocks-drifting-lower-vertex-pharma-falling-despite", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-06-27", "https://www.nasdaq.com/articles/vertex-pharma-skyrockets-on-cystic-fibrosis-drug-trial-results-analyst-blog-2014-06-25", "https://www.nasdaq.com/articles/strength-seen-in-vertex-pharmaceuticals-incorporated-vrtx-as-stock-shoots-40.41-tale-of", "https://www.nasdaq.com/articles/micron-gains-upbeat-earnings-elizabeth-arden-shares-slide-2014-06-24", "https://www.nasdaq.com/articles/sp-500-movers-ice-vrtx-2014-06-24", "https://www.nasdaq.com/articles/nasdaq-100-movers-brcm-vrtx-2014-06-24", "https://www.nasdaq.com/articles/are-biotech-stocks-overdue-summer-pullback-2014-06-27", "https://www.nasdaq.com/articles/seasonally-quiet-period-ahead-wall-street-2014-06-24", "https://www.nasdaq.com/articles/us-stock-futures-mixed-home-prices-miss-expectations-nasdaq-slightly-higher-2014-06-24", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-06-24", "https://www.nasdaq.com/articles/sector-update-shares-steady-pre-market-vertex-surges-53-results-study-cystic-fibrosis-lung", "https://www.nasdaq.com/articles/us-futures-slip-european-stocks-and-ahead-home-price-sales-and-consumer-data-2014-06-24", "https://www.nasdaq.com/articles/pre-market-most-active-jun-24-2014-bsbr-vrtx-mu-rdsa-vod-syt-wag-bbry-xiv-fb-mt-gfi-2014", "https://www.nasdaq.com/articles/tuesdays-etf-movers-fbt-fcg-2014-06-24", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-higher-walgreen-profit-misses-estimates-2014-06", "https://www.nasdaq.com/articles/sector-update-healthcare-stocks-rising-afternoon-vertex-pharmaceuticals-surging-late-stage", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-06-24-1", "https://www.nasdaq.com/articles/nasdaq-100-movers-nvda-tsla-2014-06-23", "https://www.nasdaq.com/articles/dow-30-stock-roundup-intel-ups-q2-guidance-boeing-set-win-china-easterns-74b-order-analyst", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-johnson-johnson-collaborate-on-flu-drug-analyst-blog-2014-06-19", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-crumbles-on-analyst-worries-analyst-blog-2014-06-17", "https://www.nasdaq.com/articles/nasdaq-100-movers-yhoo-tsla-2014-06-16", "https://www.nasdaq.com/articles/utility-sector-rises-elizabeth-arden-shares-slide-over-36-2014-06-24", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-new-kalydeco-data-out-analyst-blog-2014-06-13", "https://www.nasdaq.com/articles/positive-data-on-vertex-pharmas-kalydeco-analyst-blog-2014-06-05", "https://www.nasdaq.com/articles/stock-market-news-for-june-02-2014-market-news-2014-06-02", "https://www.nasdaq.com/articles/nasdaq-100-movers-avgo-tsla-2014-05-30", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-shares-cross-above-200-dma-2014-05-28", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixed-vertex-6-positive-coverage-2014-05-22", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-05-22-0", "https://www.nasdaq.com/articles/sp-500-movers-yhoo-cov-2014-06-16", "https://www.nasdaq.com/articles/nasdaq-100-movers-expe-wynn-2014-05-02", "https://www.nasdaq.com/articles/host-hotels-resorts-now-263-largest-company-surpassing-vertex-pharmaceuticals-2014-05-02", "https://www.nasdaq.com/articles/after-hours-earnings-report-may-1-2014-krft-psa-wynn-lnkd-vrtx-nu-dva-flr-sbac-mhk-akam", "https://www.nasdaq.com/articles/is-actavis-act-poised-to-beat-earnings-estimates-analyst-blog-2014-04-29", "https://www.nasdaq.com/articles/will-forest-labs-frx-keep-its-earnings-streak-alive-analyst-blog-2014-04-28", "https://www.nasdaq.com/articles/progenics-finishes-patient-enrollment-analyst-blog-2014-04-25", "https://www.nasdaq.com/articles/johnson-johnson-boosts-dividend-6.1-analyst-blog-2014-04-25", "https://www.nasdaq.com/articles/vertex-down-on-wider-than-expected-loss-analyst-blog-2014-05-05", "https://www.nasdaq.com/articles/the-medicines-co.s-q1-earnings-surpass-expectations-analyst-blog-2014-04-24", "https://www.nasdaq.com/articles/teradyne-beats-on-q1-earnings-revs-analyst-blog-2014-04-24", "https://www.nasdaq.com/articles/medivation-signs-deal-with-oncofusion-therapeutics-analyst-blog-2014-04-24", "https://www.nasdaq.com/articles/can-microsoft-msft-keep-the-earnings-streak-alive-analyst-blog-2014-04-23", "https://www.nasdaq.com/articles/will-kla-tencor-klac-outperform-earnings-analyst-blog-2014-04-23", "https://www.nasdaq.com/articles/biogens-q1-earnings-soar-y-y-on-tecfidera-sales-analyst-blog-2014-04-23", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-vrtx-sees-hammer-chart-pattern%3A-time-to-buy-tale-of-the-tape-2014", "https://www.nasdaq.com/articles/ibb-celg-vrtx-bmrn-large-inflows-detected-etf-2014-04-24", "https://www.nasdaq.com/articles/biomed-realty-trust-leases-space-life-science-firms-2014-03-19", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-intu-2014-03-07", "https://www.nasdaq.com/articles/sp-500-movers-btu-vfc-2014-03-07", "https://www.nasdaq.com/articles/nasdaq-100-movers-vip-regn-2014-03-03", "https://www.nasdaq.com/articles/vertex-kalydeco-approved-for-an-additional-indication-analyst-blog-2014-02-24", "https://www.nasdaq.com/articles/loss-widens-at-vertex-guidance-disappoints-analyst-blog-2014-01-30", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-29-2014-qcom-fb-lvs-vrtx-symc-avb-mur-ctxs-tsco-slg", "https://www.nasdaq.com/articles/sp-500-analyst-moves-vrtx-2014-04-01", "https://www.nasdaq.com/articles/biomed-realty-trust-leases-space-life-science-firms-2014-03-19", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-intu-2014-03-07", "https://www.nasdaq.com/articles/vertex-monetizes-incivo-royalty-analyst-blog-2013-11-21", "https://www.nasdaq.com/articles/narrower-than-expected-loss-at-achillion-shares-up-analyst-blog-2013-11-18", "https://www.nasdaq.com/articles/vrtx-shares-down-on-q3-results-analyst-blog-2013-11-01", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-29-2013-gild-bidu-afl-lnkd-amp-vrtx-bxp-eix-fisv-rrc", "https://www.nasdaq.com/articles/healthcare-stocks-unable-gain-much-traction-today-vertex-pharma-slips-after-arthritis-drug", "https://www.nasdaq.com/articles/setback-for-vertex-pharma-analyst-blog-2013-12-20", "https://www.nasdaq.com/articles/setback-for-achillion-analyst-blog-2013-09-30", "https://www.nasdaq.com/articles/abbvie-in-another-deal-with-galapagos-analyst-blog-2013-09-25", "https://www.nasdaq.com/articles/after-hours-most-active-sep-20-2013-amd-vrtx-ame-sai-msft-fb-bac-krft-fcx-gm-siri-qcom", "https://www.nasdaq.com/articles/u.s.-patent-allowance-for-biolinerx-bl-8020-analyst-blog-2013-09-19", "https://www.nasdaq.com/articles/bonds-stocks-rally-response-larry-summers-withdrawal-2013-09-16", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-372218-621-points-2013-09-13", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixed-pre-market-bristol-myers-study-yervoy-misses", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-10-21", "https://www.nasdaq.com/articles/after-hours-most-active-aug-16-2013-bac-snv-qqq-qcom-pgr-se-rsg-fe-vrtx-dell-gild-ca-2013", "https://www.nasdaq.com/articles/wider-loss-at-achillion-in-q2-analyst-blog-2013-08-15", "https://www.nasdaq.com/articles/vertex-pharma-posts-in-line-2q-loss-analyst-blog-2013-07-30", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-29-2013-esrx-apc-ggp-vrtx-hig-emn-xl-fmc-agnc-pcl-jec-mas", "https://www.nasdaq.com/articles/partial-clinical-hold-on-vrtx-candidate-shares-down-analyst-blog-2013-07-26", "https://www.nasdaq.com/articles/benzinga-market-primer-friday-july-26-futures-flat-mixed-global-stocks-overnight-2013-07", "https://www.nasdaq.com/articles/zynga-expedia-and-vertex-pharmaceuticals-get-downgraded-2013-07-26", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-09-12-1", "https://www.nasdaq.com/articles/chelseas-nda-for-northera-accepted-analyst-blog-2013-07-19", "https://www.nasdaq.com/articles/setback-for-achillion-analyst-blog-2013-07-03", "https://www.nasdaq.com/articles/another-setback-for-idenix-analyst-blog-2013-06-21", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-346922-4517-points-2013-06-07", "https://www.nasdaq.com/articles/mid-afternoon-market-update-markets-cool-slightly-vertex-rises-2013-06-07", "https://www.nasdaq.com/articles/vertex-loss-lower-kalydeco-outlook-up-analyst-blog-2013-05-01", "https://www.nasdaq.com/articles/benzinga-market-primer-wednesday-may-1-2013-05-01", "https://www.nasdaq.com/articles/pacira-reports-new-data-analyst-blog-2013-07-19", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-30-2013-eqr-vrtx-avb-bxp-fisv-oke-vrsk-auy-fmc-wu-oks", "https://www.nasdaq.com/articles/merck-bmy-in-hcv-deal-analyst-blog-2013-04-23", "https://www.nasdaq.com/articles/fda-approves-novartis-simbrinza-analyst-blog-2013-04-22", "https://www.nasdaq.com/articles/merck-in-licenses-from-xenon-analyst-blog-2013-04-22", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-323355-2749-points-2013-04-22", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mixed-general-electric-q1-profit-surges-16-2013-04-19", "https://www.nasdaq.com/articles/pre-market-most-active-apr-19-2013-dell-ge-vod-qqq-tot-msft-bac-vrtx-sap-nok-bios-deo-2013", "https://www.nasdaq.com/articles/benzinga-market-primer-tuesday-april-30-2013-04-30", "https://www.nasdaq.com/articles/psti-plans-to-start-phase-i-study-analyst-blog-2013-04-19", "https://www.nasdaq.com/articles/bmy-santaris-pharma-team-up-analyst-blog-2013-04-19", "https://www.nasdaq.com/articles/vertex-cf-candidate-impresses-analyst-blog-2013-04-19", "https://www.nasdaq.com/articles/mid-day-market-update-celanese-jumps-upbeat-results-rambus-declines-2013-04-19", "https://www.nasdaq.com/articles/after-hours-most-active-apr-18-2013-qqq-jcp-msft-vrtx-hta-bac-amd-ibm-vmed-mdlz-nok-orcl", "https://www.nasdaq.com/articles/achillions-hcv-candidates-progress-analyst-blog-2013-04-17", "https://www.nasdaq.com/articles/actelion-beats-earnings-sales-rise-analyst-blog-2013-04-16", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-320606-3970-points-2013-04-19", "https://www.nasdaq.com/articles/vertex-bristol-myers-collaborate-for-hcv-analyst-blog-2013-04-08", "https://www.nasdaq.com/articles/label-expansion-for-roches-pegasys-analyst-blog-2013-03-21", "https://www.nasdaq.com/articles/regeneron-pharmaceuticals-inc-regn-todays-most-compelling-buy-2013-03-14", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-324437-1228-points-2013-03-08", "https://www.nasdaq.com/articles/vertex-flu-drug-shows-promise-analyst-blog-2013-03-06", "https://www.nasdaq.com/articles/kalydeco-funding-cleared-in-ireland-analyst-blog-2013-02-06", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-314231-down-1135-points-2013-01-30", "https://www.nasdaq.com/articles/roche-teams-up-with-ascletis-analyst-blog-2013-04-15", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-29-2013-amzn-ace-brcm-bxp-vrtx-rhi-qgen-ajg-jll-fsl", "https://www.nasdaq.com/articles/safest-way-play-biotech-cooks-kitchen-2013-01-25", "https://www.nasdaq.com/articles/vertex-attracts-unusual-time-strategy-2013-01-10", "https://www.nasdaq.com/articles/weekly-guru-bargains-highlights-mbi-vrtx-grpn-pbi-pc-2012-12-16", "https://www.nasdaq.com/articles/canada-approves-vertexs-kalydeco-analyst-blog-2012-12-10", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-283694-down-987-points-2012-11-15", "https://www.nasdaq.com/articles/disappointing-quarter-from-vertex-analyst-blog-2012-11-05", "https://www.nasdaq.com/articles/4q-revenues-decline-at-vertex-analyst-blog-2013-01-30", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-298213-down-3793-points-2012-11-02", "https://www.nasdaq.com/articles/how-one-investor-hedging-vertex-2012-10-09", "https://www.nasdaq.com/articles/trade-gives-vertex-more-room-rally-2012-10-09", "https://www.nasdaq.com/articles/after-hours-most-active-oct-8-2012-qqq-actv-bac-intc-qcom-ew-vrtx-wfc-bsbr-pfe-tlab-exxi", "https://www.nasdaq.com/articles/mixed-results-from-vertex-studies-analyst-blog-2012-09-26", "https://www.nasdaq.com/articles/vertex-misses-cuts-incivek-outlook-analyst-blog-2012-08-01", "https://www.nasdaq.com/articles/eu-approval-for-vertexs-kalydeco-analyst-blog-2012-07-30", "https://www.nasdaq.com/articles/benzinga-mid-morning-market-update-2012-11-02", "https://www.nasdaq.com/articles/pre-market-most-active-jun-28-2012-bac-bcs-jpm-arna-vrtx-nok-orex-c-etp-ebay-fb-qqq-2012", "https://www.nasdaq.com/articles/follow-up-data-on-vertexs-kalydeco-analyst-blog-2012-06-08", "https://www.nasdaq.com/articles/vertex-corrects-earlier-interim-data-analyst-blog-2012-05-30", "https://www.nasdaq.com/articles/chmp-positive-on-vertexs-kalydeco-analyst-blog-2012-05-29", "https://www.nasdaq.com/articles/pre-market-most-active-may-29-2012-vrtx-bac-nok-lcry-fb-gnom-std-bhp-grfs-amrn-bud-c-2012", "https://www.nasdaq.com/articles/weekly-top-insider-sells-gmcr-vrtx-cern-and-agn-2012-05-14", "https://www.nasdaq.com/articles/vertex-pharmas-cf-drug-outperforms-analyst-blog-2012-05-08", "https://www.nasdaq.com/articles/vertex-presents-phase-ii-data-analyst-blog-2012-06-29", "https://www.nasdaq.com/articles/pre-market-most-active-may-7-2012-aig-hmc-vrtx-t-nyb-bac-dpz-siri-eric-qqq-znga-aapl-2012", "https://www.nasdaq.com/articles/western-markets-shake-euro-election-jitters-daily-markets-wrap-2012-05-07", "https://www.nasdaq.com/articles/merck-beats-by-a-penny-affirms-view-analyst-blog-2012-04-27", "https://www.nasdaq.com/articles/vertex-reports-positive-data-on-incivek-analyst-blog-2012-04-20", "https://www.nasdaq.com/articles/vertex-hcv-hiv-treatment-impresses-analyst-blog-2012-03-21", "https://www.nasdaq.com/articles/positive-data-on-vrtx-combo-therapy-analyst-blog-2012-02-29", "https://www.nasdaq.com/articles/3-killer-criteria-for-super-swing-trades-weekend-wisdom-2012-02-17", "https://www.nasdaq.com/articles/dow-endures-198-point-collapse-greece-takes-reins-2012-05-08", "https://www.nasdaq.com/articles/are-portfolio-managers-irrational-cooks-kitchen-2012-02-08", "https://www.nasdaq.com/articles/incivek-catalyst-at-play-for-vertex-analyst-blog-2012-02-03", "https://www.nasdaq.com/articles/company-news-for-february-1-2012-corporate-summary-2012-02-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-bristol-myers-squibb-inhibitex-vertex", "https://www.nasdaq.com/articles/gilead-clinches-pharmasset-buy-analyst-blog-2012-01-19", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-vertex-pharma-human-genome-sciences-biogen-idec-and", "https://www.nasdaq.com/articles/spotlight-hepatitis-c-market-analyst-blog-2011-12-06", "https://www.nasdaq.com/articles/label-update-for-mercks-victrelis-analyst-blog-2012-02-13", "https://www.nasdaq.com/articles/stocks-lower-sessions-half-europe-debt-regains-focus-commodities-lower-2011-10-17", "https://www.nasdaq.com/articles/mid-day-update-stocks-adding-early-losses-europe-manufacturing-data-weigh-2011-10-17", "https://www.nasdaq.com/articles/pfizer-poised-introduce-blockbuster-arthritis-pill-2011-09-11", "https://www.nasdaq.com/articles/healthcare-takeovers-targets-express-scripts-buys-medco-2011-07-22", "https://www.nasdaq.com/articles/cancer-conference-trade-picking-biotech-bargains-2011-07-21", "https://www.nasdaq.com/articles/stocks-follow-global-markets-lower-on-european-debt-worries-2011-05-23", "https://www.nasdaq.com/articles/mid-day-update%3A-stocks-ensconced-in-red-as-european-debt-overhangs-world-markets-2011-05", "https://www.nasdaq.com/articles/biotech-update-pharmassets-hepatitis-c-drug-shows-100-cure-rate-ph2-trial-2011-11-09", "https://www.nasdaq.com/articles/mid-day-update-stocks-mixed-gdp-data-weighs-jobless-claims-rise-2011-04-28", "https://www.nasdaq.com/articles/fda-review-hepatitis-c-medications-week-2011-04-25", "https://www.nasdaq.com/articles/stocks-positive-mid-day-despite-disappointing-consumer-housing-price-data-2011-03-29", "https://www.nasdaq.com/articles/mid-day-update-stocks-higher-investors-shrug-disappointing-consumer-confidence-data-2011", "https://www.nasdaq.com/articles/11-famous-health-care-stocks-sell-2010-07-20", "https://www.nasdaq.com/articles/stocks-mixed-sessions-half-slowing-q1-economy-crude-futures-advance-2011-04-28"], "Content": []}